| 1 | Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. (Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE) Support Care Cancer 2024 Apr 02;32(4):265 |
| 1 | Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance. (Palma FR, Coelho DR, Pulakanti K, Sakiyama MJ, Huang Y, Ogata FT, Danes JM, Meyer A, Furdui CM, Spitz DR, Gomes AP, Gantner BN, Rao S, Backman V, Bonini MG) Cell Rep 2024 Mar 26;43(3):113897 |
| 1 | ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer. (Cortina CS, Rogers CC, Teshome M) Ann Surg Oncol 2024 May;31(5):3196-3197 |
| 3 | Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery? (Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M) Ann Surg Oncol 2024 May;31(5):3128-3140 1 Citation |
| 2 | Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection. (Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN) WMJ 2023 Dec;122(5):418-421 1 Citation |
| 2 | Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature. (Gonzalez T, Nie Q, Chaudhary LN, Basel D, Reddi HV) Cancer Genet 2024 Apr;282-283:1-8 |
| 1 | Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. (Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim JF, Sun Y, Yi M, Rottschaefer A, Pathak R, Nuguri S, Fung KM, Tsaih SW, Chervoneva I, Rui H, Tanaka T) Cell Rep Med 2023 Dec 19;4(12):101330 |
| 1 | A new strategy for the treatment of heavily pretreated metastatic breast cancer: A case report and review of the literature. (Ge TT, Pan XJ, Zuo XM, Shi XG, Wang YK, Sun P, Gao X, Feng X, Gao S, Wang TS) Medicine (Baltimore) 2023 Dec 01;102(48):e36297 |
| 1 | Breast Cancer Screening and Prevention. (Farkas AH, Nattinger AB) Ann Intern Med 2023 Nov;176(11):ITC161-ITC176 2 Citations |
| 1 | "I'm not Alone; He will be There for Me": A Mixed-Method Approach Exploring the Impact of Spousal Support on Mammogram Utilization and Health Beliefs. (Alkhaifi S, Padela AI) J Immigr Minor Health 2024 Apr;26(2):257-267 |
| 4 | National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS) Breast Cancer Res Treat 2024 Jan;203(2):317-328 2 Citations |
| 1 | Impact of state telehealth policies on telehealth use among patients with newly diagnosed cancer. (Yen TWF, Pan IW, Shih YT) JNCI Cancer Spectr 2023 Aug 31;7(5) 1 Citation |
| 4 | Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals. (Cortina CS, Siegel EL, Polovneff A, Sahyouni G, Neuner JM, Petroll AE, Stolley M) Ann Surg Oncol 2023 Nov;30(12):6978-6980 |
| 1 | A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. (Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baert T, Freeman LEB, Becher H, Beckmann MW, Benitez J, Bojesen SE, Brauch H, Brenner H, Brooks-Wilson A, Campa D, Canzian F, Carracedo A, Castelao JE, Chanock SJ, Chenevix-Trench G, CTS Consortium, Cordina-Duverger E, Couch FJ, Cox A, Cross SS, Czene K, Dossus L, Dugué PA, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Fletcher O, Flyger H, Gabrielson M, Gago-Dominguez M, Giles GG, González-Neira A, Grassmann F, Grundy A, Guénel P, Haiman CA, Håkansson N, Hall P, Hamann U, Hankinson SE, Harkness EF, Holleczek B, Hoppe R, Hopper JL, Houlston RS, Howell A, Hunter DJ, Ingvar C, ABCTB Investigators, kConFab Investigators, Isaksson K, Jernström H, John EM, Jones ME, Kaaks R, Keeman R, Kitahara CM, Ko YD, Koutros S, Kurian AW, Lacey JV, Lambrechts D, Larson NL, Larsson S, Le Marchand L, Lejbkowicz F, Li S, Linet M, Lissowska J, Martinez ME, Maurer T, Mulligan AM, Mulot C, Murphy RA, Newman WG, Nielsen SF, Nordestgaard BG, Norman A, O'Brien KM, Olson JE, Patel AV, Prentice R, Rees-Punia E, Rennert G, Rhenius V, Ruddy KJ, Sandler DP, Scott CG, Shah M, Shu XO, Smeets A, Southey MC, Stone J, Tamimi RM, Taylor JA, Teras LR, Tomczyk K, Troester MA, Truong T, Vachon CM, Wang SS, Weinberg CR, Wildiers H, Willett W, Winham SJ, Wolk A, Yang XR, Zamora MP, Zheng W, Ziogas A, Dunning AM, Pharoah PDP, García-Closas M, Schmidt MK, Kraft P, Milne RL, Lindström S, Easton DF, Chang-Claude J) Breast Cancer Res 2023 Aug 09;25(1):93 2 Citations |
| 3 | Isolation and survival: The impact of local and MSA isolation on survival among non-Hispanic Black women diagnosed with breast cancer in the United States using a SEER-Medicare cohort. (Canales B, Laud PW, Tarima S, Zhou Y, Bikomeye JC, McGinley EL, Yen TWF, Bemanian A, Beyer KMM) Health Place 2023 Sep;83:103090 1 Citation |
| 1 | Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study. (Conroy M, Kamaraju S, Powell M, Harris A, Beckius A, Nagavally S, Dawson A, Min H, Wright T, Wainaina N, Binder AF) Clin Breast Cancer 2023 Oct;23(7):e434-e440 |
| 1 | Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data. (Yi M, Zhan T, Peck AR, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Sun Y, Rui H, Chervoneva I) BMC Bioinformatics 2023 Jul 22;24(1):298 |
| 7 | Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Breast Cancer Res Treat 2023 Oct;201(3):387-396 2 Citations |
| 1 | National Trends in "Going Flat" After Mastectomy. (Johnson MK, Cortina CS, Hsu TL, Huang S, Frebault J, Huang CC, Kong AL) Ann Surg Oncol 2023 Oct;30(11):6374-6382 4 Citations |
| 1 | ASO Author Reflections: The Potential Impact of the "Going Flat" Movement on National Rates of Post-Mastectomy Breast Reconstruction. (Johnson MK, Cortina CS, Kong AL) Ann Surg Oncol 2023 Oct;30(11):6383-6384 |
| 1 | ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. (Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, Achatz MI, Ambrosone C, Apostolou P, Arun BK, Auer P, Barnard M, Bertelsen B, Biobank Japan, Blok MJ, Boddicker N, Brunet J, Burnside ES, Calvello M, Campbell I, Chan SH, Chen F, Chiang JB, Coppa A, Cortesi L, Crujeiras-González A, Consortium CZECANCA, De Leeneer K, De Putter R, DePersia A, Devereux L, Domchek S, Efremidis A, Engel C, Ernst C, Evans DGR, Feliubadaló L, Fostira F, Fuentes-Ríos O, Gómez-García EB, González S, Haiman C, Hansen TVO, Hauke J, Hodge J, Hu C, Huang H, Ishak NDB, Iwasaki Y, Konstantopoulou I, Kraft P, Lacey J, Lázaro C, Li N, Lim WK, Lindstrom S, Lori A, Martinez E, Martins A, Matsuda K, Matullo G, McInerny S, Michailidou K, Montagna M, Monteiro ANA, Mori L, Nathanson K, Neuhausen SL, Nevanlinna H, Olson JE, Palmer J, Pasini B, Patel A, Piane M, Poppe B, Radice P, Renieri A, Resta N, Richardson ME, Rosseel T, Ruddy KJ, Santamariña M, Dos Santos ES, Teras L, Toland AE, Trentham-Dietz A, Vachon CM, Volk AE, Weber-Lassalle N, Weitzel JN, Wiesmuller L, Winham S, Yadav S, Yannoukakos D, Yao S, Zampiga V, Zethoven M, Zhang ZW, Zima T, Spurdle AB, Vega A, Rossing M, Del Valle J, De Nicolo A, Hahnen E, Claes KBM, Ngeow J, Momozawa Y, James PA, Couch FJ, Macurek L, Kleibl Z) Clin Cancer Res 2023 Aug 15;29(16):3037-3050 4 Citations |
| 1 | Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. (Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, Marotti JD, Goen AE, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW) Clin Cancer Res 2023 Sep 15;29(18):3717-3728 3 Citations |
| 1 | NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer. (Plasterer C, Semenikhina M, Tsaih SW, Flister MJ, Palygin O) Mol Med 2023 Jul 03;29(1):87 |
| 2 | ASO Author Reflections: Extending Optimal Care for Breast Cancer to the Elderly Population. (Thalji SZ, Cortina CS, Kong AL) Ann Surg Oncol 2023 Oct;30(11):6471-6472 |
| 1 | Surgical Management of Breast Amyloidosis. (Bacos JT, Doren E, D'Souza A, Jorns J, Kong A) Clin Breast Cancer 2023 Aug;23(6):e359-e367 |
| 2 | Applications of Viscoelastic Testing in Breast Cancer Patients: A Systematic Review Focusing on Hypercoagulability and Free Flap Thrombosis. (Pamulapati S, Conroy M, Madireddy S, Kamaraju S, Cortina C, Moore H, Hartmann J) Semin Thromb Hemost 2024 Apr;50(3):413-422 1 Citation |
| 3 | Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies. (Cheng G, Karoui H, Hardy M, Kalyanaraman B) Free Radic Biol Med 2023 Aug 20;205:175-187 1 Citation |
| 2 | Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer. (Thalji SZ, Cortina CS, Frebault J, Cho Y, Thorgerson A, Bergom CR, Huang CC, Kong AL) Ann Surg Oncol 2023 Oct;30(11):6462-6470 1 Citation |
| 1 | Evaluating Nurses' Time to Response by Severity and Cancer Stage in a Remote Symptom Monitoring Program for Patients With Breast Cancer. (Caston NE, Franks JA, Balas N, Eltoum N, Thigpen H, Patterson M, Azuero A, Ojesina AI, Dent DN, Hildreth K, Lalor FR, McGowen C, Huang CS, Dionne-Odom JN, Weiner BJ, Jackson BE, Basch EM, Stover AM, Howell D, Pierce JY, Rocque GB) JCO Clin Cancer Inform 2023 Jun;7:e2300015 1 Citation |
| 1 | Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. (Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW) Clin Cancer Res 2023 Aug 01;29(15):2767-2773 2 Citations |
| 1 | Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study. (Rentscher KE, Bethea TN, Zhai W, Small BJ, Zhou X, Ahles TA, Ahn J, Breen EC, Cohen HJ, Extermann M, Graham DMA, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Root JC, Saykin AJ, Van Dyk K, Mandelblatt JS, Carroll JE) Cancer 2023 Sep 01;129(17):2741-2753 5 Citations |
| 2 | Invited Commentary: Does Time Heal All Wounds after Complication from Postmastectomy Breast Reconstruction? (Rodriguez-Unda N, Cortina CS) J Am Coll Surg 2023 Aug 01;237(2):330-331 |
| 2 | Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics. (Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, Ng CCY, Liu W, Lee JY, Lim AH, Guan P, Teh BT, Tan PH) Histopathology 2023 Sep;83(3):357-365 |
| 1 | Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. (Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim HSL, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Carroll JE) Cancer 2023 Aug 01;129(15):2409-2421 |
| 1 | Quantile Index Biomarkers Based on Single-Cell Expression Data. (Yi M, Zhan T, Peck AR, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Sun Y, Rui H, Chervoneva I) Lab Invest 2023 Aug;103(8):100158 |
| 1 | Current Trends in the Utilization of Preoperative Breast Magnetic Resonance Imaging Among Women With Newly Diagnosed Breast Cancer. (Pan IW, Yen TWF, Bedrosian I, Shih YT) JCO Oncol Pract 2023 Jul;19(7):446-455 |
| 3 | Invited Commentary: Current and Future Opportunities in Mitigating Breast Cancer Disparity. (Cortina CS, Cobb AN, Kong AL) J Am Coll Surg 2023 Jun 01;236(6):1239-1241 |
| 1 | Breast cancer screening among immigrant Muslim arab women in the United States: Analyzing relationships between beliefs, knowledge, spousal support and mammogram utilization. (Alkhaifi S, Padela AI, Hodge F, Brecht ML) J Natl Med Assoc 2023 Jun;115(3):302-313 |
| 1 | Breast sensorisexual function: a novel patient-reported outcome measure of sexual sensory functions of the breast. (Abramsohn EM, Pinkerton EA, Wroblewski K, Anitescu M, Flynn KE, Hazen A, Schumm P, Lindau ST) J Sex Med 2023 Apr 27;20(5):671-683 1 Citation |
| 3 | Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy. (Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS) JCO Oncol Pract 2023 May;19(5):e794-e800 6 Citations |
| 1 | Access to Radiation Therapy and Related Clinical Outcomes in Patients With Cervical and Breast Cancer Across Sub-Saharan Africa: A Systematic Review. (Beltrán Ponce SE, Abunike SA, Bikomeye JC, Sieracki R, Niyonzima N, Mulamira P, Kibudde S, Ortiz de Choudens S, Siker M, Small C, Beyer KMM) JCO Glob Oncol 2023 Feb;9:e2200218 5 Citations |
| 4 | Historical redlining and breast cancer treatment and survival among older women in the United States. (Bikomeye JC, Zhou Y, McGinley EL, Canales B, Yen TWF, Tarima S, Ponce SB, Beyer KMM) J Natl Cancer Inst 2023 Jun 08;115(6):652-661 7 Citations |
| 2 | Worsening Rash in a Patient With Metastatic Breast Cancer. (Pierro MJ, Zhang AJ, Chaudhary LN) JAMA Oncol 2023 Apr 01;9(4):564-565 |
| 1 | Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry. (Robbins CJ, Fernandez AI, Han G, Wong S, Harigopal M, Podoll M, Singh K, Ly A, Kuba MG, Wen H, Sanders MA, Brock J, Wei S, Fadare O, Hanley K, Jorns J, Snir OL, Yoon E, Rabe K, Soong TR, Reisenbichler ES, Rimm DL) Mod Pathol 2023 Jan;36(1):100032 18 Citations |
| 2 | Racial disparities in postmastectomy breast reconstruction following implementation of the affordable care act: A systematic review using a minority health and disparities research framework. (Doren EL, Park K, Olson J) Am J Surg 2023 Jul;226(1):37-47 2 Citations |
| 1 | Using the tools we have to improve perioperative outcomes for mastectomy patients with severe persistent mental illness. (Cortina CS, Kong AL) Am J Surg 2023 Jul;226(1):2-3 1 Citation |
| 1 | Assessing Breast and Ovarian Cancer Risk Prior to Gender-Affirming Surgery. (Cortina CS) JAMA Surg 2023 Apr 01;158(4):339-340 4 Citations |
| 1 | Alpelisib Efficacy without Cherry-PI3King Mutations. (Tau S, Miller TW) Clin Cancer Res 2023 Mar 14;29(6):989-990 |
| 3 | Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer. (Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE) J Clin Oncol 2023 Apr 10;41(11):2067-2075 1 Citation |
| 1 | Electronic Medical Record-Based Electronic Messaging Among Patients with Breast Cancer: A Systematic Review. (Conroy M, Powell M, Suelzer E, Pamulapati S, Min H, Wright T, Kamaraju S) Appl Clin Inform 2023 Jan;14(1):134-143 4 Citations |
| 1 | Longitudinal Sedentary Time and Symptoms in Breast Cancer Patients during Chemotherapy Using Ecological Momentary Assessment. (Welch WA, Solk P, Auster-Gussman L, Whitaker M, Siddique J, Fanning J, Mishory A, Khan S, Santa-Maria C, Kulkarni S, Phillips SM) Med Sci Sports Exerc 2023 May 01;55(5):966-974 1 Citation |
| 1 | Exploring the relationship between DNA methylation age measures and psychoneurological symptoms in women with early-stage breast cancer. (Yang GS, Yang K, Weaver MT, Lynch Kelly D, Dorsey SG, Jackson-Cook CK, Lyon DE) Support Care Cancer 2022 Dec 20;31(1):65 |
| 1 | Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis. (Chen Z, Gong X, Cheng C, Fu Y, Wu W, Luo Z) Clin Breast Cancer 2023 Feb;23(2):143-154 3 Citations |
| 2 | Postoperative Complications from Breast and Axillary Surgery. (Thalji SZ, Cortina CS, Guo MS, Kong AL) Surg Clin North Am 2023 Feb;103(1):121-139 3 Citations |
| 3 | Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer. (Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN) Breast Cancer Res Treat 2023 Jan;197(1):223-233 3 Citations |
| 2 | Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens. (Gellings JA, Cortina CS, Jorns JM, Johnson MK, Huang CC, Kong AL) Am J Surg 2023 Feb;225(2):304-308 |
| 2 | Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma. (Moreno GA, Molina MI, Eastwood D, Auer PL, Jorns JM) Breast Cancer Res Treat 2022 Dec;196(3):453-461 |
| 1 | Consensus Quality Measures and Dose Constraints for Breast Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. (Puckett LL, Kodali D, Solanki AA, Park JH, Katsoulakis E, Kudner R, Kapoor R, Kujundzic K, Chapman CH, Hagan M, Kelly M, Palta J, Bazan JG, Dragun A, Fisher C, Haffty B, Nichols E, Shah C, Salehpour M, Dawes S, Wilson E, Buchholz TA) Pract Radiat Oncol 2023;13(3):217-230 1 Citation |
| 1 | Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study. (Van Dyk K, Ahn J, Zhou X, Zhai W, Ahles TA, Bethea TN, Carroll JE, Cohen HJ, Dilawari AA, Graham D, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Saykin AJ, Small BJ, Mandelblatt JS, Root JC) J Geriatr Oncol 2022 Nov;13(8):1132-1140 1 Citation |
| 1 | ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved. (Cobb AN, Sun SX) Ann Surg Oncol 2022 Oct;29(10):6393-6394 |
| 1 | A Statewide Approach to Reducing Re-excision Rates for Women With Breast-conserving Surgery. (Schumacher JR, Lawson EH, Kong AL, Weber JJ, May J, Landercasper J, Hanlon B, Marka N, Venkatesh M, Cartmill RS, Pavuluri Quamme S, Nikolay C, Greenberg CC) Ann Surg 2022 Oct 01;276(4):665-672 1 Citation |
| 1 | No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity. (Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C, Tyrer J, Coles CE, Haviland JS, Parker C, Gómez-Caamaño A, Calvo-Crespo P, Sosa-Fajardo P, Burnet NG, Summersgill H, Webb A, De Ruysscher D, Seibold P, Chang-Claude J, Talbot CJ, Rattay T, Parliament M, De Ruyck K, Rosenstein BS, Pharoah PDP, Dunning AM, Vega A, West CML, RGC and REQUITE Consortia) Int J Radiat Oncol Biol Phys 2022 Nov 01;114(3):494-501 2 Citations |
| 1 | Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. (Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX) Ann Surg Oncol 2022 Oct;29(10):6381-6392 2 Citations |
| 3 | ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology. (Martinez EO, Jorns JM, Kong AL, Cortina CS) Ann Surg Oncol 2022 Oct;29(10):6347-6348 1 Citation |
| 3 | Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database. (Martinez EO, Jorns JM, Kong AL, Kijak J, Lee WY, Huang CC, Cortina CS) Ann Surg Oncol 2022 Oct;29(10):6339-6346 7 Citations |
| 3 | Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database. (Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang CC, Kong AL) Clin Breast Cancer 2022 Aug;22(6):547-552 1 Citation |
| 1 | Latent Class Models of Early-life Trauma and Incident Breast Cancer. (Woo JMP, Simanek A, O'Brien KM, Parks C, Gaston S, Auer PL, Konkel RH, Jackson CL, Meier HCS, Sandler DP) Epidemiology 2022 Sep 01;33(5):729-738 2 Citations |
| 1 | Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer. (Coleman IM, DeSarkar N, Morrissey C, Xin L, Roudier MP, Sayar E, Li D, Corey E, Haffner MC, Nelson PS) Clin Cancer Res 2022 Jul 15;28(14):3127-3140 12 Citations |
| 1 | Pathophysiological role of NNAT in ER+ breast cancer. (Semenikhina M, Plasterer C, Tsaih SW, Flister M, Palygin O) FASEB J 2022 May;36 Suppl 1 |
| 2 | Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner. (Wu J, Liu X, Reeser JAW, Trimboli AJ, Pécot T, Sizemore GM, Naidu SK, Fernandez SA, Yu L, Hallett M, Park M, Leone GW, Hildreth BE, Ostrowski MC) Mol Cancer Res 2022 Aug 05;20(8):1233-1246 5 Citations |
| 1 | Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. (Song Y, Bugada L, Li R, Hu H, Zhang L, Li C, Yuan H, Rajanayake KK, Truchan NA, Wen F, Gao W, Sun D) Sci Transl Med 2022 May 04;14(643):eabl3649 36 Citations |
| 1 | Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy. (Whitaker M, Welch WA, Fanning J, Santa-Maria CA, Auster-Gussman LA, Solk P, Khan SA, Kulkarni SA, Gradishar W, Siddique J, Phillips SM) Support Care Cancer 2022 Aug;30(8):6613-6622 2 Citations |
| 1 | Origin, activation and heterogeneity of fibroblasts associated with pancreas and breast cancers. (Han L, Seward C, Leone G, Ostrowski MC) Adv Cancer Res 2022;154:169-201 |
| 1 | Does Angiosarcoma of the Breast Need Nodal Staging? (Herb J, Maduekwe UN, Goel N, Rosenberger LH, Spanheimer PM) J Am Coll Surg 2022 May 01;234(5):774-782 1 Citation |
| 1 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. (Wang X, Kapoor PM, Auer PL, Dennis J, Dunning AM, Wang Q, Lush M, Michailidou K, Bolla MK, Aronson KJ, Murphy RA, Brooks-Wilson A, Lee DG, Cordina-Duverger E, Guénel P, Truong T, Mulot C, Teras LR, Patel AV, Dossus L, Kaaks R, Hoppe R, Lo WY, Brüning T, Hamann U, Czene K, Gabrielson M, Hall P, Eriksson M, Jung A, Becher H, Couch FJ, Larson NL, Olson JE, Ruddy KJ, Giles GG, MacInnis RJ, Southey MC, Le Marchand L, Wilkens LR, Haiman CA, Olsson H, Augustinsson A, Krüger U, Wagner P, Scott C, Winham SJ, Vachon CM, Perou CM, Olshan AF, Troester MA, Hunter DJ, Eliassen HA, Tamimi RM, Brantley K, Andrulis IL, Figueroa J, Chanock SJ, Ahearn TU, García-Closas M, Evans GD, Newman WG, van Veen EM, Howell A, Wolk A, Håkansson N, Anton-Culver H, Ziogas A, Jones ME, Orr N, Schoemaker MJ, Swerdlow AJ, Kitahara CM, Linet M, Prentice RL, Easton DF, Milne RL, Kraft P, Chang-Claude J, Lindström S) Sci Rep 2022 Apr 13;12(1):6199 2 Citations |
| 1 | Exploratory Analysis of Associations Between Whole Blood Mitochondrial Gene Expression and Cancer-Related Fatigue Among Breast Cancer Survivors. (Kleckner AS, Kleckner IR, Culakova E, Wojtovich AP, Klinedinst NJ, Kerns SL, Hardy SJ, Inglis JE, Padula GDA, Mustian KM, Janelsins MC, Dorsey SG, Saligan LN, Peppone LJ) Nurs Res 2022 Sep-Oct 01;71(5):411-417 2 Citations |
| 3 | Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. (Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE) J Am Pharm Assoc (2003) 2022;62(4):1321-1328.e3 3 Citations |
| 1 | Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study. (Bethea TN, Zhai W, Zhou X, Ahles TA, Ahn J, Cohen HJ, Dilawari AA, Graham DMA, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Root J, Saykin AJ, Small BJ, Van Dyk KM, Mandelblatt JS, Carroll JE) Cancer Med 2022 Sep;11(17):3352-3363 7 Citations |
| 1 | Providing High-Quality Surgical Care for Mastectomy Patients. (Cortina CS) J Am Coll Surg 2022 Jan 01;234(1):23-24 |
| 4 | Enhancing foci on breast MRI: Identifying criteria that increase levels of suspicion. (Cherian S, Vagvala S, Majidi SS, Deitch SG, Dykstra DS, Sullivan JR, Field LR, Wadhwa A) Clin Imaging 2022 Apr;84:104-109 1 Citation |
| 1 | Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer. (Cobb AN, Adesoye T, Teshome M) Ann Surg Oncol 2022 May;29(5):2756-2758 |
| 1 | Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue. (Fernandez AI, Liu M, Bellizzi A, Brock J, Fadare O, Hanley K, Harigopal M, Jorns JM, Kuba MG, Ly A, Podoll M, Rabe K, Sanders MA, Singh K, Snir OL, Soong TR, Wei S, Wen H, Wong S, Yoon E, Pusztai L, Reisenbichler E, Rimm DL) JAMA Oncol 2022 Apr 01;8(4):1-4 150 Citations |
| 2 | Keratin 7 and ERBB2 Negative Mammary Paget Disease Without an Underlying in Situ and Invasive Carcinoma. (Ratiani M, Farooq A, Jorns J, Sheinin Y) Int J Surg Pathol 2022 Aug;30(5):590-592 1 Citation |
| 1 | Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine. (Charo LM, Eskander RN, Sicklick J, Kim KH, Lim HJ, Okamura R, Lee S, Subramanian R, Schwab R, Shatsky R, Plaxe S, Kato S, Kurzrock R) JCO Precis Oncol 2022 Jan;6:e2000508 8 Citations |
| 1 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes. (Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baten A, Becher H, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Clarke CL, NBCS Collaborators, Collée JM, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dwek M, Eccles DM, Evans DG, Fasching PA, Figueroa J, Floris G, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Giles GG, Goldberg MS, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haiman CA, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, ABCTB Investigators, kConFab/AOCS Investigators, Jakimovska M, Jakubowska A, John EM, Jones ME, Jung A, Kaaks R, Kauppila S, Keeman R, Khusnutdinova E, Kitahara CM, Ko YD, Koutros S, Kristensen VN, Krüger U, Kubelka-Sabit K, Kurian AW, Kyriacou K, Lambrechts D, Lee DG, Lindblom A, Linet M, Lissowska J, Llaneza A, Lo WY, MacInnis RJ, Mannermaa A, Manoochehri M, Margolin S, Martinez ME, McLean C, Meindl A, Menon U, Nevanlinna H, Newman WG, Nodora J, Offit K, Olsson H, Orr N, Park-Simon TW, Patel AV, Peto J, Pita G, Plaseska-Karanfilska D, Prentice R, Punie K, Pylkäs K, Radice P, Rennert G, Romero A, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Schmutzler RK, Schoemaker MJ, Schöttker B, Sherman ME, Shu XO, Smichkoska S, Southey MC, Spinelli JJ, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Teras LR, Terry MB, Torres D, Troester MA, Vachon CM, van Deurzen CHM, van Veen EM, Wagner P, Weinberg CR, Wendt C, Wesseling J, Winqvist R, Wolk A, Yang XR, Zheng W, Couch FJ, Simard J, Kraft P, Easton DF, Pharoah PDP, Schmidt MK, García-Closas M, Chatterjee N) Breast Cancer Res 2022 Jan 04;24(1):2 11 Citations |
| 1 | Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields. (Lee W, Law T, Lu Y, Lee TK, Ibarra JA) Pathology 2022 Feb;54(1):43-48 |
| 1 | Management of Postsurgical Pyoderma Gangrenosum Following Deep Inferior Epigastric Perforator Flap Breast Reconstruction: A Role for a Dermal Regeneration Template. (Ramamurthi A, Adamson KA, Yang KJ, Sanger J, Ling-LeBlanc JP, Wilson B, LoGiudice JA) Wounds 2021 Nov;33(11):E67-E74 2 Citations |
| 2 | Breast cancer-related lymphedema rates after modern axillary treatments: How accurate are our estimates? (Cortina CS, Yen TWF, Bergom C, Fields B, Craft MA, Currey A, Kong AL) Surgery 2022 Mar;171(3):682-686 4 Citations |
| 1 | A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). (Adams S, Othus M, Patel SP, Miller KD, Chugh R, Schuetze SM, Chamberlin MD, Haley BJ, Storniolo AMV, Reddy MP, Anderson SA, Zimmerman CT, O'Dea AP, Mirshahidi HR, Ahnert JR, Brescia FJ, Hahn O, Raymond JM, Biggs DD, Connolly RM, Sharon E, Korde LA, Gray RJ, Mayerson E, Plets M, Blanke CD, Chae YK, Kurzrock R) Clin Cancer Res 2022 Jan 15;28(2):271-278 45 Citations |
| 1 | Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. (Yadav S, Hu C, Nathanson KL, Weitzel JN, Goldgar DE, Kraft P, Gnanaolivu RD, Na J, Huang H, Boddicker NJ, Larson N, Gao C, Yao S, Weinberg C, Vachon CM, Trentham-Dietz A, Taylor JA, Sandler DR, Patel A, Palmer JR, Olson JE, Neuhausen S, Martinez E, Lindstrom S, Lacey JV, Kurian AW, John EM, Haiman C, Bernstein L, Auer PW, Anton-Culver H, Ambrosone CB, Karam R, Chao E, Yussuf A, Pesaran T, Dolinsky JS, Hart SN, LaDuca H, Polley EC, Domchek SM, Couch FJ) J Clin Oncol 2021 Dec 10;39(35):3918-3926 19 Citations |
| 2 | Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination. (Auster-Gussman LA, Gavin KL, Siddique J, Welch WA, Solk P, Whitaker M, Cullather E, Fanning J, Maria CS, Gradishar W, Khan S, Kulkarni S, Phillips SM) Psychooncology 2022 Mar;31(3):425-435 6 Citations |
| 1 | Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance. (Li J, Fang K, Choppavarapu L, Yang K, Yang Y, Wang J, Cao R, Jatoi I, Jin VX) Clin Epigenetics 2021 Sep 17;13(1):175 8 Citations |
| 1 | Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors. (Dilawari A, Rentscher KE, Zhai W, Zhou X, Ahles TA, Ahn J, Bethea TN, Carroll JE, Cohen HJ, Graham DA, Jim HSL, McDonald B, Nakamura ZM, Patel SK, Root JC, Small BJ, Saykin AJ, Tometich D, Van Dyk K, Mandelblatt JS, Thinking and Living with Cancer Study) Breast Cancer Res Treat 2021 Nov;190(2):287-293 8 Citations |
| 1 | Impact of Hepatic Metastasectomy in the Multimodal Treatment of Metastatic Breast Cancer. (Ellis OV, Hornock SL, Bohan PMK, Dilday JC, Chang SC, Bader JO, Vreeland TJ, Nelson DW) J Surg Res 2021 Dec;268:650-659 3 Citations |
| 1 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. (Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Cheng TD, Clarke CL, NBCS Collaborators, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Dörk T, Dossus L, Dunning AM, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Flyger H, Fritschi L, Gago-Dominguez M, García-Sáenz JA, Giles GG, Grip M, Guénel P, Gündert M, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hart SN, Hartikainen JM, Hartmann A, He W, Hooning MJ, Hoppe R, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators, kConFab Investigators, Jager A, Jakubowska A, Janni W, John EM, Jung AY, Kaaks R, Keupers M, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kurian AW, Lacey JV, Lambrechts D, Le Marchand L, Lindblom A, Linet M, Luben RN, Lubiński J, Lush M, Mannermaa A, Manoochehri M, Margolin S, Martens JWM, Martinez ME, Mavroudis D, Michailidou K, Milne RL, Mulligan AM, Muranen TA, Nevanlinna H, Newman WG, Nielsen SF, Nordestgaard BG, Olshan AF, Olsson H, Orr N, Park-Simon TW, Patel AV, Peissel B, Peterlongo P, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Rack B, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Ruebner M, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Scott C, Shah M, Smichkoska S, Southey MC, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teras LR, Terry MB, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Vachon CM, Wang Q, Hurson AN, Winqvist R, Wolk A, Ziogas A, Brauch H, García-Closas M, Pharoah PDP, Easton DF, Chenevix-Trench G, Schmidt MK) Breast Cancer Res 2021 Aug 18;23(1):86 3 Citations |
| 2 | User-centered development of a smartphone application (Fit2Thrive) to promote physical activity in breast cancer survivors. (Welch WA, Solk P, Auster-Gussman L, Gavin KL, Whitaker M, Cullather E, Izenman E, Courneya KS, Ackermann R, Spring B, Cella D, Penedo F, Phillips SM) Transl Behav Med 2022 Feb 16;12(2):203-213 5 Citations |
| 2 | Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. (Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang CC, Kong AL) Clin Breast Cancer 2022 Jan;22(1):49-59 8 Citations |
| 1 | Prevalence and predictors of peripheral neuropathy after breast cancer treatment. (Kamgar M, Greenwald MK, Assad H, Hastert TA, McLaughlin EM, Reding KW, Paskett ED, Bea JW, Shadyab AH, Neuhouser ML, Nassir R, Crane TE, Sreeram K, Simon MS) Cancer Med 2021 Oct;10(19):6666-6676 15 Citations |
| 2 | ASO Author Reflections: The Evolving Multidisciplinary Management of the Axilla in Mastectomy Patients. (Cortina CS, Kong AL) Ann Surg Oncol 2022 Jun;29(6):3853-3854 1 Citation |
| 3 | Pharmacy deserts and patients with breast cancer receipt of influenza vaccines. (Neuner JM, Zhou Y, Fergestrom N, Winn A, Pezzin L, Laud PW, Beyer K) J Am Pharm Assoc (2003) 2021;61(6):e25-e31 3 Citations |
| 2 | AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism. (Palma FR, Ratti BA, Paviani V, Coelho DR, Miguel R, Danes JM, Zaichik SV, de Abreu AL, Silva SO, Chen Y, Silverstein RL, Karan U, Jones DP, Bonini MG) Oncogene 2021 Sep;40(36):5455-5467 12 Citations |
| 1 | Risk of Late-Onset Breast Cancer in Genetically Predisposed Women. (Boddicker NJ, Hu C, Weitzel JN, Kraft P, Nathanson KL, Goldgar DE, Na J, Huang H, Gnanaolivu RD, Larson N, Yussuf A, Yao S, Vachon CM, Trentham-Dietz A, Teras L, Taylor JA, Scott CE, Sandler DP, Pesaran T, Patel AV, Palmer JR, Ong IM, Olson JE, O'Brien K, Neuhausen S, Martinez E, Ma H, Lindstrom S, Le Marchand L, Kooperberg C, Karam R, Hunter DJ, Hodge JM, Haiman C, Gaudet MM, Gao C, LaDuca H, Lacey JV, Dolinsky JS, Chao E, Carter BD, Burnside ES, Bertrand KA, Bernstein L, Auer PW, Ambrosone C, Yadav S, Hart SN, Polley EC, Domchek SM, Couch FJ) J Clin Oncol 2021 Nov 01;39(31):3430-3440 17 Citations |
| 2 | A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients. (Cortina CS, Bergom C, Craft MA, Fields B, Brazauskas R, Currey A, Kong AL) Ann Surg Oncol 2021 Oct;28(10):5568-5579 11 Citations |
| 1 | Learning from and Leveraging Multi-Level Changes in Responses to the COVID 19 Pandemic to Facilitate Breast Cancer Prevention Efforts. (Bowen DJ, Rentscher KE, Wu A, Darien G, Haile HG, Mandelblatt J, Kavanaugh-Lynch M) Int J Environ Res Public Health 2021 Jun 30;18(13) 4 Citations |
| 1 | Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent. (Behring M, Ye Y, Elkholy A, Bajpai P, Agarwal S, Kim HG, Ojesina AI, Wiener HW, Manne U, Shrestha S, Vazquez AI) Cancer Med 2021 Aug;10(16):5712-5720 4 Citations |
| 1 | How Do Pathologists in Academic Institutions Across the United States and Canada Evaluate Sentinel Lymph Nodes in Breast Cancer? A Practice Survey. (Asirvatham JR, Jorns JM) Am J Clin Pathol 2021 Nov 08;156(6):980-988 4 Citations |
| 1 | Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls. (Rentscher KE, Zhou X, Small BJ, Cohen HJ, Dilawari AA, Patel SK, Bethea TN, Van Dyk KM, Nakamura ZM, Ahn J, Zhai W, Ahles TA, Jim HSL, McDonald BC, Saykin AJ, Root JC, Graham DMA, Carroll JE, Mandelblatt JS) Cancer 2021 Oct 01;127(19):3671-3679 44 Citations |
| 1 | A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores. (Fujii T, Masuda H, Cheng YC, Yang F, Sahin AA, Naoi Y, Matsunaga Y, Raghavendra A, Sinha AK, Fernandez JRE, James A, Yamagishi K, Matsushima T, Schuetz R, Tripathy D, Tada S, Jackson RS, Noguchi S, Nakamura S, Acoba JD, Ueno NT) Breast Cancer Res Treat 2021 Sep;189(2):455-461 6 Citations |
| 5 | Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States. (Beyer KMM, Zhou Y, Laud PW, McGinley EL, Yen TWF, Jankowski C, Rademacher N, Namin S, Kwarteng J, Beltrán Ponce S, Nattinger AB) J Clin Oncol 2021 Sep 01;39(25):2749-2757 31 Citations |
| 1 | Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score. (Gao C, Polley EC, Hart SN, Huang H, Hu C, Gnanaolivu R, Lilyquist J, Boddicker NJ, Na J, Ambrosone CB, Auer PL, Bernstein L, Burnside ES, Eliassen AH, Gaudet MM, Haiman C, Hunter DJ, Jacobs EJ, John EM, Lindström S, Ma H, Neuhausen SL, Newcomb PA, O'Brien KM, Olson JE, Ong IM, Patel AV, Palmer JR, Sandler DP, Tamimi R, Taylor JA, Teras LR, Trentham-Dietz A, Vachon CM, Weinberg CR, Yao S, Weitzel JN, Goldgar DE, Domchek SM, Nathanson KL, Couch FJ, Kraft P) J Clin Oncol 2021 Aug 10;39(23):2564-2573 38 Citations |
| 1 | Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care. (Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL) Ann Surg Oncol 2022 Apr;29(4):2176-2180 28 Citations |
| 1 | Incidence and Treatment Efficacy of Trigger Finger in the Breast Cancer Population on Aromatase Inhibitors. (Regent-Smith AJ, Childers EJ, Dzwierzynski WW, Morgan AL) Hand (N Y) 2023 Mar;18(2):250-253 1 Citation |
| 2 | Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation. (Moreno G, Molina M, Wu R, Sullivan JR, Jorns JM) Breast Cancer Res Treat 2021 Jun;187(3):673-680 3 Citations |
| 1 | Sudden Paralysis in a 39-Year-Old Woman With Metastatic Breast Cancer. (Griffiths C, Connelly J, Chaudhary LN) JAMA Oncol 2021 Aug 01;7(8):1239-1240 1 Citation |
| 1 | HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update. (Wang L, Asirvatham JR, Ma Y, Reisenbichler ES, Jorns JM) Breast J 2021 Aug;27(8):631-637 4 Citations |
| 3 | The association of stressful life events on weight loss efforts among African American breast cancer survivors. (Kwarteng JL, Matthews L, Banerjee A, Sharp LK, Gerber BS, Stolley MR) J Cancer Surviv 2022 Jun;16(3):604-613 2 Citations |
| 2 | Patient-Physician Concordance for Quantitative Formats and Treatment Options and the Relationship with State Anxiety. (Smallwood AJ, Neuner JM, Fletcher KE, Walker CM, Schapira MM) J Cancer Educ 2022 Dec;37(6):1684-1690 |
| 1 | Clinical course of venous thromboembolism following abdominally based microsurgical breast reconstruction: A case series. (Zarb RM, Ramamurthi A, Doren EL, LoGiudice JA, Hijjawi JB, Adamson KA) J Plast Reconstr Aesthet Surg 2021 Oct;74(10):2550-2556 4 Citations |
| 1 | Postmastectomy breast reconstruction in women aged 70 and older: An analysis of the National Cancer Database (NCDB). (Cortina CS, Bergom CR, Kijack J, Thorgerson AA, Huang CS, Kong AL) Surgery 2021 Jul;170(1):30-38 6 Citations |
| 1 | High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer. (Traphagen NA, Hosford SR, Jiang A, Marotti JD, Brauer BL, Demidenko E, Miller TW) Oncogene 2021 May;40(19):3408-3421 11 Citations |
| 1 | Management of Pediatric Breast Masses: A Multi-institutional Retrospective Cohort Study. (Lawrence AE, Saito J, Onwuka A, Port E, Bowder A, Courtney C, Deans KJ, Downard CD, Duran YK, Fallat ME, Fraser JD, Gadepalli S, Kabre R, Kalbfell EL, Knaus ME, Kohler J, Lal D, Landman MP, Leys CM, Lu P, Mak GZ, Markel T, Merchant N, Nguyen T, Pilkington M, Rymeski B, Sato TT, St Peter SD, Wright T, Minneci PC, Grabowski JE) J Surg Res 2021 Aug;264:309-315 3 Citations |
| 2 | Comment on "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy". (Cortina CS, Kong AL) Ann Surg Oncol 2021 Dec;28(Suppl 3):772-773 3 Citations |
| 2 | Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast. (Mehdi M, Kong AL, Frebault J, Huang S, Huang CC, Cortina CS) J Surg Res 2021 Aug;264:138-148 5 Citations |
| 1 | Clinical and Psychosocial Challenges of Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years. (Chaudhary LN) JCO Oncol Pract 2021 Jun;17(6):317-319 2 Citations |
| 4 | Every Day Counts: a randomized pilot lifestyle intervention for women with metastatic breast cancer. (Sheean P, Matthews L, Visotcky A, Banerjee A, Moosreiner A, Kelley K, Chitambar CR, Papanek PE, Stolley M) Breast Cancer Res Treat 2021 Jun;187(3):729-741 12 Citations |
| 3 | Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. (Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C) Endocrinology 2021 Aug 01;162(8) 7 Citations |
| 1 | Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant. (Schwartz G, Shee K, Romo B, Marotti J, Kisselev A, Lewis L, Miller T) Oncologist 2021 Jun;26(6):467-e924 4 Citations |
| 1 | A Population-Based Study of Genes Previously Implicated in Breast Cancer. (Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, Gao C, Lilyquist J, Yadav S, Boddicker NJ, Samara R, Klebba J, Ambrosone CB, Anton-Culver H, Auer P, Bandera EV, Bernstein L, Bertrand KA, Burnside ES, Carter BD, Eliassen H, Gapstur SM, Gaudet M, Haiman C, Hodge JM, Hunter DJ, Jacobs EJ, John EM, Kooperberg C, Kurian AW, Le Marchand L, Lindstroem S, Lindstrom T, Ma H, Neuhausen S, Newcomb PA, O'Brien KM, Olson JE, Ong IM, Pal T, Palmer JR, Patel AV, Reid S, Rosenberg L, Sandler DP, Scott C, Tamimi R, Taylor JA, Trentham-Dietz A, Vachon CM, Weinberg C, Yao S, Ziogas A, Weitzel JN, Goldgar DE, Domchek SM, Nathanson KL, Kraft P, Polley EC, Couch FJ) N Engl J Med 2021 Feb 04;384(5):440-451 375 Citations |
| 1 | Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch. (Yuan B, Clark CA, Wu B, Yang J, Drerup JM, Li T, Jin VX, Hu Y, Curiel TJ, Li R) J Immunother Cancer 2021 Jan;9(1) 15 Citations |
| 2 | The consideration for outpatient mastectomy during the COVID-19 global pandemic. (Cortina CS, Ward EP, Kong AL) Am J Surg 2021 Aug;222(2):290-291 8 Citations |
| 3 | Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer. (Yen TWF, Garacci Z, Laud PW, Pezzin LE, Nattinger AB) Breast Cancer 2021 May;28(3):698-709 2 Citations |
| 1 | Laparoscopy allows the harvest of the DIEP flap with shorter fascial incisions as compared to endoscopic harvest: A single surgeon retrospective cohort study. (Shakir S, Spencer AB, Piper M, Kozak GM, Soriano IS, Kanchwala SK) J Plast Reconstr Aesthet Surg 2021 Jun;74(6):1203-1212 15 Citations |
| 3 | Rapid assessment of breast tumor margins using deep ultraviolet fluorescence scanning microscopy. (Lu T, Jorns JM, Patton M, Fisher R, Emmrich A, Doehring T, Schmidt TG, Ye DH, Yen T, Yu B) J Biomed Opt 2020 Nov;25(12) 10 Citations |
| 1 | Breast Sentinel Lymph Node Frozen Section Practice: An Enterprise Audit as a Guide for Moving Forward. (Czaja R, Wu R, Jorns JM) Arch Pathol Lab Med 2021 Aug 01;145(8):1018-1024 6 Citations |
| 2 | Can Regionalization of Care Reduce Socioeconomic Disparities in Breast Cancer Survival? (Nattinger AB, Rademacher N, McGinley EL, Bickell NA, Pezzin LE) Med Care 2021 Jan;59(1):77-81 9 Citations |
| 3 | Aromatase Inhibitor Symptom Management Practices: A Retrospective Study. (Ernst A, Flynn KE, Weil EM, Crotty BH, Kamaraju S, Fergestrom N, Neuner J) Clin Breast Cancer 2021 Feb;21(1):e38-e47 3 Citations |
| 4 | The Use and Concurrent Use of Side Effect Controlling Medications Among Women on Aromatase Inhibitors. (Farkas AH, Winn A, Pezzin LE, Fergestrom N, Laud P, Neuner JM) J Womens Health (Larchmt) 2021 Jan;30(1):131-136 4 Citations |
| 1 | Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation. (Meyer AE, Furumo Q, Stelloh C, Minella AC, Rao S) Neoplasia 2020 Nov;22(11):644-658 11 Citations |
| 2 | Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer. (Danes JM, de Abreu ALP, Kerketta R, Huang Y, Palma FR, Gantner BN, Mathison AJ, Urrutia RA, Bonini MG) FASEB J 2020 Dec;34(12):16034-16048 8 Citations |
| 2 | Community and Research Perspectives on Cancer Disparities in Wisconsin. (Olson J, Cawthra T, Beyer K, Frazer D, Ignace L, Maurana C, Millon-Underwood S, Pinsoneault L, Salazar J, Walker A, Williams C, Stolley M) Prev Chronic Dis 2020 Oct 08;17:E122 4 Citations |
| 1 | Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area. (Collin LJ, Gaglioti AH, Beyer KM, Zhou Y, Moore MA, Nash R, Switchenko JM, Miller-Kleinhenz JM, Ward KC, McCullough LE) Cancer Epidemiol Biomarkers Prev 2021 Jan;30(1):53-60 80 Citations |
| 1 | Minimally invasive robotic-assisted harvest of the deep inferior epigastric perforator flap for autologous breast reconstruction. (Piper M, Ligh CA, Shakir S, Messa C, Soriano I, Kanchwala S) J Plast Reconstr Aesthet Surg 2021 Apr;74(4):890-930 3 Citations |
| 1 | Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal Examination. (Phillips SM, Welch WA, Fanning J, Santa-Maria CA, Gavin KL, Auster-Gussman LA, Solk P, Lu M, Cullather E, Khan SA, Kulkarni SA, Gradishar W, Siddique J) Cancer Epidemiol Biomarkers Prev 2020 Dec;29(12):2608-2616 13 Citations |
| 1 | Response to Strassels and Durham. (Check DK, Winn AN, Fergestrom N, Reeder-Hayes KE, Neuner JM, Roberts AW) J Natl Cancer Inst 2020 Dec 14;112(12):1280 |
| 1 | The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells. (Yang Y, Choppavarapu L, Fang K, Naeini AS, Nosirov B, Li J, Yang K, He Z, Zhou Y, Schiff R, Li R, Hu Y, Wang J, Jin VX) Biochim Biophys Acta Gene Regul Mech 2020 Nov;1863(11):194631 7 Citations |
| 1 | Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. (Emerson MA, Golightly YM, Aiello AE, Reeder-Hayes KE, Tan X, Maduekwe U, Johnson-Thompson M, Olshan AF, Troester MA) Cancer 2020 Nov 15;126(22):4957-4966 44 Citations |
| 1 | Big Data Solutions for Controversies in Breast Cancer Treatment. (Cobb AN, Janjua HM, Kuo PC) Clin Breast Cancer 2021 Jun;21(3):e199-e203 4 Citations |
| 1 | Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer. (Winn AN, Check DK, Farkas A, Fergestrom NM, Neuner JM, Roberts AW) JAMA Netw Open 2020 Sep 01;3(9):e2016858 12 Citations |
| 1 | Immediate Lymphatic Reconstruction after Axillary Lymphadenectomy: A Single-Institution Early Experience. (Cook JA, Sasor SE, Loewenstein SN, DeBrock W, Lester M, Socas J, Ludwig KK, Fisher CS, Hassanein AH) Ann Surg Oncol 2021 Mar;28(3):1381-1387 18 Citations |
| 1 | Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy? (Cortina CS, Gottschalk N, Kulkarni SA, Karst I) J Surg Res 2021 Jan;257:412-418 5 Citations |
| 1 | Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer. (Patwari A, Bhatlapenumarthi V) Breast J 2020 Nov;26(11):2233-2234 2 Citations |
| 1 | Laparoscopically Assisted DIEP Flap Harvest Minimizes Fascial Incision in Autologous Breast Reconstruction. (Shakir S, Spencer AB, Kozak GM, Nathan SL, Soriano IS, Kanchwala SK) Plast Reconstr Surg 2020 Sep;146(3):265e-275e 11 Citations |
| 1 | Choice of local therapy for young women with early-stage breast cancer who have young-aged children. (Pan IW, Yen TWF, Huo J, Chen C, Smith BD, Shih YT) Cancer 2020 Nov 01;126(21):4761-4769 |
| 1 | Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer. (Aubry S, Strassle PD, Maduekwe U, Downs-Canner S) J Surg Res 2020 Dec;256:13-22 1 Citation |
| 1 | Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer. (Chamberlin MD, Wells JD, Shee K, Bean JR, Marotti JD, Wells WA, Trask HW, Kolling FW, Bhatt A, Kaufman PA, Schwartz GN, Gemery JM, McNulty NJ, Tsapakos MJ, Barth RJ, Arrick BA, Gui J, Miller TW) Breast Cancer Res Treat 2020 Aug;182(3):665-677 1 Citation |
| 1 | Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer. (Zhang Z, Yu W, Tang D, Zhou Y, Bi M, Wang H, Zheng Y, Chen M, Li L, Xu X, Zhang W, Tao H, Jin VX, Liu Z, Chen L) RNA Biol 2020 Nov;17(11):1590-1602 10 Citations |
| 1 | Delving deeper into disparity: The impact of health literacy on the surgical care of breast cancer patients. (Portelli Tremont JN, Downs-Canner S, Maduekwe U) Am J Surg 2020 Oct;220(4):806-810 6 Citations |
| 1 | Wellness Coaching: An Intervention to Increase Healthy Behavior in Breast Cancer Survivors. (Stan DL, Cutshall SM, Adams TF, Ghosh K, Clark MM, Wieneke KC, Kebede EB, Donelan Dunlap BJ, Ruddy KJ, Hazelton JK, Butts AM, Jenkins SM, Croghan IT, Bauer BA) Clin J Oncol Nurs 2020 Jun 01;24(3):305-315 11 Citations |
| 1 | Parental Status in Treatment Decision Making among Women with Nonmetastatic Breast Cancer. (Jewett PI, Vogel RI, Schroeder MC, Neuner JM, Blaes AH) Med Decis Making 2020 May;40(4):540-544 |
| 1 | Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. (Bi M, Zhang Z, Jiang YZ, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z, Ruan J, Jin VX, Marangoni E, Montaudon E, Glass CK, Li W, Huang TH, Shao ZM, Schiff R, Chen L, Liu Z) Nat Cell Biol 2020 Jun;22(6):701-715 69 Citations |
| 1 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. (Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Arun BK, Auer PL, Azzollini J, Barrowdale D, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bialkowska K, Blanco A, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Bondavalli D, Borg A, Brauch H, Brenner H, Briceno I, Broeks A, Brucker SY, Brüning T, Burwinkel B, Buys SS, Byers H, Caldés T, Caligo MA, Calvello M, Campa D, Castelao JE, Chang-Claude J, Chanock SJ, Christiaens M, Christiansen H, Chung WK, Claes KBM, Clarke CL, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Diez O, Domchek SM, Dörk T, Dwek M, Eccles DM, Ekici AB, Evans DG, Fasching PA, Figueroa J, Foretova L, Fostira F, Friedman E, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, García-Sáenz JA, Gaudet MM, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Häberle L, Hahnen E, Haiman CA, Hake CR, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Hillemanns P, Hogervorst FBL, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huebner H, Hulick PJ, Imyanitov EN, kConFab Investigators, ABCTB Investigators, Isaacs C, Izatt L, Jager A, Jakimovska M, Jakubowska A, James P, Janavicius R, Janni W, John EM, Jones ME, Jung A, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khan S, Khusnutdinova E, Kitahara CM, Ko YD, Konstantopoulou I, Koppert LB, Koutros S, Kristensen VN, Laenkholm AV, Lambrechts D, Larsson SC, Laurent-Puig P, Lazaro C, Lazarova E, Lejbkowicz F, Leslie G, Lesueur F, Lindblom A, Lissowska J, Lo WY, Loud JT, Lubinski J, Lukomska A, MacInnis RJ, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Matricardi L, McGuffog L, McLean C, Mebirouk N, Meindl A, Menon U, Miller A, Mingazheva E, Montagna M, Mulligan AM, Mulot C, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen FC, Nikitina-Zake L, Nodora J, Offit K, Olah E, Olopade OI, Olsson H, Orr N, Papi L, Papp J, Park-Simon TW, Parsons MT, Peissel B, Peixoto A, Peshkin B, Peterlongo P, Peto J, Phillips KA, Piedmonte M, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Prokofyeva D, Rack B, Radice P, Ramus SJ, Rantala J, Rashid MU, Rennert G, Rennert HS, Risch HA, Romero A, Rookus MA, Rübner M, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Scheuner MT, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schöttker B, Schürmann P, Senter L, Sharma P, Sherman ME, Shu XO, Singer CF, Smichkoska S, Soucy P, Southey MC, Spinelli JJ, Stone J, Stoppa-Lyonnet D, EMBRACE Study, GEMO Study Collaborators, Swerdlow AJ, Szabo CI, Tamimi RM, Tapper WJ, Taylor JA, Teixeira MR, Terry M, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Tomlinson I, Torres D, Troester MA, Truong T, Tung N, Untch M, Vachon CM, van den Ouweland AMW, van der Kolk LE, van Veen EM, vanRensburg EJ, Vega A, Wappenschmidt B, Weinberg CR, Weitzel JN, Wildiers H, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zheng W, Zorn KK, Milne RL, Kraft P, Simard J, Pharoah PDP, Michailidou K, Antoniou AC, Schmidt MK, Chenevix-Trench G, Easton DF, Chatterjee N, García-Closas M) Nat Genet 2020 Jun;52(6):572-581 200 Citations |
| 4 | Facilitators of behavior change and weight loss in an intervention for African American Breast Cancer Survivors. (Kwarteng JL, Beyer KMM, Banerjee A, Stolley MR) Cancer Causes Control 2020 Aug;31(8):737-747 11 Citations |
| 1 | Reciprocal fine-tuning of progesterone and prolactin-regulated gene expression in breast cancer cells. (Holloran SM, Nosirov B, Walter KR, Trinca GM, Lai Z, Jin VX, Hagan CR) Mol Cell Endocrinol 2020 Jul 01;511:110859 3 Citations |
| 1 | Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers. (Odnokoz O, Yu P, Peck AR, Sun Y, Kovatich AJ, Hooke JA, Hu H, Mitchell EP, Rui H, Fuchs SY) Cancer Biol Ther 2020 Jul 02;21(7):629-636 6 Citations |
| 2 | Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy. (Sharma G, Jagtap JM, Parchur AK, Gogineni VR, Ran S, Bergom C, White SB, Flister MJ, Joshi A) Theranostics 2020;10(12):5368-5383 14 Citations |
| 1 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. (Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q, Jung A, Abu-Ful Z, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Freeman LEB, Becher H, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernstein L, Bojesen SE, Brauch H, Brenner H, Brüning T, Cai Q, Campa D, Canzian F, Carracedo A, Carter BD, Castelao JE, Chanock SJ, Chatterjee N, Chenevix-Trench G, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Dai JY, Earp HS, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Figueroa J, Fritschi L, Gabrielson M, Gago-Dominguez M, Gao C, Gapstur SM, Gaudet MM, Giles GG, González-Neira A, Guénel P, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Hatse S, Heyworth J, Holleczek B, Hoover RN, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators, kConFab/AOCS Investigators, John EM, Jones ME, Kaaks R, Keeman R, Kitahara CM, Ko YD, Koutros S, Kurian AW, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Linet M, Lissowska J, Llaneza A, MacInnis RJ, Martinez ME, Maurer T, McLean C, Neuhausen SL, Newman WG, Norman A, O'Brien KM, Olshan AF, Olson JE, Olsson H, Orr N, Perou CM, Pita G, Polley EC, Prentice RL, Rennert G, Rennert HS, Ruddy KJ, Sandler DP, Saunders C, Schoemaker MJ, Schöttker B, Schumacher F, Scott C, Scott RJ, Shu XO, Smeets A, Southey MC, Spinelli JJ, Stone J, Swerdlow AJ, Tamimi RM, Taylor JA, Troester MA, Vachon CM, van Veen EM, Wang X, Weinberg CR, Weltens C, Willett W, Winham SJ, Wolk A, Yang XR, Zheng W, Ziogas A, Dunning AM, Pharoah PDP, Schmidt MK, Kraft P, Easton DF, Milne RL, García-Closas M, Chang-Claude J) J Natl Cancer Inst 2021 Mar 01;113(3):329-337 37 Citations |
| 2 | Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain. (Thies KA, Hammer AM, Hildreth BE 3rd, Steck SA, Spehar JM, Kladney RD, Geisler JA, Das M, Russell LO, Bey JF 4th, Bolyard CM, Pilarski R, Trimboli AJ, Cuitiño MC, Koivisto CS, Stover DG, Schoenfield L, Otero J, Godbout JP, Chakravarti A, Ringel MD, Ramaswamy B, Li Z, Kaur B, Leone G, Ostrowski MC, Sizemore ST, Sizemore GM) Cancer Res 2021 Feb 01;81(3):606-618 30 Citations |
| 1 | AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. (Hampsch RA, Wells JD, Traphagen NA, McCleery CF, Fields JL, Shee K, Dillon LM, Pooler DB, Lewis LD, Demidenko E, Huang YH, Marotti JD, Goen AE, Kinlaw WB, Miller TW) Clin Cancer Res 2020 Jul 15;26(14):3707-3719 51 Citations |
| 3 | Team triathlon effects on physiological, psychological, and immunological measures in women breast cancer survivors. (Tjoe JA, Piacentine LB, Papanek PE, Raff H, Richards J, Harkins AL, Yin J, Ng AV) Support Care Cancer 2020 Dec;28(12):6095-6104 4 Citations |
| 1 | The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1793-1797 14 Citations |
| 1 | The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2566-2570 9 Citations |
| 2 | The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence. (Winn AN, Fergestrom NM, Pezzin LE, Laud PW, Neuner JM) Pharmacoepidemiol Drug Saf 2020 May;29(5):550-557 2 Citations |
| 2 | Benign vascular lesions and angiolipomas of the breast: Radiologic-pathologic correlation. (Kravtsov O, Techawatanaset K, Cherian S, Jorns JM) Breast J 2020 Sep;26(9):1906-1908 3 Citations |
| 1 | Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence. (Haskins CB, Neuner JM, McDowell BD, Carnahan RM, Fiedorowicz JG, Wallace RB, Smith BJ, Chrischilles EA) Clin Breast Cancer 2020 Jun;20(3):e261-e280 1 Citation |
| 1 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. (Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Auer PL, Azzollini J, Balmaña J, Barkardottir RB, Barnes DR, Barrowdale D, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Białkowska K, Blanco A, Blomqvist C, Boeckx B, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borg A, Brauch H, Brenner H, Briceno I, Broeks A, Brüning T, Burwinkel B, Cai Q, Caldés T, Caligo MA, Campbell I, Canisius S, Campa D, Carter BD, Carter J, Castelao JE, Chang-Claude J, Chanock SJ, Christiansen H, Chung WK, Claes KBM, Clarke CL, GEMO Study Collaborators, EMBRACE Collaborators, GC-HBOC study Collaborators, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Daly MB, de la Hoya M, De Leeneer K, Dennis J, Devilee P, Diez O, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Ejlertsen B, Ellberg C, Engel C, Eriksson M, Fasching PA, Fletcher O, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gabrielson M, Ganz PA, Gapstur SM, Garber J, García-Closas M, García-Sáenz JA, Gaudet MM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Haiman CA, Hall P, Hamann U, Hake C, He W, Heyworth J, Hogervorst FBL, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Huang G, Hulick PJ, Humphreys K, Imyanitov EN, ABCTB Investigators, HEBON Investigators, BCFR Investigators, OCGN Investigators, Isaacs C, Jakimovska M, Jakubowska A, James P, Janavicius R, Jankowitz RC, John EM, Johnson N, Joseph V, Jung A, Karlan BY, Khusnutdinova E, Kiiski JI, Konstantopoulou I, Kristensen VN, Laitman Y, Lambrechts D, Lazaro C, Leroux D, Leslie G, Lester J, Lesueur F, Lindor N, Lindström S, Lo WY, Loud JT, Lubiński J, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martens JWM, Martinez ME, Matricardi L, Maurer T, Mavroudis D, McGuffog L, Meindl A, Menon U, Michailidou K, Kapoor PM, Miller A, Montagna M, Moreno F, Moserle L, Mulligan AM, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna H, Nevelsteen I, Nielsen FC, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Olsson H, Osorio A, Papp J, Park-Simon TW, Parsons MT, Pedersen IS, Peixoto A, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Plaseska-Karanfilska D, Poppe B, Pradhan N, Prajzendanc K, Presneau N, Punie K, Pylkäs K, Radice P, Rantala J, Rashid MU, Rennert G, Risch HA, Robson M, Romero A, Saloustros E, Sandler DP, Santos C, Sawyer EJ, Schmidt MK, Schmidt DF, Schmutzler RK, Schoemaker MJ, Scott RJ, Sharma P, Shu XO, Simard J, Singer CF, Skytte AB, Soucy P, Southey MC, Spinelli JJ, Spurdle AB, Stone J, Swerdlow AJ, Tapper WJ, Taylor JA, Teixeira MR, Terry MB, Teulé A, Thomassen M, Thöne K, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Torres D, Truong T, Tung N, Vachon CM, van Asperen CJ, van den Ouweland AMW, van Rensburg EJ, Vega A, Viel A, Vieiro-Balo P, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Winqvist R, Yang XR, Yannoukakos D, Ziogas A, Milne RL, Easton DF, Chenevix-Trench G, Zheng W, Kraft P, Jiang X) Genet Epidemiol 2020 Jul;44(5):442-468 25 Citations |
| 1 | Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study. (Kurzrock R, Bowles DW, Kang H, Meric-Bernstam F, Hainsworth J, Spigel DR, Bose R, Burris H, Sweeney CJ, Beattie MS, Blotner S, Schulze K, Cuchelkar V, Swanton C) Ann Oncol 2020 Mar;31(3):412-421 81 Citations |
| 1 | Lymphocytic mastitis mimicking breast cancer in an elderly woman. (Wang L, Jorns JM) Breast J 2020 Jul;26(7):1414-1415 |
| 2 | Integrative pathway enrichment analysis of multivariate omics data. (Paczkowska M, Barenboim J, Sintupisut N, Fox NS, Zhu H, Abd-Rabbo D, Mee MW, Boutros PC, PCAWG Drivers and Functional Interpretation Working Group, Reimand J, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):735 93 Citations |
| 5 | Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy. (Brandt AC, McNally L, Lorimer EL, Unger B, Koehn OJ, Suazo KF, Rein L, Szabo A, Tsaih SW, Distefano MD, Flister MJ, Rigo F, McNally MT, Williams CL) Proc Natl Acad Sci U S A 2020 Feb 18;117(7):3627-3636 17 Citations |
| 1 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. (Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Børresen-Dale AL, Brauch H, Brenner H, Brucker SY, Burwinkel B, Caldas C, Canzian F, Chang-Claude J, Chanock SJ, Chin SF, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Devilee P, Dunn JA, Dunning AM, Dwek M, Earl HM, Eccles DM, Eliassen AH, Ellberg C, Evans DG, Fasching PA, Figueroa J, Flyger H, Gago-Dominguez M, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, George A, Giles GG, Goldgar DE, González-Neira A, Grip M, Guénel P, Guo Q, Haiman CA, Håkansson N, Hamann U, Harrington PA, Hiller L, Hooning MJ, Hopper JL, Howell A, Huang CS, Huang G, Hunter DJ, Jakubowska A, John EM, Kaaks R, Kapoor PM, Keeman R, Kitahara CM, Koppert LB, Kraft P, Kristensen VN, Lambrechts D, Le Marchand L, Lejbkowicz F, Lindblom A, Lubiński J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Maurer T, Mavroudis D, Meindl A, Milne RL, Mulligan AM, Neuhausen SL, Nevanlinna H, Newman WG, Olshan AF, Olson JE, Olsson H, Orr N, Peterlongo P, Petridis C, Prentice RL, Presneau N, Punie K, Ramachandran D, Rennert G, Romero A, Sachchithananthan M, Saloustros E, Sawyer EJ, Schmutzler RK, Schwentner L, Scott C, Simard J, Sohn C, Southey MC, Swerdlow AJ, Tamimi RM, Tapper WJ, Teixeira MR, Terry MB, Thorne H, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Turnbull C, Vachon CM, van der Kolk LE, Wang Q, Winqvist R, Wolk A, Yang XR, Ziogas A, Pharoah PDP, Hall P, Wessels LFA, Chenevix-Trench G, Bader GD, Dörk T, Easton DF, Canisius S, Schmidt MK) Nat Commun 2020 Jan 16;11(1):312 27 Citations |
| 1 | Profiling of O-acetylated Gangliosides Expressed in Neuroectoderm Derived Cells. (Cavdarli S, Yamakawa N, Clarisse C, Aoki K, Brysbaert G, Le Doussal JM, Delannoy P, Guérardel Y, Groux-Degroote S) Int J Mol Sci 2020 Jan 06;21(1) 19 Citations |
| 2 | Engaging young African American women breast cancer survivors: A novel storytelling approach to identify patient-centred research priorities. (Yan A, Millon-Underwood S, Walker A, Patten C, Nevels D, Dookeran K, Hennessy R, Knobloch MJ, Egede L, Stolley M) Health Expect 2020 Apr;23(2):473-482 8 Citations |
| 1 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. (Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, Moradi Marjaneh M, Jiang X, Agata S, Aittomäki K, Alonso MR, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Aronson KJ, Arun BK, Auber B, Auer PL, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Beeghly-Fadiel A, Benitez J, Bermisheva M, Białkowska K, Blanco AM, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borg A, Bosse K, Brauch H, Brenner H, Briceno I, Brock IW, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldés T, Caligo MA, Camp NJ, Campbell I, Canzian F, Carroll JS, Carter BD, Castelao JE, Chiquette J, Christiansen H, Chung WK, Claes KBM, Clarke CL, GEMO Study Collaborators, EMBRACE Collaborators, Collée JM, Cornelissen S, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Daly MB, de la Hoya M, Devilee P, Diez O, Ding YC, Dite GS, Domchek SM, Dörk T, Dos-Santos-Silva I, Droit A, Dubois S, Dumont M, Duran M, Durcan L, Dwek M, Eccles DM, Engel C, Eriksson M, Evans DG, Fasching PA, Fletcher O, Floris G, Flyger H, Foretova L, Foulkes WD, Friedman E, Fritschi L, Frost D, Gabrielson M, Gago-Dominguez M, Gambino G, Ganz PA, Gapstur SM, Garber J, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Tibiletti MG, Greene MH, Grip M, Gronwald J, Grundy A, Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hartikainen JM, Hartman M, He W, Healey CS, Heemskerk-Gerritsen BAM, Heyworth J, Hillemanns P, Hogervorst FBL, Hollestelle A, Hooning MJ, Hopper JL, Howell A, Huang G, Hulick PJ, Imyanitov EN, KConFab Investigators, HEBON Investigators, ABCTB Investigators, Isaacs C, Iwasaki M, Jager A, Jakimovska M, Jakubowska A, James PA, Janavicius R, Jankowitz RC, John EM, Johnson N, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kang D, Kapoor PM, Karlan BY, Keeman R, Kerin MJ, Khusnutdinova E, Kiiski JI, Kirk J, Kitahara CM, Ko YD, Konstantopoulou I, Kosma VM, Koutros S, Kubelka-Sabit K, Kwong A, Kyriacou K, Laitman Y, Lambrechts D, Lee E, Leslie G, Lester J, Lesueur F, Lindblom A, Lo WY, Long J, Lophatananon A, Loud JT, Lubiński J, MacInnis RJ, Maishman T, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Matsuo K, Maurer T, Mavroudis D, Mayes R, McGuffog L, McLean C, Mebirouk N, Meindl A, Miller A, Miller N, Montagna M, Moreno F, Muir K, Mulligan AM, Muñoz-Garzon VM, Muranen TA, Narod SA, Nassir R, Nathanson KL, Neuhausen SL, Nevanlinna H, Neven P, Nielsen FC, Nikitina-Zake L, Norman A, Offit K, Olah E, Olopade OI, Olsson H, Orr N, Osorio A, Pankratz VS, Papp J, Park SK, Park-Simon TW, Parsons MT, Paul J, Pedersen IS, Peissel B, Peshkin B, Peterlongo P, Peto J, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Prokofyeva D, Pujana MA, Pylkäs K, Radice P, Ramus SJ, Rantala J, Rau-Murthy R, Rennert G, Risch HA, Robson M, Romero A, Rossing M, Saloustros E, Sánchez-Herrero E, Sandler DP, Santamariña M, Saunders C, Sawyer EJ, Scheuner MT, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schöttker B, Schürmann P, Scott C, Scott RJ, Senter L, Seynaeve CM, Shah M, Sharma P, Shen CY, Shu XO, Singer CF, Slavin TP, Smichkoska S, Southey MC, Spinelli JJ, Spurdle AB, Stone J, Stoppa-Lyonnet D, Sutter C, Swerdlow AJ, Tamimi RM, Tan YY, Tapper WJ, Taylor JA, Teixeira MR, Tengström M, Teo SH, Terry MB, Teulé A, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Tomlinson I, Torres D, Torres-Mejía G, Troester MA, Truong T, Tung N, Tzardi M, Ulmer HU, Vachon CM, van Asperen CJ, van der Kolk LE, van Rensburg EJ, Vega A, Viel A, Vijai J, Vogel MJ, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wildiers H, Winqvist R, Wolk A, Wu AH, Yannoukakos D, Zhang Y, Zheng W, Hunter D, Pharoah PDP, Chang-Claude J, García-Closas M, Schmidt MK, Milne RL, Kristensen VN, French ) Nat Genet 2020 Jan;52(1):56-73 92 Citations |
| 3 | A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology. (Arispe Angulo KR, Jawa Z, Visotcky A, Majidi SS, Chitambar CR, Jorns JM) Histopathology 2020 Apr;76(5):661-670 |
| 1 | New-onset persistent opioid use following breast cancer treatment in older adult women. (Roberts AW, Fergestrom N, Neuner JM, Winn AN) Cancer 2020 Feb 15;126(4):814-822 14 Citations |
| 1 | Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells. (Lupien LE, Bloch K, Dehairs J, Traphagen NA, Feng WW, Davis WL, Dennis T, Swinnen JV, Wells WA, Smits NC, Kuemmerle NB, Miller TW, Kinlaw WB) J Lipid Res 2020 Feb;61(2):205-218 30 Citations |
| 1 | Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages. (Behring M, Vazquez AI, Cui X, Irvin MR, Ojesina AI, Agarwal S, Manne U, Shrestha S) Mol Genet Genomic Med 2019 Dec;7(12):e1001 8 Citations |
| 1 | High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature. (Kapke JT, Schneidewend RJ, Jawa ZA, Huang CC, Connelly JM, Chitambar CR) Hematol Oncol Stem Cell Ther 2019 Dec;12(4):189-193 23 Citations |
| 1 | Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast Cancer. (Check DK, Winn AN, Fergestrom N, Reeder-Hayes KE, Neuner JM, Roberts AW) J Natl Cancer Inst 2020 Jul 01;112(7):765-768 6 Citations |
| 3 | SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer. (He C, Danes JM, Hart PC, Zhu Y, Huang Y, de Abreu AL, O'Brien J, Mathison AJ, Tang B, Frasor JM, Wakefield LM, Ganini D, Stauder E, Zielonka J, Gantner BN, Urrutia RA, Gius D, Bonini MG) Proc Natl Acad Sci U S A 2019 Nov 19;116(47):23534-23541 49 Citations |
| 1 | In vivo longitudinal imaging of RNA interference-induced endocrine therapy resistance in breast cancer. (Biswal NC, Fu X, Jagtap JM, Shea MJ, Kumar V, Lords T, Roy R, Schiff R, Joshi A) J Biophotonics 2020 Jan;13(1):e201900180 1 Citation |
| 1 | A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. (Shee K, Wells JD, Ung M, Hampsch RA, Traphagen NA, Yang W, Liu SC, Zeldenrust MA, Wang L, Kalari KR, Yu J, Boughey JC, Demidenko E, Kettenbach AN, Cheng C, Goetz MP, Miller TW) Clin Cancer Res 2020 Jan 01;26(1):159-170 1 Citation |
| 4 | Prevalence and scope of advanced practice provider oncology care among Medicare beneficiaries with breast cancer. (Yen TWF, Laud PW, McGinley EL, Pezzin LE, Nattinger AB) Breast Cancer Res Treat 2020 Jan;179(1):57-65 2 Citations |
| 1 | Endosalpingiosis and other benign epithelial inclusions in breast sentinel lymph nodes. (Moreno G, Jorns JM) Breast J 2020 Feb;26(2):274-275 4 Citations |
| 2 | Microsurgical Breast Reconstruction in the Obese: A Better Option Than Tissue Expander/Implant Reconstruction? (Klement KA, Hijjawi JB, LoGiudice JA, Alghoul M, Omesiete-Adejare P) Plast Reconstr Surg 2019 Sep;144(3):539-546 24 Citations |
| 1 | Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation. (Jorns JM) Arch Pathol Lab Med 2019 Dec;143(12):1444-1449 15 Citations |
| 6 | The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence. (Neuner JM, Fergestrom NM, Laud PW, Nattinger AB, Beyer KMM, Flynn KE, Pezzin LE) Cancer 2019 Nov 15;125(22):3960-3965 5 Citations |
| 1 | Preferences for mHealth physical activity interventions during chemotherapy for breast cancer: a qualitative evaluation. (Nielsen AM, Welch WA, Gavin KL, Cottrell AM, Solk P, Torre EA, Blanch-Hartigan D, Phillips SM) Support Care Cancer 2020 Apr;28(4):1919-1928 17 Citations |
| 1 | The Standardization of Outpatient Procedure (STOP) Narcotics: A Prospective Health Systems Intervention to Reduce Opioid Use in Ambulatory Breast Surgery. (Hartford LB, Van Koughnett JAM, Murphy PB, Knowles SA, Wigen RB, Allen LJ, Clarke CFM, Brackstone M, Gray DK, Maciver AH) Ann Surg Oncol 2019 Oct;26(10):3295-3304 13 Citations |
| 1 | Repeat Biomarker Status in Breast Resection Specimens With Controlled Cold Ischemic Time. (East EG, Roberts E, Zhao L, Jorns JM) Am J Clin Pathol 2019 Nov 04;152(6):766-774 1 Citation |
| 1 | Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer. (Basree MM, Shinde N, Koivisto C, Cuitino M, Kladney R, Zhang J, Stephens J, Palettas M, Zhang A, Kim HK, Acero-Bedoya S, Trimboli A, Stover DG, Ludwig T, Ganju R, Weng D, Shields P, Freudenheim J, Leone GW, Sizemore GM, Majumder S, Ramaswamy B) Breast Cancer Res 2019 Jul 17;21(1):80 29 Citations |
| 1 | Surgery in the Older Patient with Breast Cancer. (Frebault J, Bergom C, Kong AL) Curr Oncol Rep 2019 Jun 25;21(8):69 3 Citations |
| 4 | Improving Communication in Breast Cancer Treatment Consultation: Use of a Computer Test of Health Numeracy. (Schapira MM, Fletcher KE, Ganschow PS, Jacobs EA, Walker CM, Smallwood AJ, Gil D, Faghri A, Kong AL, Yen TW, McDunn S, Marcus E, Neuner JM) J Womens Health (Larchmt) 2019 Oct;28(10):1407-1417 7 Citations |
| 1 | Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues. (Chen H, Kichaev G, Bien SA, MacDonald JW, Wang L, Bammler TK, Auer P, Pasaniuc B, Lindström S) Hum Genet 2019 Oct;138(10):1091-1104 6 Citations |
| 7 | The p52 isoform of SHC1 is a key driver of breast cancer initiation. (Wright KD, Miller BS, El-Meanawy S, Tsaih SW, Banerjee A, Geurts AM, Sheinin Y, Sun Y, Kalyanaraman B, Rui H, Flister MJ, Sorokin A) Breast Cancer Res 2019 Jun 15;21(1):74 26 Citations |
| 1 | Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer. (Hosford SR, Shee K, Wells JD, Traphagen NA, Fields JL, Hampsch RA, Kettenbach AN, Demidenko E, Miller TW) Mol Oncol 2019 Aug;13(8):1778-1794 16 Citations |
| 1 | The association between cancer care coordination and quality of life is stronger for breast cancer patients with lower health literacy: A Greater Plains Collaborative study. (McDowell BD, Klemp J, Blaes A, Cohee AA, Trentham-Dietz A, Kamaraju S, Otte JL, Mott SL, Chrischilles EA) Support Care Cancer 2020 Feb;28(2):887-895 6 Citations |
| 4 | Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. (Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ) Breast Cancer Res Treat 2019 Aug;177(1):77-91 3 Citations |
| 3 | Factors Influencing Prescription Drug Synchronization: The Complex Role of Number of Medications. (Neuner JM, Fergestrom N, Laud PW, Pezzin L) J Manag Care Spec Pharm 2019 Jun;25(6):714-718 3 Citations |
| 1 | Microglandular Adenosis and Associated Invasive Carcinoma. (Kravtsov O, Jorns JM) Arch Pathol Lab Med 2020 Jan;144(1):42-46 14 Citations |
| 1 | The temporal and financial benefit of intraoperative breast specimen imaging: A pilot study of the Kubtec MOZART. (Kornfeld HW, Mulder LL, Spivey TL, Cortina CS, Madrigrano A, Kopkash KA) Breast J 2019 Jul;25(4):766-768 2 Citations |
| 2 | Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1. (Zarnecki KG, Kristianto J, Charlson J, Wilson B, Blank RD, Shaker JL) Osteoporos Int 2019 Aug;30(8):1699-1703 3 Citations |
| 1 | A Quantitative Ultrasound-Based Multi-Parameter Classifier for Breast Masses. (Nasief HG, Rosado-Mendez IM, Zagzebski JA, Hall TJ) Ultrasound Med Biol 2019 Jul;45(7):1603-1616 31 Citations |
| 1 | Adherence to American Cancer Society and American Institute of Cancer Research dietary guidelines in overweight African American breast cancer survivors. (Springfield S, Odoms-Young A, Tussing-Humphreys L, Freels S, Stolley M) J Cancer Surviv 2019 Apr;13(2):257-268 18 Citations |
| 1 | Effects of reallocating sedentary time with physical activity on quality of life indicators in breast cancer survivors. (Welch WA, Ehlers D, Gavin KL, Aguinaga S, Cottrell A, Nielsen A, Solk P, McAuley E, Phillips SM) Psychooncology 2019 Jul;28(7):1430-1437 19 Citations |
| 3 | Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference? (Neuner JM, Nattinger AB, Yen T, McGinley E, Nattinger M, Pezzin LE) Breast Cancer Res Treat 2019 Jul;176(1):205-215 11 Citations |
| 2 | Encapsulated and solid papillary carcinomas of the breast: Tumors in transition from in situ to invasive? (Solanki MH, Derylo AF, Visotcky AM, Jorns JM) Breast J 2019 May;25(3):539-541 4 Citations |
| 1 | Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance. (Zhou Y, Gerrard DL, Wang J, Li T, Yang Y, Fritz AJ, Rajendran M, Fu X, Stein G, Schiff R, Lin S, Frietze S, Jin VX) Nat Commun 2019 Apr 03;10(1):1522 45 Citations |
| 1 | Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer. (Goodman ML, Trinca GM, Walter KR, Papachristou EK, D'Santos CS, Li T, Liu Q, Lai Z, Chalise P, Madan R, Fan F, Markiewicz MA, Jin VX, Carroll JS, Hagan CR) J Immunol 2019 May 15;202(10):3076-3086 25 Citations |
| 1 | Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. (Shatsky R, Parker BA, Bui NQ, Helsten T, Schwab RB, Boles SG, Kurzrock R) Mol Cancer Ther 2019 May;18(5):1001-1011 31 Citations |
| 3 | Discussion of preoperative mammography in women undergoing reduction mammaplasty. (Klement KA, Hijjawi JB, Neuner J, Kelley K, Kong AL) Breast J 2019 May;25(3):439-443 7 Citations |
| 1 | Sedentary behavior after breast cancer: motivational, demographic, disease, and health status correlates of sitting time in breast cancer survivors. (Gavin KL, Welch WA, Conroy DE, Kozey-Keadle S, Pellegrini C, Cottrell A, Nielsen A, Solk P, Siddique J, Phillips SM) Cancer Causes Control 2019 Jun;30(6):569-580 9 Citations |
| 3 | Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients. (Plasterer C, Tsaih SW, Lemke A, Schilling R, Dwinell M, Rau A, Auer P, Rui H, Flister MJ) G3 (Bethesda) 2019 May 07;9(5):1739-1743 4 Citations |
| 1 | Breast cancer survivors' preferences for mHealth physical activity interventions: findings from a mixed methods study. (Phillips SM, Courneya KS, Welch WA, Gavin KL, Cottrell A, Nielsen A, Solk P, Blanch-Hartigan D, Cella D, Ackermann RT, Spring B, Penedo F) J Cancer Surviv 2019 Apr;13(2):292-305 25 Citations |
| 1 | Hypercalcemia in Metaplastic Squamous Cell Carcinoma of the Breast. (Hardy BM, Cortina CS, Javidiparsijani S, Ghai R, Madrigrano A) Am J Case Rep 2019 Mar 20;20:366-369 6 Citations |
| 1 | Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network. (Chrischilles EA, Riley D, Letuchy E, Koehler L, Neuner J, Jernigan C, Gryzlak B, Segal N, McDowell B, Smith B, Sugg SL, Armer JM, Lizarraga IM) Breast Cancer Res Treat 2019 Jun;175(3):675-689 32 Citations |
| 1 | Obesity Does Not Influence Management of Advanced Breast Cancer in the Elderly. (Tangalakis LL, Cortina CS, Son JD, Poirier J, Madrigrano A) Clin Breast Cancer 2019 Jun;19(3):197-199 1 Citation |
| 2 | Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes. (Ferrigni E, Bergom C, Yin Z, Szabo A, Kong AL) Clin Breast Cancer 2019 Jun;19(3):157-164 24 Citations |
| 1 | Genome-wide association study of germline variants and breast cancer-specific mortality. (Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Boeckx B, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brentnall A, Brinton L, Broberg P, Brock IW, Brucker SY, Burwinkel B, Caldas C, Caldés T, Campa D, Canzian F, Carracedo A, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Cheng TD, Chin SF, Clarke CL, NBCS Collaborators, Cordina-Duverger E, Couch FJ, Cox DG, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dunn JA, Dunning AM, Durcan L, Dwek M, Earl HM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Figueroa J, Flesch-Janys D, Flyger H, Gabrielson M, Gago-Dominguez M, Galle E, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, George A, Georgoulias V, Giles GG, Glendon G, Goldgar DE, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hankinson S, Harkness EF, Harrington PA, Hart SN, Hartikainen JM, Hein A, Hillemanns P, Hiller L, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Janni W, John EM, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kabisch M, Kaczmarek K, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kitahara CM, Knight JA, Ko YD, Koppert LB, Kosma VM, Kraft P, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Li L, Lindblom A, Lindström S, Linet M, Lissowska J, Lo WY, Loibl S, Lubiński J, Lux MP, MacInnis RJ, Maierthaler M, Maishman T, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Mavroudis D, McLean C, Meindl A, Middha P, Miller N, Milne RL, Moreno F, Mulligan AM, Mulot C, Nassir R, Neuhausen SL, Newman WT, Nielsen SF, Nordestgaard BG, Norman A, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Petridis C, Pinchev M, Prajzendanc K, Prentice R, Presneau N, Prokofieva D, Pylkäs K, Rack B, Radice P, Ramachandran D, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Saloustros E, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schwentner L, Scott RJ, Scott C, Seynaeve C, Shah M, Simard J, Smeets A, Sohn C, Southey MC, Swerdlow AJ, Talhouk A, Tamimi RM, Tapper WJ, Teixeira MR, Tengström M, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Torres D, Truong T, Turman C, Turnbull C, Ulmer HU, Untch M, Vachon C, van Asperen CJ, van den Ouweland AMW, van Veen EM, Wendt C, Whittemore AS, Willett W, Winqvist R, Wolk A, Yang XR, Zhang Y, Easton DF, Fasching PA, Nevanlinna H, Eccles DM, Pharoah PDP, Schmidt MK) Br J Cancer 2019 Mar;120(6):647-657 41 Citations |
| 1 | A Step toward Understanding Diet Quality in Urban African-American Breast Cancer Survivors: A Cross-sectional Analysis of Baseline Data from the Moving Forward Study. (Springfield S, Odoms-Young A, Tussing-Humphreys LM, Freels S, Stolley MR) Nutr Cancer 2019;71(1):61-76 5 Citations |
| 1 | Culture, identity, strength and spirituality: A qualitative study to understand experiences of African American women breast cancer survivors and recommendations for intervention development. (Yan AF, Stevens P, Holt C, Walker A, Ng A, McManus P, Basen-Enguist K, Weinhardt LS, Underwood SM, Asan O, Wang MQ) Eur J Cancer Care (Engl) 2019 May;28(3):e13013 20 Citations |
| 1 | Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier. (Chen Y, Wang Y, Salas LA, Miller TW, Mark K, Marotti JD, Kettenbach AN, Cheng C, Christensen BC) Breast Cancer Res 2019 Jan 25;21(1):14 5 Citations |
| 1 | Complexity of health news reporting on breast implant-associated anaplastic large cell lymphoma. (Cook JA, Sasor SE, Tholpady SS, Chu MW, Momeni A) Breast J 2019 Jan;25(1):163-165 3 Citations |
| 1 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. (Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Bremer M, Brenner H, Brentnall A, Brock IW, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Campa D, Carter BD, Castelao JE, Chanock SJ, Chlebowski R, Christiansen H, Clarke CL, Collée JM, Cordina-Duverger E, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Fletcher O, Flyger H, Försti A, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Gilyazova IR, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hankinson SE, Harkness EF, Hart SN, He W, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Jakimovska M, Jakubowska A, Janni W, John EM, Johnson N, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kaczmarek K, Kataja V, Keeman R, Kerin MJ, Khusnutdinova E, Kiiski JI, Knight JA, Ko YD, Kosma VM, Koutros S, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Lilyquist J, Lindblom A, Lindström S, Lissowska J, Lo WY, Loibl S, Long J, Lubiński J, Lux MP, MacInnis RJ, Maishman T, Makalic E, Maleva Kostovska I, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Martinez ME, Mavroudis D, McLean C, Meindl A, Menon U, Middha P, Miller N, Moreno F, Mulligan AM, Mulot C, Muñoz-Garzon VM, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen SF, Nordestgaard BG, Norman A, Offit K, Olson JE, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Peto J, Pinchev M, Plaseska-Karanfilska D, Polley EC, Prentice R, Presneau N, Prokofyeva D, Purrington K, Pylkäs K, Rack B, Radice P, Rau-Murthy R, Rennert G, Rennert HS, Rhenius V, Robson M, Romero A, Ruddy KJ, Ruebner M, Saloustros E, Sandler DP, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Schwentner L, Scott C, Scott RJ, Seynaeve C, Shah M, Sherman ME, Shrubsole MJ, Shu XO, Slager S, Smeets A, Sohn C, Soucy P, Southey MC, Spinelli JJ, Stegmaier C, Stone J, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Truong T, Tzardi M, Ulmer HU, Untch M, Vachon CM, van Veen EM, Vijai J, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zhang Y, Zheng W, Ziogas A, ABCTB Investigators, kConFab/AOCS Investigators, NBCS Collaborators, Dunning AM, Thompson DJ, Chenevix-Trench G, Chang-Claude J, Schmidt MK, Hall P, Milne RL, Pharoah PDP, Antoniou AC, Chatterjee N, Kraft P, García-Closas M, Simard J, Easton DF) Am J Hum Genet 2019 Jan 03;104(1):21-34 582 Citations |
| 1 | Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer. (Winn AN, Fergestrom NM, Neuner JM) Med Care 2019 Jan;57(1):85-93 8 Citations |
| 1 | Patterns of Practice in Canadian Radiation Treatment Centres: Results of a National Survey. (Giddings A, Nica L, French J, Davis CA, Smoke M, Bolderston A) J Med Imaging Radiat Sci 2018 Mar;49(1):23-30 9 Citations |
| 1 | Improved long-term patient-reported health and well-being outcomes of early-stage breast cancer treated with partial breast proton therapy. (Teichman SL, Do S, Lum S, Teichman TS, Preston W, Cochran SE, Garberoglio CA, Grove R, Davis CA, Slater JD, Bush DA) Cancer Med 2018 Dec;7(12):6064-6076 11 Citations |
| 1 | Breast cancer survivors' preferences for social support features in technology-supported physical activity interventions: findings from a mixed methods evaluation. (Lloyd GR, Hoffman SA, Welch WA, Blanch-Hartigan D, Gavin KL, Cottrell A, Cadmus-Bertram L, Spring B, Penedo F, Courneya KS, Phillips SM) Transl Behav Med 2020 May 20;10(2):423-434 13 Citations |
| 4 | Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study. (Kamaraju S, Shi Y, Smith E, Nattinger AB, Laud P, Neuner J) Clin Cardiol 2019 Jan;42(1):93-100 23 Citations |
| 1 | Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing. (Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ) Am J Pathol 2019 May;189(5):956-965 16 Citations |
| 1 | Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. (Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu S, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou X, Leonard EJ, Schilder RJ) JAMA Oncol 2019 Jan 01;5(1):e183773 58 Citations |
| 1 | A feasibility study of breast cancer genetic risk assessment in a federally qualified health center. (Hoskins KF, Tejeda S, Vijayasiri G, Chukwudozie IB, Remo MH, Shah HA, Abraham IE, Balay LE, Maga TK, Searles ER, Korah VJ, Biggers A, Stolley MR, Warnecke RB) Cancer 2018 Sep 15;124(18):3733-3741 19 Citations |
| 3 | Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations. (Currey A, Patten CR, Bergom C, Wilson JF, Kong AL) Breast J 2018 Nov;24(6):902-910 10 Citations |
| 1 | The association of socioeconomic status with receipt of neoadjuvant chemotherapy. (Neuner JM, Kong A, Blaes A, Riley D, Chrischilles E, Smallwood A, Lizarraga I, Schroeder M) Breast Cancer Res Treat 2019 Jan;173(1):179-188 12 Citations |
| 2 | Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review. (Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM) Int J Lab Hematol 2019 Feb;41(1):69-79 7 Citations |
| 1 | Sexual dysfunction and reproductive concerns in young women with breast cancer: Type, prevalence, and predictors of problems. (Ljungman L, Ahlgren J, Petersson LM, Flynn KE, Weinfurt K, Gorman JR, Wettergren L, Lampic C) Psychooncology 2018 Dec;27(12):2770-2777 94 Citations |
| 1 | Outcomes of benign intraductal papillomas diagnosed on core biopsy: a review of 104 cases with subsequent excision from a single institution. (Asirvatham JR, Jorns JM, Zhao L, Jeffries DO, Wu AJ) Virchows Arch 2018 Dec;473(6):679-686 9 Citations |
| 1 | Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity. (Dravis C, Chung CY, Lytle NK, Herrera-Valdez J, Luna G, Trejo CL, Reya T, Wahl GM) Cancer Cell 2018 Sep 10;34(3):466-482.e6 90 Citations |
| 1 | Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. (Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW) FASEB J 2019 Feb;33(2):1644-1657 13 Citations |
| 1 | Obesity and mortality after locoregional breast cancer diagnosis. (Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, Hampton J, Wu XC, Anderson RT, Lipscomb J, Kimmick GG, Cress R, Wilson JF, Sabatino SA, Fleming ST) Breast Cancer Res Treat 2018 Dec;172(3):647-657 7 Citations |
| 2 | Promoting Team-Based Exercise Among African American Breast Cancer Survivors. (Piacentine LB, Robinson KM, Waltke LJ, Tjoe JA, Ng AV) West J Nurs Res 2018 Dec;40(12):1885-1902 11 Citations |
| 2 | Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling. (Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H) Clin Cancer Res 2018 Dec 15;24(24):6355-6366 15 Citations |
| 6 | Community Breast Health Education for Immigrants and Refugees: Lessons Learned in Outreach Efforts to Reduce Cancer Disparities. (Kamaraju S, Olson J, DeNomie M, Visotcky A, Banerjee A, Asan O, Tavares E, Rao A, LaCroix M, Krause K, Neuner J, Stolley M) J Cancer Educ 2019 Dec;34(6):1092-1096 5 Citations |
| 1 | Are Providers and Patients Following Hormonal Therapy Guidelines for Patients Over the Age of 70? The Influence of CALGB 9343. (Cortina CS, Agarwal S, Mulder LL, Poirier J, Rao R, Ansell DA, Madrigrano A) Clin Breast Cancer 2018 Dec;18(6):e1289-e1292 9 Citations |
| 4 | Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67 5 Citations |
| 5 | Increasing Mammography Uptake Through Academic-Community Partnerships Targeting Immigrant and Refugee Communities in Milwaukee. (Kamaraju S, DeNomie M, Visotcky A, Banerjee A, Krause K, Tavares E, Rao A, Drew E, Neuner J, Stolley M) WMJ 2018 Jun;117(2):55-61 13 Citations |
| 1 | An uncommon disease: Periductal stromal tumor of the breast. (Cortina CS, Robin AZ, Lin DM, Gattuso P, Kopkash K, Madrigrano A) Breast J 2018 Nov;24(6):1080-1081 1 Citation |
| 2 | Stromal PTEN determines mammary epithelial response to radiotherapy. (Sizemore GM, Balakrishnan S, Thies KA, Hammer AM, Sizemore ST, Trimboli AJ, Cuitiño MC, Steck SA, Tozbikian G, Kladney RD, Shinde N, Das M, Park D, Majumder S, Krishnan S, Yu L, Fernandez SA, Chakravarti A, Shields PG, White JR, Yee LD, Rosol TJ, Ludwig T, Park M, Leone G, Ostrowski MC) Nat Commun 2018 Jul 17;9(1):2783 18 Citations |
| 1 | Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks. (Do D, Bozdag S) PLoS Comput Biol 2018 Jul;14(7):e1006318 18 Citations |
| 1 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. (Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, Zeng C, Feng H, Gusev A, Barfield RT, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Barrdahl M, Baynes C, Beckmann MW, Benitez J, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brinton L, Broberg P, Brucker SY, Burwinkel B, Caldés T, Canzian F, Carter BD, Castelao JE, Chang-Claude J, Chen X, Cheng TD, Christiansen H, Clarke CL, NBCS Collaborators, Collée M, Cornelissen S, Couch FJ, Cox D, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dörk T, Dos-Santos-Silva I, Dumont M, Dwek M, Eccles DM, Eilber U, Eliassen AH, Engel C, Eriksson M, Fachal L, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Closas M, Gaudet MM, Ghoussaini M, Giles GG, Goldberg MS, Goldgar DE, González-Neira A, Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hallberg E, Hamann U, Harrington P, Hein A, Hicks B, Hillemanns P, Hollestelle A, Hoover RN, Hopper JL, Huang G, Humphreys K, Hunter DJ, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones ME, Jung A, Kaaks R, Kerin MJ, Khusnutdinova E, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Li J, Lindström S, Lissowska J, Lo WY, Loibl S, Lubinski J, Luccarini C, Lux MP, MacInnis RJ, Maishman T, Kostovska IM, Mannermaa A, Manson JE, Margolin S, Mavroudis D, Meijers-Heijboer H, Meindl A, Menon U, Meyer J, Mulligan AM, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Nordestgaard BG, Olopade OI, Olson JE, Olsson H, Peterlongo P, Peto J, Plaseska-Karanfilska D, Prentice R, Presneau N, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Rudolph A, Saloustros E, Sandler DP, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Scott RJ, Scott CG, Seal S, Shah M, Shrubsole MJ, Smeets A, Southey MC, Spinelli JJ, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper W, Taylor JA, Terry MB, Tessier DC, Thomas A, Thöne K, Tollenaar RAEM, Torres D, Truong T, Untch M, Vachon C, Van Den Berg D, Vincent D, Waisfisz Q, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett WC, Winqvist R, Wolk A, Xia L, Yang XR, Ziogas A, Ziv E, kConFab/AOCS Investigators, Dunning AM, Pharoah PDP, Simard J, Milne RL, Edwards SL, Kraft P, Easton DF, Chenevix-Trench G, Zheng W) Nat Genet 2018 Jul;50(7):968-978 137 Citations |
| 3 | The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer. (Kong AL, Nattinger AB, McGinley E, Pezzin LE) Breast Cancer Res Treat 2018 Sep;171(2):477-488 6 Citations |
| 1 | Measuring estrogens in women, men, and children: Recent advances 2012-2017. (Smy L, Straseski JA) Clin Biochem 2018 Dec;62:11-23 18 Citations |
| 1 | Cancer in Pregnancy. (McCormick A, Peterson E) Obstet Gynecol Clin North Am 2018 Jun;45(2):187-200 37 Citations |
| 1 | Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. (Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy B, Zhang X, Ostrowski MC, Leone G, Ganju RK) Oncogene 2018 Aug;37(32):4428-4442 88 Citations |
| 1 | Reducing Muslim Mammography Disparities: Outcomes From a Religiously Tailored Mosque-Based Intervention. (Padela AI, Malik S, Ally SA, Quinn M, Hall S, Peek M) Health Educ Behav 2018 Dec;45(6):1025-1035 21 Citations |
| 1 | A rapid triage protocol to optimize cold ischemic time for breast resection specimens. (East EG, Gabbeart M, Roberts E, Zhao L, Jorns JM) Ann Diagn Pathol 2018 Jun;34:94-97 3 Citations |
| 2 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. (Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Cancer Genome Atlas Research Network, Weinstein JN, Mills GB, Levine DA, Akbani R) Cancer Cell 2018 Apr 09;33(4):690-705.e9 372 Citations |
| 1 | Invasive Mammary Carcinoma With Mixed Invasive Papillary and Glycogen Rich Clear Cell Features. (Solanki MH, Derylo AF, Jorns JM) Int J Surg Pathol 2018 Sep;26(6):569-572 3 Citations |
| 1 | Secretory carcinoma of the parotid with adenoid cystic carcinoma cytological pattern: A cytological-pathological correlation with literature review. (Kravtsov O, Hunt B, Peterson J, Carrillo L, Bonneau P, Giorgadze T) Ann Diagn Pathol 2018 Apr;33:58-61 6 Citations |
| 1 | Metastatic and hematolymphoid neoplasms involving the breast: 20-year experience at a Tertiary Center. (Muller KE, Zhao L, Jorns JM) Breast J 2018 Jul;24(4):680-682 2 Citations |
| 1 | Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. (Floros KV, Lochmann TL, Hu B, Monterrubio C, Hughes MT, Wells JD, Morales CB, Ghotra MS, Costa C, Souers AJ, Boikos SA, Leverson JD, Tan M, Serra V, Koblinski JE, Arribas J, Prat A, Paré L, Miller TW, Dozmorov MG, Harada H, Windle BE, Scaltriti M, Faber AC) Proc Natl Acad Sci U S A 2018 Mar 13;115(11):E2594-E2603 24 Citations |
| 1 | A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. (Rudolph M, Sizemore ST, Lu Y, Teng KY, Basree MM, Reinbolt R, Timmers CD, Leone G, Ostrowski MC, Majumder S, Ramaswamy B) Breast Cancer Res Treat 2018 Jun;169(3):457-467 8 Citations |
| 1 | Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. (Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW) J Exp Med 2018 Mar 05;215(3):895-910 56 Citations |
| 1 | Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. (Jin Y, Hu W, Liu T, Rana U, Aguilera-Barrantes I, Kong A, Kumar SN, Wang B, Gao P, Wang X, Duan Y, Shi A, Song D, Yang M, Li S, Han B, Zhao G, Fan Z, Miao QR) Cancer Lett 2018 Apr 10;419:233-244 13 Citations |
| 1 | Primary Breast Atypical Lipomatous Tumor/ Well-Differentiated Liposarcoma and Dedifferentiated Liposarcoma. (Briski LM, Jorns JM) Arch Pathol Lab Med 2018 Feb;142(2):268-274 11 Citations |
| 1 | Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors. (Sheean P, Arroyo C, Woo J, Schiffer L, Stolley M) J Acad Nutr Diet 2018 Apr;118(4):568-577 2 Citations |
| 1 | Glycogen-Rich Clear Cell Carcinoma: A Rare Variant of Breast Carcinoma of Uncertain Significance. (Akagi NE, Jorns JM) Int J Surg Pathol 2018 Sep;26(6):530-531 1 Citation |
| 1 | Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment. (Qu LT, Peters S, Cobb AN, Godellas CV, Perez CB, Vaince FT) Am J Surg 2018 Mar;215(3):530-533 6 Citations |
| 5 | Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. (Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA) J Cancer Surviv 2018 Apr;12(2):268-275 8 Citations |
| 4 | Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D. (Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE) J Natl Compr Canc Netw 2017 Dec;15(12):1509-1517 2 Citations |
| 1 | Pleomorphic Lobular Carcinoma: A Controversially Aggressive Variant of Invasive Lobular Carcinoma of the Breast. (Abdelkader A, Jorns JM) Int J Surg Pathol 2018 Aug;26(5):434-436 3 Citations |
| 1 | Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. (Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC, Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Geriatr Oncol 2018 May;9(3):214-220 23 Citations |
| 1 | Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. (Krishnamurthy N, Kurzrock R) Cancer Treat Rev 2018 Jan;62:50-60 720 Citations |
| 1 | Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. (McFall T, McKnight B, Rosati R, Kim S, Huang Y, Viola-Villegas N, Ratnam M) J Biol Chem 2018 Jan 26;293(4):1163-1177 31 Citations |
| 1 | Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up. (Muller KE, Roberts E, Zhao L, Jorns JM) Arch Pathol Lab Med 2018 Mar;142(3):391-395 16 Citations |
| 1 | Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer. (Yang W, Hosford SR, Traphagen NA, Shee K, Demidenko E, Liu S, Miller TW) FASEB J 2018 Mar;32(3):1222-1235 21 Citations |
| 5 | Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer. (Yen TWF, Laud PW, Pezzin LE, McGinley EL, Wozniak E, Sparapani R, Nattinger AB) Med Care 2018 Jan;56(1):78-84 13 Citations |
| 1 | Association analysis identifies 65 new breast cancer risk loci. (Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal L, McCue K, McCart Reed AE, Ghoussaini M, Carroll JS, Jiang X, Finucane H, Adams M, Adank MA, Ahsan H, Aittomäki K, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Arun B, Auer PL, Bacot F, Barrdahl M, Baynes C, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Brinton L, Broberg P, Brock IW, Broeks A, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Butterbach K, Cai Q, Cai H, Caldés T, Canzian F, Carracedo A, Carter BD, Castelao JE, Chan TL, David Cheng TY, Seng Chia K, Choi JY, Christiansen H, Clarke CL, NBCS Collaborators, Collée M, Conroy DM, Cordina-Duverger E, Cornelissen S, Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Elvira M, Engel C, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gaborieau V, Gabrielson M, Gago-Dominguez M, Gao YT, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hamel N, Hankinson S, Harrington P, Hart SN, Hartikainen JM, Hartman M, Hein A, Heyworth J, Hicks B, Hillemanns P, Ho DN, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Hou MF, Hsiung CN, Huang G, Humphreys K, Ishiguro J, Ito H, Iwasaki M, Iwata H, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kasuga Y, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Kosma VM, Kristensen VN, Krüger U, Kwong A, Lambrechts D, Le Marchand L, Lee E, Lee MH, Lee JW, Neng Lee C, Lejbkowicz F, Li J, Lilyquist J, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Lophatananon A, Lubinski J, Luccarini C, Lux MP, Ma ESK, MacInnis RJ, Maishman T, Makalic E, Malone KE, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mariapun S, Martinez ME, Matsuo K, Mavroudis D, McKay J, McLean C, Meijers-Heijboer H, Meindl A, Menéndez P, Menon U, Meyer J, Miao H, Miller N, Taib NAM, Muir K, Mulligan AM, Mulot C, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Noh DY, Nordestgaard BG, Norman A, Olopade OI, Olson JE, Olsson H, Olswold C, Orr N, Pankratz VS, Park SK, Park-Simon TW, Lloyd R, Perez JIA, Peterlongo P, Peto J, Phillips KA, Pinchev M, Plaseska-Karanfilska D, Prentice R, Presneau N, Prokofyeva D, Pugh E, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Ruddy KJ, Rüdiger T, Rudolph A, Ruebner M, Rutgers EJT, Saloustros E, Sandler DP, Sangrajrang S, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Scott RJ, Scott C, Seal S, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng G, Sherman ME, Shrubsole MJ, Shu XO, Smeets A, Sohn C, Southey MC, Spinelli JJ, Stegmaier C, Stewart-Brown S, Stone J, Stram DO, Surowy H, Swerdlow A, Tamimi R, Taylor JA, Tengström M, Teo SH, Beth Terry M, Tessier DC, Thanasitthichai S, Thöne K, Tollenaar RAEM, Tomlinson I, Tong L, Torres D, Truong T, Tseng CC, Tsugane S, Ulmer HU, Ursin G, Untch M, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van der Kolk L, van der Luijt RB, Vincent D, Vollenweider J, Waisfisz Q, Wang-Gohrke S, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yamaji T, Yang XR, Har Yip C, Yoo KY, Yu JC, Zheng W, Zheng Y, Zhu B, Ziogas A, Ziv E, ABCTB Investigators, ConFab/AOCS Investigators, Lakhani SR, Antoniou AC, Droit A, Andrulis IL, Amos CI, Couch FJ, Pharoah PDP, C) Nature 2017 Nov 02;551(7678):92-94 835 Citations |
| 1 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. (Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang Q, Aalfs CM, ABCTB Investigators, Adams M, Adlard J, Agata S, Ahmed S, Ahsan H, Aittomäki K, Al-Ejeh F, Allen J, Ambrosone CB, Amos CI, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, Aronson KJ, Auber B, Auer PL, Ausems MGEM, Azzollini J, Bacot F, Balmaña J, Barile M, Barjhoux L, Barkardottir RB, Barrdahl M, Barnes D, Barrowdale D, Baynes C, Beckmann MW, Benitez J, Bermisheva M, Bernstein L, Bignon YJ, Blazer KR, Blok MJ, Blomqvist C, Blot W, Bobolis K, Boeckx B, Bogdanova NV, Bojesen A, Bojesen SE, Bonanni B, Børresen-Dale AL, Bozsik A, Bradbury AR, Brand JS, Brauch H, Brenner H, Bressac-de Paillerets B, Brewer C, Brinton L, Broberg P, Brooks-Wilson A, Brunet J, Brüning T, Burwinkel B, Buys SS, Byun J, Cai Q, Caldés T, Caligo MA, Campbell I, Canzian F, Caron O, Carracedo A, Carter BD, Castelao JE, Castera L, Caux-Moncoutier V, Chan SB, Chang-Claude J, Chanock SJ, Chen X, Cheng TD, Chiquette J, Christiansen H, Claes KBM, Clarke CL, Conner T, Conroy DM, Cook J, Cordina-Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks E, Diez O, Ding YC, Ditsch N, Doheny KF, Domchek SM, Dorfling CM, Dörk T, Dos-Santos-Silva I, Dubois S, Dugué PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles D, Eeles R, Ehrencrona H, Eilber U, Ejlertsen B, Ekici AB, Eliassen AH, EMBRACE, Engel C, Eriksson M, Fachal L, Faivre L, Fasching PA, Faust U, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost D, Gabrielson M, Gaddam P, Gammon MD, Ganz PA, Gapstur SM, Garber J, Garcia-Barberan V, García-Sáenz JA, Gaudet MM, Gauthier-Villars M, Gehrig A, GEMO Study Collaborators, Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Goodfellow P, Greene MH, Alnæs GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Guénel P, Guo Q, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hallberg E, Hamann U, Hamel N, Hankinson S, Hansen TVO, Harrington P, Hart SN, Hartikainen JM, Healey CS, HEBON, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kast K, kConFab/AOCS Investigators, Keeman R, Kerin MJ, Kets CM, Keupers M, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou I, Kosma VM, Kristensen VN, Kruse TA, Kwong A, Lænkholm AV, Laitman Y, Lalloo F, Lambrechts D, Landsman K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini C, Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Menéndez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan AM, Mulot C, Nadesan S, Nathanson KL, NBSC Collaborators, Neuhausen SL, Nevanlinna H, Nevelsteen I, Niederacher D, Nielsen SF, Nordestgaard BG, Norman A, Nussbaum RL, Olah E, Olopade OI, Olson JE, Olswold C, Ong KR, Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice R, Presneau N, Prokofieva D, Pugh E, Pujana MA, Pylkäs K, Rack B, Radice) Nat Genet 2017 Dec;49(12):1767-1778 223 Citations |
| 1 | Cancer stemness in bone marrow micrometastases of human breast cancer. (Kuo MC, Kothari AN, Kuo PC, Mi Z) Surgery 2018 Feb;163(2):330-335 17 Citations |
| 1 | Localization for Breast Surgery: The Next Generation. (Jeffries DO, Dossett LA, Jorns JM) Arch Pathol Lab Med 2017 Oct;141(10):1324-1329 60 Citations |
| 2 | Socioeconomic status and breast cancer treatment. (Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE) Breast Cancer Res Treat 2018 Jan;167(1):1-8 99 Citations |
| 1 | Primary atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) of the breast. (Briski LM, Jeffries DO, Jorns JM) Breast J 2018 May;24(3):400-401 |
| 1 | Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice. (Patten CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, Forster MR, Robinson M, White RL Jr) J Surg Oncol 2017 Dec;116(8):1040-1045 20 Citations |
| 1 | Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer. (Walter KR, Goodman ML, Singhal H, Hall JA, Li T, Holloran SM, Trinca GM, Gibson KA, Jin VX, Greene GL, Hagan CR) Mol Cancer Res 2017 Oct;15(10):1331-1340 27 Citations |
| 1 | Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis. (Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R) Nat Commun 2017 Jun 26;8:15908 109 Citations |
| 1 | Vaginal Testosterone for Management of Aromatase Inhibitor-Related Sexual Dysfunction: An Integrative Review. (Lemke EA, Madsen LT, Dains JE) Oncol Nurs Forum 2017 May 01;44(3):296-301 9 Citations |
| 3 | Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors. (Stolley M, Sheean P, Gerber B, Arroyo C, Schiffer L, Banerjee A, Visotcky A, Fantuzzi G, Strahan D, Matthews L, Dakers R, Carridine-Andrews C, Seligman K, Springfield S, Odoms-Young A, Hong S, Hoskins K, Kaklamani V, Sharp L) J Clin Oncol 2017 Aug 20;35(24):2820-2828 38 Citations |
| 1 | Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. (Liu H, Dowdle JA, Khurshid S, Sullivan NJ, Bertos N, Rambani K, Mair M, Daniel P, Wheeler E, Tang X, Toth K, Lause M, Harrigan ME, Eiring K, Sullivan C, Sullivan MJ, Chang SW, Srivastava S, Conway JS, Kladney R, McElroy J, Bae S, Lu Y, Tofigh A, Saleh SMI, Fernandez SA, Parvin JD, Coppola V, Macrae ER, Majumder S, Shapiro CL, Yee LD, Ramaswamy B, Hallett M, Ostrowski MC, Park M, Chamberlin HM, Leone G) Dev Cell 2017 May 22;41(4):392-407.e6 23 Citations |
| 1 | Institutional variation in surgical care for early-stage breast cancer at community hospitals. (Dodgion CM, Lipsitz SR, Decker MR, Hu YY, Quamme SRP, Karcz A, D'Avolio L, Greenberg CC) J Surg Res 2017 May 01;211:196-205 2 Citations |
| 1 | Negative psychological consequences of breast cancer among recently diagnosed ethnically diverse women. (Tejeda S, Stolley MR, Vijayasiri G, Campbell RT, Estwing Ferrans C, Warnecke RB, Rauscher GH) Psychooncology 2017 Dec;26(12):2245-2252 19 Citations |
| 1 | ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer. (Baur B, Bozdag S) Genomics 2017 Jul;109(3-4):233-240 2 Citations |
| 1 | Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer. (Hampsch RA, Shee K, Bates D, Lewis LD, Désiré L, Leblond B, Demidenko E, Stefan K, Huang YH, Miller TW) Oncotarget 2017 Mar 28;8(13):21806-21817 30 Citations |
| 1 | Metaplastic Carcinoma With Extensive Chondromyxoid Differentiation Arising in Association With Microglandular Adenosis. (Muller KE, Jorns JM) Int J Surg Pathol 2017 Sep;25(6):513-514 3 Citations |
| 1 | Characteristics of a Breast Pathology Consultation Practice. (East EG, Zhao L, Pang JC, Jorns JM) Arch Pathol Lab Med 2017 Apr;141(4):578-584 4 Citations |
| 2 | Measures Matter: The Local Exposure/Isolation (LEx/Is) Metrics and Relationships between Local-Level Segregation and Breast Cancer Survival. (Bemanian A, Beyer KM) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):516-524 27 Citations |
| 1 | Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis. (Costa R, Gill N, Rademaker AW, Carneiro BA, Chae YK, Kumthekar P, Gradishar WJ, Kurzrock R, Giles FJ) Cancer Treat Rev 2017 Apr;55:10-15 20 Citations |
| 1 | Frozen sections in patients undergoing breast conserving surgery at a single ambulatory surgical center: 5 year experience. (Jorns JM, Daignault S, Sabel MS, Myers JL, Wu AJ) Eur J Surg Oncol 2017 Jul;43(7):1273-1281 12 Citations |
| 1 | Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. (Saab J, Hoda RS, Narula N, Hoda SA, Geraghty BE, Nasar A, Alperstein SA, Port JL, Giorgadze T) Cancer Cytopathol 2017 Feb;125(2):128-137 39 Citations |
| 1 | Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. (Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, Singh P, Chi YI, Wang C, Dong C, Li W, Tao M, Napier D, Shi Q, Deng J, Evers BM, Zhou BP) Nat Commun 2017 Feb 15;8:14228 104 Citations |
| 4 | Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling. (Dong L, Yuan Y, Opansky C, Chen Y, Aguilera-Barrantes I, Wu S, Yuan R, Cao Q, Cheng YC, Sahoo D, Silverstein RL, Ren B) Oncotarget 2017 Apr 04;8(14):22550-22562 28 Citations |
| 1 | The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. (Viswanathan AN, Erickson BA, Ibbott GS, Small W Jr, Eifel PJ) Brachytherapy 2017;16(1):68-74 10 Citations |
| 1 | The Nogo-B receptor promotes Ras plasma membrane localization and activation. (Zhao B, Hu W, Kumar S, Gonyo P, Rana U, Liu Z, Wang B, Duong WQ, Yang Z, Williams CL, Miao QR) Oncogene 2017 Jun 15;36(24):3406-3416 25 Citations |
| 1 | Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach. (Zhang X, Li Y, Akinyemiju T, Ojesina AI, Buckhaults P, Liu N, Xu B, Yi N) Genetics 2017 Jan;205(1):89-100 29 Citations |
| 3 | Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D. (Nattinger AB, Wozniak EM, McGinley EL, Li J, Laud P, Pezzin LE) Med Care 2017 May;55(5):463-469 14 Citations |
| 2 | Triathlon training for women breast cancer survivors: feasibility and initial efficacy. (Ng AV, Cybulski AN, Engel AA, Papanek PE, Sheffer MA, Waltke LJ, Tjoe JA) Support Care Cancer 2017 May;25(5):1465-1473 13 Citations |
| 4 | Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. (Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM) J Clin Oncol 2016 Dec 20;34(36):4398-4404 32 Citations |
| 1 | Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample. (Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJ) Breast Cancer Res Treat 2017 Jan;161(2):375-384 20 Citations |
| 1 | Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer. (Hosford SR, Dillon LM, Bouley SJ, Rosati R, Yang W, Chen VS, Demidenko E, Morra RP Jr, Miller TW) Clin Cancer Res 2017 Jun 01;23(11):2795-2805 26 Citations |
| 5 | Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study. (Yen TW, Pezzin LE, Li J, Sparapani R, Laud PW, Nattinger AB) Cancer 2017 May 15;123(6):957-966 31 Citations |
| 1 | Fertility drugs and cancer: a guideline. (Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine) Fertil Steril 2016 Dec;106(7):1617-1626 35 Citations |
| 1 | Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer. (Wang Y, Mark KM, Ung MH, Kettenbach A, Miller T, Xu W, Cheng W, Xia T, Cheng C) Genome Med 2016 Oct 27;8(1):114 2 Citations |
| 1 | Papillary Lesions of the Breast: A Practical Approach to Diagnosis. (Jorns JM) Arch Pathol Lab Med 2016 Oct;140(10):1052-9 19 Citations |
| 1 | Contraception for the perimenopausal woman. (Linton A, Golobof A, Shulman LP) Climacteric 2016 Dec;19(6):526-534 9 Citations |
| 3 | Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. (Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL) Am J Surg 2016 Oct;212(4):660-669 153 Citations |
| 1 | Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls. (Sheean P, Liang H, Schiffer L, Arroyo C, Stolley M) J Cancer Surviv 2017 Feb;11(1):102-110 8 Citations |
| 5 | A statewide controlled trial intervention to reduce use of unproven or ineffective breast cancer care. (Pezzin LE, Laud P, Neuner J, Yen TW, Nattinger AB) Contemp Clin Trials 2016 Sep;50:150-6 3 Citations |
| 7 | Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer. (Bergom C, Kelly T, Bedi M, Saeed H, Prior P, Rein LE, Szabo A, Wilson JF, Currey AD, White J) Int J Radiat Oncol Biol Phys 2016 Sep 01;96(1):65-71 21 Citations |
| 1 | Ultrasound-Guided Placement of Gold Fiducial Markers for Stereotactic Partial-Breast Irradiation. (Seiler S, Rahimi A, Choudhery S, Garwood D, Spangler A, Cherian S, Goudreau S) AJR Am J Roentgenol 2016 Sep;207(3):685-8 14 Citations |
| 4 | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer. (Yen TWF, Li J, Sparapani RA, Laud PW, Nattinger AB) Medicine (Baltimore) 2016 Aug;95(31):e4392 18 Citations |
| 1 | The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. (Margonis GA, Buettner S, Sasaki K, Kim Y, Ratti F, Russolillo N, Ferrero A, Berger N, Gamblin TC, Poultsides G, Tran T, Postlewait LM, Maithel S, Michaels AD, Bauer TW, Marques H, Barroso E, Aldrighetti L, Pawlik TM) HPB (Oxford) 2016 Aug;18(8):700-5 44 Citations |
| 1 | Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. (White J, Winter K, Kuske RR, Bolton JS, Arthur DW, Scroggins T, Rabinovitch RA, Kelly T, Toonkel LM, Vicini FA, McCormick B) Int J Radiat Oncol Biol Phys 2016 Aug 01;95(5):1460-1465 45 Citations |
| 1 | Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. (Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J, International Radiogenomics Consortium (RgC)) Radiother Oncol 2016 Dec;121(3):431-439 88 Citations |
| 1 | MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells. (Deng W, Wang Y, Gu L, Duan B, Cui J, Zhang Y, Chen Y, Sun S, Dong J, Du J) BMC Cancer 2016 Jul 18;16:489 50 Citations |
| 1 | Religious beliefs and mammography intention: findings from a qualitative study of a diverse group of American Muslim women. (Padela AI, Vu M, Muhammad H, Marfani F, Mallick S, Peek M, Quinn MT) Psychooncology 2016 Oct;25(10):1175-1182 45 Citations |
| 3 | Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. (Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM) J Natl Compr Canc Netw 2016 Jul;14(7):875-80 6 Citations |
| 2 | Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body. (Campoy EM, Laurito SR, Branham MT, Urrutia G, Mathison A, Gago F, Orozco J, Urrutia R, Mayorga LS, Roqué M) PLoS One 2016;11(7):e0157416 7 Citations |
| 1 | Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection. (Jorns JM, Kidwell KM) Am J Clin Pathol 2016 Jul;146(1):57-66 31 Citations |
| 2 | Breast Cancer Screening and Prevention. (Nattinger AB, Mitchell JL) Ann Intern Med 2016 Jun 07;164(11):ITC81-ITC96 26 Citations |
| 1 | Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. (Akinyemiju T, Moore JX, Ojesina AI, Waterbor JW, Altekruse SF) Breast Cancer Res Treat 2016 Jun;157(3):575-86 62 Citations |
| 1 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. (Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, Gail MH, Graubard BI, Haiman CA, Hankinson SE, Hoover RN, Isaacs C, Kolonel LN, Le Marchand L, Lee IM, Lindström S, Overvad K, Romieu I, Sanchez MJ, Southey MC, Stram DO, Tumino R, VanderWeele TJ, Willett WC, Zhang S, Buring JE, Canzian F, Gapstur SM, Henderson BE, Hunter DJ, Giles GG, Prentice RL, Ziegler RG, Kraft P, Garcia-Closas M, Chatterjee N) JAMA Oncol 2016 Oct 01;2(10):1295-1302 245 Citations |
| 1 | RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. (Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, Batra SK, Ouellette MM, Yan Y) Oncogene 2016 Dec 08;35(49):6319-6329 57 Citations |
| 4 | New spatially continuous indices of redlining and racial bias in mortgage lending: links to survival after breast cancer diagnosis and implications for health disparities research. (Beyer KM, Zhou Y, Matthews K, Bemanian A, Laud PW, Nattinger AB) Health Place 2016 Jul;40:34-43 89 Citations |
| 1 | MetaKTSP: a meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis. (Kim S, Lin CW, Tseng GC) Bioinformatics 2016 Jul 01;32(13):1966-73 29 Citations |
| 1 | Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer. (Chamberlin MD, Bernhardt EB, Miller TW) J Cell Biochem 2016 Nov;117(11):2454-63 8 Citations |
| 1 | Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers. (Muller KE, Marotti JD, de Abreu FB, Peterson JD, Miller TW, Chamberlin MD, Tsongalis GJ, Tafe LJ) Exp Mol Pathol 2016 Jun;100(3):421-5 26 Citations |
| 2 | Missed Breast Cancer: What Can We Learn? (Wadhwa A, Sullivan JR, Gonyo MB) Curr Probl Diagn Radiol 2016;45(6):402-419 31 Citations |
| 1 | Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors. (Rauscher GH, Campbell RT, Wiley EL, Hoskins K, Stolley MR, Warnecke RB) Am J Epidemiol 2016 May 15;183(10):884-93 19 Citations |
| 4 | Breast and Colorectal Cancer Survival Disparities in Southeastern Wisconsin. (Beyer KM, Zhou Y, Matthews K, Hoormann K, Bemanian A, Laud PW, Nattinger AB) WMJ 2016 Feb;115(1):17-21 19 Citations |
| 4 | A Comparison of Lumpectomy Cavity Delineations Between Use of Magnetic Resonance Imaging and Computed Tomography Acquired With Patient in Prone Position for Radiation Therapy Planning of Breast Cancer. (Huang W, Currey A, Chen X, Li B, Bergom C, Kelly T, Wilson JF, Li XA) Int J Radiat Oncol Biol Phys 2016 Mar 15;94(4):832-40 13 Citations |
| 1 | Cutaneous metastasis of breast adenoid cystic carcinoma to the scalp. (Little AJ, Seline AE, Swick BL, Wanat KA) J Cutan Pathol 2016 Aug;43(8):684-7 5 Citations |
| 1 | A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data. (Baur B, Bozdag S) PLoS One 2016;11(2):e0148977 24 Citations |
| 1 | Cost Differential of Chemotherapy for Solid Tumors. (Nadeem H, Jayakrishnan TT, Rajeev R, Johnston FM, Gamblin TC, Turaga KK) J Oncol Pract 2016 Mar;12(3):e299-307, 251 11 Citations |
| 1 | Perceived cognitive changes with chemotherapy for breast cancer: A pilot study. (Piacentine LB, Miller JF, Haberlein S, Bloom AS) Appl Nurs Res 2016 Feb;29:9-11 9 Citations |
| 1 | Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue. (Inyang A, Thomas DG, Jorns J) Breast J 2016 May;22(3):282-6 21 Citations |
| 2 | The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases. (Bergom C, Hauser AD, Rymaszewski A, Gonyo P, Prokop JW, Jennings BC, Lawton AJ, Frei A, Lorimer EL, Aguilera-Barrantes I, Mackinnon AC, Noon K, Fierke CA, Williams CL) J Biol Chem 2016 Mar 18;291(12):6534-45 24 Citations |
| 1 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. (Gaudet MM, Barrdahl M, Lindström S, Travis RC, Auer PL, Buring JE, Chanock SJ, Eliassen AH, Gapstur SM, Giles GG, Gunter M, Haiman C, Hunter DJ, Joshi AD, Kaaks R, Khaw KT, Lee IM, Le Marchand L, Milne RL, Peeters PH, Sund M, Tamimi R, Trichopoulou A, Weiderpass E, Yang XR, Prentice RL, Feigelson HS, Canzian F, Kraft P) Breast Cancer Res Treat 2016 Feb;155(3):531-40 1 Citation |
| 2 | Survivors speak: a qualitative analysis of motivational factors influencing breast cancer survivors' participation in a sprint distance triathlon. (Robinson KM, Piacentine LB, Waltke LJ, Ng AV, Tjoe JA) J Clin Nurs 2016 Jan;25(1-2):247-56 12 Citations |
| 1 | Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer. (Yang W, Hosford SR, Dillon LM, Shee K, Liu SC, Bean JR, Salphati L, Pang J, Zhang X, Nannini MA, Demidenko E, Bates D, Lewis LD, Marotti JD, Eastman AR, Miller TW) Clin Cancer Res 2016 May 01;22(9):2250-60 26 Citations |
| 1 | Study design and protocol for moving forward: a weight loss intervention trial for African-American breast cancer survivors. (Stolley MR, Sharp LK, Fantuzzi G, Arroyo C, Sheean P, Schiffer L, Campbell R, Gerber B) BMC Cancer 2015 Dec 29;15:1018 22 Citations |
| 1 | Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer. (Branham MT, Campoy E, Laurito S, Branham R, Urrutia G, Orozco J, Gago F, Urrutia R, Roqué M) Breast Cancer Res Treat 2016 Jan;155(1):13-23 12 Citations |
| 1 | Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma. (East EG, Pang JC, Kidwell KM, Jorns JM) Am J Clin Pathol 2015 Dec;144(6):952-9 9 Citations |
| 2 | Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy. (Nudelman KN, McDonald BC, Wang Y, Smith DJ, West JD, O'Neill DP, Zanville NR, Champion VL, Schneider BP, Saykin AJ) J Clin Oncol 2016 Mar 01;34(7):677-83 39 Citations |
| 5 | Reexamining the Relationship of Breast Cancer Hospital and Surgical Volume to Mortality: An Instrumental Variable Analysis. (Pezzin LE, Laud P, Yen TW, Neuner J, Nattinger AB) Med Care 2015 Dec;53(12):1033-9 28 Citations |
| 1 | Erythropoietin Stimulates Tumor Growth via EphB4. (Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, Nagaraja AS, Previs RA, Vivas-Mejia P, Han HD, Hu W, Mangala LS, Zand B, Stagg LJ, Ladbury JE, Ozpolat B, Alpay SN, Nishimura M, Stone RL, Matsuo K, Armaiz-Peña GN, Dalton HJ, Danes C, Goodman B, Rodriguez-Aguayo C, Kruger C, Schneider A, Haghpeykar S, Jaladurgam P, Hung MC, Coleman RL, Liu J, Li C, Urbauer D, Lopez-Berestein G, Jackson DB, Sood AK) Cancer Cell 2015 Nov 09;28(5):610-622 71 Citations |
| 1 | Acoustic Properties of Breast Fat. (Nasief HG, Rosado-Mendez IM, Zagzebski JA, Hall TJ) J Ultrasound Med 2015 Nov;34(11):2007-16 22 Citations |
| 2 | Reducing the Human Burden of Breast Cancer: Advanced Radiation Therapy Yields Improved Treatment Outcomes. (Currey AD, Bergom C, Kelly TR, Wilson JF) Breast J 2015;21(6):610-20 7 Citations |
| 1 | Morphologic Mimics of Invasive Lobular Carcinoma. (Ishikawa MK, Pinsky RW, Smith LB, Jorns JM) Arch Pathol Lab Med 2015 Oct;139(10):1253-7 10 Citations |
| 3 | Identifying patterns of breast cancer care provided at high-volume hospitals: a classification and regression tree analysis. (Kong AL, Pezzin LE, Nattinger AB) Breast Cancer Res Treat 2015 Oct;153(3):689-98 19 Citations |
| 1 | Weight Measurement and Volumetric Displacement of Breast Implants and Tissue Expanders: Why Port and Shell Volumes Matter in Breast Reconstruction, Augmentation, and Revision. (Wenzel CG, Wacholtz WF, Janssen DA, Bengtson BP) Clin Plast Surg 2015 Oct;42(4):481-91 2 Citations |
| 1 | Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges. (McFall T, Patki M, Rosati R, Ratnam M) Oncotarget 2015 Oct 20;6(32):33146-64 13 Citations |
| 1 | Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells. (Hsu PY, Hsu HK, Hsiao TH, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH) Oncogene 2016 May 05;35(18):2379-89 16 Citations |
| 3 | Perceived Neighborhood Quality and Cancer Screening Behavior: Evidence from the Survey of the Health of Wisconsin. (Beyer KM, Malecki KM, Hoormann KA, Szabo A, Nattinger AB) J Community Health 2016 Feb;41(1):134-7 21 Citations |
| 1 | Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center. (Parker BA, Schwaederlé M, Scur MD, Boles SG, Helsten T, Subramanian R, Schwab RB, Kurzrock R) J Oncol Pract 2015 Nov;11(6):442-9 51 Citations |
| 1 | β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells. (Wilson JM, Lorimer E, Tyburski MD, Williams CL) Cancer Biol Ther 2015;16(9):1364-74 41 Citations |
| 4 | Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). (Ma S, Yin N, Qi X, Pfister SL, Zhang MJ, Ma R, Chen G) Oncotarget 2015 May 30;6(15):13320-33 15 Citations |
| 1 | XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. (Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, Rattay T, Suga T, Kerns SL, Bourgier C, Vallis KA, Sautter-Bihl ML, Claßen J, Debus J, Schnabel T, Rosenstein BS, Wenz F, West CM, Popanda O, Chang-Claude J) Int J Radiat Oncol Biol Phys 2015 Aug 01;92(5):1084-1092 62 Citations |
| 1 | Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study. (Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF) J Oncol Pract 2015 Jul;11(4):e460-7 15 Citations |
| 1 | Multiple gene aberrations and breast cancer: lessons from super-responders. (Wheler JJ, Atkins JT, Janku F, Moulder SL, Yelensky R, Stephens PJ, Kurzrock R) BMC Cancer 2015 May 29;15:442 14 Citations |
| 1 | Exploring Diet, Physical Activity, and Quality of Life in Females with Metastatic Breast Cancer: A Pilot Study to Support Future Intervention. (Sheean P, Kabir C, Rao R, Hoskins K, Stolley M) J Acad Nutr Diet 2015 Oct;115(10):1690-8 17 Citations |
| 5 | The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. (Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE) J Natl Cancer Inst 2015 Aug;107(8) 39 Citations |
| 1 | Breast lumps: a rare site for rheumatoid nodules. (Iqbal FM, Ali H, Vidya R) BMJ Case Rep 2015 Apr 22;2015 8 Citations |
| 1 | Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. (Moulder S, Helgason T, Janku F, Wheler J, Moroney J, Booser D, Albarracin C, Morrow PK, Atkins J, Koenig K, Gilcrease M, Kurzrock R) Ann Oncol 2015 Jul;26(7):1346-52 48 Citations |
| 1 | A canonical correlation analysis-based dynamic bayesian network prior to infer gene regulatory networks from multiple types of biological data. (Baur B, Bozdag S) J Comput Biol 2015 Apr;22(4):289-99 18 Citations |
| 1 | Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case-control study. (Sheean P, Liang H, Schiffer L, Arroyo C, Troy K, Stolley M) J Cancer Surviv 2016 Feb;10(1):21-30 8 Citations |
| 2 | A one-to-one mentoring support service for breast cancer survivors. (Amin AL, Neuner J, Duthie EA, Finn VR, Kong AL) WMJ 2014 Oct;113(5):185-9 7 Citations |
| 1 | SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. (Gonzalez-Angulo AM, Krop I, Akcakanat A, Chen H, Liu S, Li Y, Culotta KS, Tarco E, Piha-Paul S, Moulder-Thompson S, Velez-Bravo V, Sahin AA, Doyle LA, Do KA, Winer EP, Mills GB, Kurzrock R, Meric-Bernstam F) J Natl Cancer Inst 2015 Mar;107(3) 28 Citations |
| 2 | Racial differences in the surgical management of papillary lesions diagnosed by core needle biopsy. (Kong AL, Saving A, Rathke S, Basir Z, Yen TW) Breast J 2015;21(2):203-4 |
| 1 | Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. (Sine J, Urban C, Thayer D, Charron H, Valim N, Tata DB, Schiff R, Blumenthal R, Joshi A, Puri A) Int J Nanomedicine 2015;10:125-45 28 Citations |
| 1 | Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer. (Weber CE, Kothari AN, Wai PY, Li NY, Driver J, Zapf MA, Franzen CA, Gupta GN, Osipo C, Zlobin A, Syn WK, Zhang J, Kuo PC, Mi Z) Oncogene 2015 Sep 10;34(37):4821-33 161 Citations |
| 1 | MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. (Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE) Cell Stem Cell 2014 Dec 04;15(6):762-74 147 Citations |
| 1 | The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer. (Bean JR, Hosford SR, Symonds LK, Owens P, Dillon LM, Yang W, Shee K, Schwartz GN, Marotti JD, Muller KE, Rosenkranz KM, Barth RJ, Chen VS, Agarwal VR, Miller TW) Breast Cancer Res Treat 2015 Jan;149(1):69-79 13 Citations |
| 2 | Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers. (Chaluvally-Raghavan P, Zhang F, Pradeep S, Hamilton MP, Zhao X, Rupaimoole R, Moss T, Lu Y, Yu S, Pecot CV, Aure MR, Peuget S, Rodriguez-Aguayo C, Han HD, Zhang D, Venkatanarayan A, Krohn M, Kristensen VN, Gagea M, Ram P, Liu W, Lopez-Berestein G, Lorenzi PL, Børresen-Dale AL, Chin K, Gray J, Dusetti NJ, McGuire SE, Flores ER, Sood AK, Mills GB) Cancer Cell 2014 Dec 08;26(6):863-879 44 Citations |
| 4 | Adaptive replanning to account for lumpectomy cavity change in sequential boost after whole-breast irradiation. (Chen X, Qiao Q, DeVries A, Li W, Currey A, Kelly T, Bergom C, Wilson JF, Li XA) Int J Radiat Oncol Biol Phys 2014 Dec 01;90(5):1208-15 14 Citations |
| 1 | Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. (Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R) Oncotarget 2014 Nov 15;5(21):10280-92 49 Citations |
| 1 | Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma. (Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW) Arch Pathol Lab Med 2014 Nov;138(11):1507-13 3 Citations |
| 1 | Unique molecular landscapes in cancer: implications for individualized, curated drug combinations. (Wheler J, Lee JJ, Kurzrock R) Cancer Res 2014 Dec 15;74(24):7181-4 55 Citations |
| 1 | Is intraoperative frozen section analysis of reexcision specimens of value in preventing reoperation in breast-conserving therapy? (Jorns JM, Daignault S, Sabel MS, Wu AJ) Am J Clin Pathol 2014 Nov;142(5):601-8 24 Citations |
| 1 | P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. (Dillon LM, Bean JR, Yang W, Shee K, Symonds LK, Balko JM, McDonald WH, Liu S, Gonzalez-Angulo AM, Mills GB, Arteaga CL, Miller TW) Oncogene 2015 Jul 23;34(30):3968-76 64 Citations |
| 1 | Lobular neoplasia: morphology and management. (Jorns J, Sabel MS, Pang JC) Arch Pathol Lab Med 2014 Oct;138(10):1344-9 18 Citations |
| 1 | CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth. (Mathsyaraja H, Thies K, Taffany DA, Deighan C, Liu T, Yu L, Fernandez SA, Shapiro C, Otero J, Timmers C, Lustberg MB, Chalmers J, Leone G, Ostrowski MC) Oncogene 2015 Jul;34(28):3651-61 54 Citations |
| 1 | Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision. (Walters LL, Pang JC, Zhao L, Jorns JM) Histopathology 2015 Mar;66(4):577-86 7 Citations |
| 1 | Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. (Fu X, Creighton CJ, Biswal NC, Kumar V, Shea M, Herrera S, Contreras A, Gutierrez C, Wang T, Nanda S, Giuliano M, Morrison G, Nardone A, Karlin KL, Westbrook TF, Heiser LM, Anur P, Spellman P, Guichard SM, Smith PD, Davies BR, Klinowska T, Lee AV, Mills GB, Rimawi MF, Hilsenbeck SG, Gray JW, Joshi A, Osborne CK, Schiff R) Breast Cancer Res 2014 Sep 11;16(5):430 63 Citations |
| 1 | Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. (Wu X, Zhang W, Font-Burgada J, Palmer T, Hamil AS, Biswas SK, Poidinger M, Borcherding N, Xie Q, Ellies LG, Lytle NK, Wu LW, Fox RG, Yang J, Dowdy SF, Reya T, Karin M) Proc Natl Acad Sci U S A 2014 Sep 23;111(38):13870-5 82 Citations |
| 4 | An algorithm to identify the development of lymphedema after breast cancer treatment. (Yen TW, Laud PW, Sparapani RA, Li J, Nattinger AB) J Cancer Surviv 2015 Jun;9(2):161-71 5 Citations |
| 5 | CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. (Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ) Cancer Res 2014 Nov 15;74(22):6419-29 25 Citations |
| 1 | A planning comparison of 7 irradiation options allowed in RTOG 1005 for early-stage breast cancer. (Chen GP, Liu F, White J, Vicini FA, Freedman GM, Arthur DW, Li XA) Med Dosim 2015;40(1):21-5 22 Citations |
| 1 | Comparison of the artifacts caused by metallic implants in breast MRI using dual-echo dixon versus conventional fat-suppression techniques. (Le Y, Kipfer HD, Majidi SS, Holz S, Lin C) AJR Am J Roentgenol 2014 Sep;203(3):W307-14 18 Citations |
| 4 | Quality of life among a population-based cohort of older patients with breast cancer. (Neuner JM, Zokoe N, McGinley EL, Pezzin LE, Yen TW, Schapira MM, Nattinger AB) Breast 2014 Oct;23(5):609-16 35 Citations |
| 1 | Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast. (Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC) Ann Surg Oncol 2014 Dec;21(13):4152-8 14 Citations |
| 1 | Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer. (Liu S, Meng X, Chen H, Liu W, Miller T, Murph M, Lu Y, Zhang F, Gagea M, Arteaga CL, Mills GB, Meric-Bernstam F, González-Angulo AM) Oncotarget 2014 Oct 15;5(19):9049-64 23 Citations |
| 1 | Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. (Wheler JJ, Moulder SL, Naing A, Janku F, Piha-Paul SA, Falchook GS, Zinner R, Tsimberidou AM, Fu S, Hong DS, Atkins JT, Yelensky R, Stephens PJ, Kurzrock R) Oncotarget 2014 May 30;5(10):3029-38 35 Citations |
| 1 | Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. (Barrdahl M, Canzian F, Joshi AD, Travis RC, Chang-Claude J, Auer PL, Gapstur SM, Gaudet M, Diver WR, Henderson BE, Haiman CA, Schumacher FR, Le Marchand L, Berg CD, Chanock SJ, Hoover RN, Rudolph A, Ziegler RG, Giles GG, Baglietto L, Severi G, Hankinson SE, Lindström S, Willet W, Hunter DJ, Buring JE, Lee IM, Zhang S, Dossus L, Cox DG, Khaw KT, Lund E, Naccarati A, Peeters PH, Quirós JR, Riboli E, Sund M, Trichopoulos D, Prentice RL, Kraft P, Kaaks R, Campa D) Hum Mol Genet 2014 Oct 01;23(19):5260-70 33 Citations |
| 1 | Nodular papillomatosis in a 12-year-old female. (Jorns JM) Breast J 2014;20(4):426-7 |
| 2 | Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. (Nudelman KN, Wang Y, McDonald BC, Conroy SK, Smith DJ, West JD, O'Neill DP, Schneider BP, Saykin AJ) PLoS One 2014;9(5):e96713 44 Citations |
| 1 | Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells. (Opyrchal M, Salisbury JL, Zhang S, McCubrey J, Hawse J, Goetz MP, Lomberk GA, Haddad T, Degnim A, Lange C, Ingle JN, Galanis E, D'Assoro AB) PLoS One 2014;9(5):e96995 28 Citations |
| 1 | Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. (Wheler JJ, Parker BA, Lee JJ, Atkins JT, Janku F, Tsimberidou AM, Zinner R, Subbiah V, Fu S, Schwab R, Moulder S, Valero V, Schwaederle M, Yelensky R, Miller VA, Stephens MP, Meric-Bernstam F, Kurzrock R) Oncotarget 2014 May 15;5(9):2349-54 50 Citations |
| 1 | Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function. (Mouradian M, Kikawa KD, Dranka BP, Komas SM, Kalyanaraman B, Pardini RS) Mol Carcinog 2015 Sep;54(9):810-20 42 Citations |
| 1 | HER2 aberrations in cancer: implications for therapy. (Yan M, Parker BA, Schwab R, Kurzrock R) Cancer Treat Rev 2014 Jul;40(6):770-80 178 Citations |
| 1 | Vertebral sarcoidosis masquerading as breast metastasis. (Braza DW, Nelson PA) Am J Phys Med Rehabil 2014 Mar;93(3):274 5 Citations |
| 1 | SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers. (Schuld NJ, Hauser AD, Gastonguay AJ, Wilson JM, Lorimer EL, Williams CL) Cell Cycle 2014;13(6):941-52 18 Citations |
| 1 | Comorbidity burden and guideline-concordant care for breast cancer. (Kimmick G, Fleming ST, Sabatino SA, Wu XC, Hwang W, Wilson JF, Lund MJ, Cress R, Anderson RT, Centers for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Am Geriatr Soc 2014 Mar;62(3):482-8 33 Citations |
| 1 | Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. (Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW) Oncotarget 2014 Jan 30;5(2):403-16 320 Citations |
| 1 | Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells. (Stuart CH, Horita DA, Thomas MJ, Salsbury FR Jr, Lively MO, Gmeiner WH) Bioconjug Chem 2014 Feb 19;25(2):406-13 22 Citations |
| 1 | Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors. (Wang C, Zimmermann MT, Prodduturi N, Chute CG, Jiang G) AMIA Annu Symp Proc 2014;2014:1160-9 2 Citations |
| 1 | Free nipple grafting: an alternative for patients ineligible for nipple-sparing mastectomy? (Doren EL, Van Eldik Kuykendall L, Lopez JJ, Laronga C, Smith PD) Ann Plast Surg 2014;72(6):S112-5 17 Citations |
| 4 | Surgeon specialization and use of sentinel lymph node biopsy for breast cancer. (Yen TW, Laud PW, Sparapani RA, Nattinger AB) JAMA Surg 2014 Feb;149(2):185-92 28 Citations |
| 1 | Managing breast cancers with low estrogen receptor and HER2 by drugging both. (Miller TW) Clin Cancer Res 2014 Feb 01;20(3):528-30 2 Citations |
| 1 | Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation. (Zhang Y, Dayalan Naidu S, Samarasinghe K, Van Hecke GC, Pheely A, Boronina TN, Cole RN, Benjamin IJ, Cole PA, Ahn YH, Dinkova-Kostova AT) Br J Cancer 2014 Jan 07;110(1):71-82 25 Citations |
| 3 | Astrocytes directly influence tumor cell invasion and metastasis in vivo. (Wang L, Cossette SM, Rarick KR, Gershan J, Dwinell MB, Harder DR, Ramchandran R) PLoS One 2013;8(12):e80933 76 Citations |
| 1 | Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis. (Wu L, de Bruin A, Wang H, Simmons T, Cleghorn W, Goldenberg LE, Sites E, Sandy A, Trimboli A, Fernandez SA, Eng C, Shapiro C, Leone G) Oncogene 2015 Jan 02;34(1):119-28 27 Citations |
| 1 | Protein-tyrosine phosphatase H1 increases breast cancer sensitivity to antiestrogens by dephosphorylating estrogen receptor at Tyr537. (Suresh PS, Ma S, Migliaccio A, Chen G) Mol Cancer Ther 2014 Jan;13(1):230-8 22 Citations |
| 1 | Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer. (Wang B, Zhao B, North P, Kong A, Huang J, Miao QR) PLoS One 2013;8(11):e78083 38 Citations |
| 1 | The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer. (Hauser AD, Bergom C, Schuld NJ, Chen X, Lorimer EL, Huang J, Mackinnon AC, Williams CL) Mol Cancer Res 2014 Jan;12(1):130-42 23 Citations |
| 1 | Sensitizing cancer cells to TRAIL-induced death by micellar delivery of mitoxantrone. (Grandhi TS, Potta T, Taylor DJ, Tian Y, Johnson RH, Meldrum DR, Rege K) Nanomedicine (Lond) 2014;9(12):1775-88 6 Citations |
| 1 | Review of estrogen receptor, progesterone receptor, and HER-2/neu immunohistochemistry impacts on treatment for a small subset of breast cancer patients transferring care to another institution. (Jorns JM, Healy P, Zhao L) Arch Pathol Lab Med 2013 Nov;137(11):1660-3 13 Citations |
| 1 | Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer. (Falchook GS, Moulder SL, Wheler JJ, Jiang Y, Bastida CC, Kurzrock R) Ann Oncol 2013 Dec;24(12):3004-11 26 Citations |
| 1 | Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells. (Kim J, Escalante LE, Dollar BA, Hanson SE, Hematti P) Cancer Invest 2013 Oct;31(8):550-4 22 Citations |
| 1 | Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer. (Wallace JA, Li F, Balakrishnan S, Cantemir-Stone CZ, Pecot T, Martin C, Kladney RD, Sharma SM, Trimboli AJ, Fernandez SA, Yu L, Rosol TJ, Stromberg PC, Lesurf R, Hallett M, Park M, Leone G, Ostrowski MC) PLoS One 2013;8(8):e71533 32 Citations |
| 1 | Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. (Balko JM, Schwarz LJ, Bhola NE, Kurupi R, Owens P, Miller TW, Gómez H, Cook RS, Arteaga CL) Cancer Res 2013 Oct 15;73(20):6346-58 119 Citations |
| 1 | Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer. (Hsu PY, Hsu HK, Lan X, Juan L, Yan PS, Labanowska J, Heerema N, Hsiao TH, Chiu YC, Chen Y, Liu Y, Li L, Li R, Thompson IM, Nephew KP, Sharp ZD, Kirma NB, Jin VX, Huang TH) Cancer Cell 2013 Aug 12;24(2):197-212 44 Citations |
| 3 | Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model. (Dickey JS, Gonzalez Y, Aryal B, Mog S, Nakamura AJ, Redon CE, Baxa U, Rosen E, Cheng G, Zielonka J, Parekh P, Mason KP, Joseph J, Kalyanaraman B, Bonner W, Herman E, Shacter E, Rao VA) PLoS One 2013;8(8):e70575 57 Citations |
| 4 | A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position. (Bergom C, Prior P, Kainz K, Morrow NV, Ahunbay EE, Walker A, Allen Li X, White J) Radiother Oncol 2013 Aug;108(2):215-9 19 Citations |
| 1 | Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. (Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL) Breast Cancer Res 2013;15(4):R55 72 Citations |
| 2 | Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan. (Bischof AG, Yüksel D, Mammoto T, Mammoto A, Krause S, Ingber DE) Integr Biol (Camb) 2013 Aug;5(8):1045-56 33 Citations |
| 4 | Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death. (Cheng G, Zielonka J, McAllister DM, Mackinnon AC Jr, Joseph J, Dwinell MB, Kalyanaraman B) BMC Cancer 2013 Jun 13;13:285 105 Citations |
| 1 | Posterior reversible encephalopathy syndrome: more than meets the eye. (Munoz J, Kumar VA, Hamilton J, Pasche LJ, Langford LA, Taggart MW, Kamiya-Matsuoka C, Tummala S, Moulder S, Kurzrock R) J Clin Oncol 2013 Jul 10;31(20):e360-3 9 Citations |
| 1 | Endocrine resistance: what do we know? (Miller TW) Am Soc Clin Oncol Educ Book 2013 14 Citations |
| 1 | A case of juvenile papillomatosis, aka "Swiss cheese disease". (Patterson SK, Jorns JM) Breast J 2013;19(4):440-1 5 Citations |
| 3 | Diagnosis and treatment of lymphedema after breast cancer: a population-based study. (Sayko O, Pezzin LE, Yen TW, Nattinger AB) PM R 2013 Nov;5(11):915-23 13 Citations |
| 1 | Patient barriers to follow-up care for breast and cervical cancer abnormalities. (Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA) J Womens Health (Larchmt) 2013 Jun;22(6):507-17 65 Citations |
| 1 | Tumors masquerading in patients with thyroid eye disease. (Griepentrog GJ, Burkat CN, Kikkawa DO, Lucarelli MJ) Orbit 2013 Aug;32(4):260-2 2 Citations |
| 1 | Fatty acid metabolites in rapidly proliferating breast cancer. (O'Flaherty JT, Wooten RE, Samuel MP, Thomas MJ, Levine EA, Case LD, Akman SA, Edwards IJ) PLoS One 2013;8(5):e63076 32 Citations |
| 1 | Black women's awareness of breast cancer disparity and perceptions of the causes of disparity. (Kaiser K, Cameron KA, Curry G, Stolley M) J Community Health 2013 Aug;38(4):766-72 10 Citations |
| 1 | Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. (Morris PG, Zhou XK, Milne GL, Goldstein D, Hawks LC, Dang CT, Modi S, Fornier MN, Hudis CA, Dannenberg AJ) Cancer Prev Res (Phila) 2013 May;6(5):428-36 60 Citations |
| 1 | Benign breast disease. (Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM) Surg Clin North Am 2013 Apr;93(2):299-308 58 Citations |
| 1 | Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases. (Nangia-Makker P, Raz T, Tait L, Shekhar MP, Li H, Balan V, Makker H, Fridman R, Maddipati K, Raz A) Cancer Biol Ther 2013 May;14(5):417-27 29 Citations |
| 1 | Hierarchical modularity in ERα transcriptional network is associated with distinct functions and implicates clinical outcomes. (Tang B, Hsu HK, Hsu PY, Bonneville R, Chen SS, Huang TH, Jin VX) Sci Rep 2012;2:875 25 Citations |
| 1 | A hidden Markov model to identify combinatorial epigenetic regulation patterns for estrogen receptor α target genes. (Bonneville R, Jin VX) Bioinformatics 2013 Jan 01;29(1):22-8 8 Citations |
| 1 | Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. (Jorns JM, Visscher D, Sabel M, Breslin T, Healy P, Daignaut S, Myers JL, Wu AJ) Am J Clin Pathol 2012 Nov;138(5):657-69 103 Citations |
| 1 | Differentiating fat necrosis from recurrent malignancy in fat-grafted breasts: an imaging classification system to guide management. (Parikh RP, Doren EL, Mooney B, Sun WV, Laronga C, Smith PD) Plast Reconstr Surg 2012 Oct;130(4):761-772 46 Citations |
| 1 | Alveolar variant of invasive lobular carcinoma in a fibroadenoma. (Butler R, Pinsky R, Jorns JM) Breast J 2012;18(6):613-4 3 Citations |
| 1 | Phosphatidylethanolamine is externalized at the surface of microparticles. (Larson MC, Woodliff JE, Hillery CA, Kearl TJ, Zhao M) Biochim Biophys Acta 2012 Dec;1821(12):1501-7 50 Citations |
| 1 | Biomarkers of response to Akt inhibitor MK-2206 in breast cancer. (Sangai T, Akcakanat A, Chen H, Tarco E, Wu Y, Do KA, Miller TW, Arteaga CL, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F) Clin Cancer Res 2012 Oct 15;18(20):5816-28 128 Citations |
| 1 | Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. (Moroney J, Fu S, Moulder S, Falchook G, Helgason T, Levenback C, Hong D, Naing A, Wheler J, Kurzrock R) Clin Cancer Res 2012 Oct 15;18(20):5796-805 73 Citations |
| 1 | Body composition changes in females treated for breast cancer: a review of the evidence. (Sheean PM, Hoskins K, Stolley M) Breast Cancer Res Treat 2012 Oct;135(3):663-80 76 Citations |
| 1 | Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification. (Balko JM, Mayer IA, Sanders ME, Miller TW, Kuba MG, Meszoely IM, Wagle N, Garraway LA, Arteaga CL) Mol Cancer Ther 2012 Oct;11(10):2301-5 20 Citations |
| 1 | Subject-specific models of susceptibility-induced B0 field variations in breast MRI. (Jordan CD, Daniel BL, Koch KM, Yu H, Conolly S, Hargreaves BA) J Magn Reson Imaging 2013 Jan;37(1):227-32 8 Citations |
| 1 | Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. (Wu F, Zhang J, Wang P, Ye X, Jung K, Bone KM, Pearson JD, Ingham RJ, McMullen TP, Ma Y, Lai R) Cell Signal 2012 Nov;24(11):1989-98 43 Citations |
| 1 | Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. (Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML) Hum Pathol 2012 Dec;43(12):2207-12 35 Citations |
| 1 | Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. (Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, González-Angulo AM, Mills GB, Pinto JA, Gómez HL, Arteaga CL) Nat Med 2012 Jul;18(7):1052-9 211 Citations |
| 1 | Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. (Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F) Cancer 2012 Dec 15;118(24):6287-96 36 Citations |
| 1 | Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. (Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore H, Budd GT, Dietz J, Crowe JP, Macklis R) Int J Radiat Oncol Biol Phys 2012 Aug 01;83(5):e577-81 86 Citations |
| 1 | Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. (Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG, Chi YI, Evers BM, Zhou BP) Oncogene 2013 Mar 14;32(11):1351-62 171 Citations |
| 1 | Blogging through cancer: young women's persistent problems shared online. (Keim-Malpass J, Baernholdt M, Erickson JM, Ropka ME, Schroen AT, Steeves RH) Cancer Nurs 2013;36(2):163-72 57 Citations |
| 1 | Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition. (Diers AR, Broniowska KA, Chang CF, Hogg N) Biochem J 2012 Jun 15;444(3):561-71 101 Citations |
| 2 | Simultaneous irradiation of the breast and regional lymph nodes in prone position using helical tomotherapy. (Kainz K, White J, Chen GP, Hermand J, England M, Li XA) Br J Radiol 2012 Oct;85(1018):e899-905 9 Citations |
| 1 | A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. (Kang JH, Krause S, Tobin H, Mammoto A, Kanapathipillai M, Ingber DE) Lab Chip 2012 Jun 21;12(12):2175-81 250 Citations |
| 3 | Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. (Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr, Joseph J, Kalyanaraman B) Cancer Res 2012 May 15;72(10):2634-44 198 Citations |
| 1 | Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. (Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC) J Am Coll Surg 2012 May;214(5):769-77 116 Citations |
| 1 | PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors. (Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rashid A, Crosby K, Dong M, Phan AT, Wolff RA, Gupta S, Mills GB, Yao J) Clin Cancer Res 2012 Mar 15;18(6):1777-89 186 Citations |
| 2 | p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription. (Qi X, Zhi H, Lepp A, Wang P, Huang J, Basir Z, Chitambar CR, Myers CR, Chen G) J Biol Chem 2012 Apr 27;287(18):14681-91 24 Citations |
| 1 | Initiating breast cancer by PIK3CA mutation. (Miller TW) Breast Cancer Res 2012 Feb 07;14(1):301 17 Citations |
| 1 | Genetic variants at 14q24.1 and breast cancer susceptibility: a fine-mapping study in Chinese women. (Ma H, Li H, Jin G, Dai J, Dong J, Qin Z, Chen J, Wang S, Wang X, Hu Z, Shen H) DNA Cell Biol 2012 Jun;31(6):1114-20 3 Citations |
| 1 | Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. (Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H) Carcinogenesis 2012 Apr;33(4):828-34 188 Citations |
| 1 | Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. (Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H, Shen H) Breast Cancer Res 2012 Jan 23;14(1):R17 61 Citations |
| 1 | PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. (Janku F, Wheler JJ, Westin SN, Moulder SL, Naing A, Tsimberidou AM, Fu S, Falchook GS, Hong DS, Garrido-Laguna I, Luthra R, Lee JJ, Lu KH, Kurzrock R) J Clin Oncol 2012 Mar 10;30(8):777-82 394 Citations |
| 1 | Isotropic 3D nuclear morphometry of normal, fibrocystic and malignant breast epithelial cells reveals new structural alterations. (Nandakumar V, Kelbauskas L, Hernandez KF, Lintecum KM, Senechal P, Bussey KJ, Davies PC, Johnson RH, Meldrum DR) PLoS One 2012;7(1):e29230 53 Citations |
| 1 | Perception of cancer recurrence risk: more information is better. (Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L, Abraham J, Agnese D) Patient Educ Couns 2013 Mar;90(3):361-6 22 Citations |
| 1 | Limitation of in vivo models investigating angiogenesis in breast cancer. (Gehmert S, Gehmert S, Bai X, Klein S, Ortmann O, Prantl L) Clin Hemorheol Microcirc 2011;49(1-4):519-26 11 Citations |
| 4 | Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts. (Bergom C, Kelly T, Morrow N, Wilson JF, Walker A, Xiang Q, Ahn KW, White J) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):821-8 46 Citations |
| 2 | Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. (Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F, Yu L, Fernandez SA, Pécot T, Rosol TJ, Cory S, Hallett M, Park M, Piper MG, Marsh CB, Yee LD, Jimenez RE, Nuovo G, Lawler SE, Chiocca EA, Leone G, Ostrowski MC) Nat Cell Biol 2011 Dec 18;14(2):159-67 244 Citations |
| 1 | Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. (Sabel MS, Jorns JM, Wu A, Myers J, Newman LA, Breslin TM) Am J Surg 2012 Jul;204(1):66-77 22 Citations |
| 1 | S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. (Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK) Cancer Res 2012 Feb 01;72(3):604-15 97 Citations |
| 1 | Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. (Miller TW, Rexer BN, Garrett JT, Arteaga CL) Breast Cancer Res 2011;13(6):224 350 Citations |
| 1 | Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. (Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME) Breast Cancer Res Treat 2012 Jan;131(2):713-21 17 Citations |
| 1 | ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. (Miller TW, Balko JM, Fox EM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, Jiang A, Smith RA, Maira SM, Manning HC, González-Angulo AM, Mills GB, Higham C, Chanthaphaychith S, Kuba MG, Miller WR, Shyr Y, Arteaga CL) Cancer Discov 2011 Sep;1(4):338-51 260 Citations |
| 1 | Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. (Miller TW, Balko JM, Arteaga CL) J Clin Oncol 2011 Nov 20;29(33):4452-61 332 Citations |
| 1 | Non-parametric population analysis of cellular phenotypes. (Singh S, Janoos F, Pécot T, Caserta E, Huang K, Rittscher J, Leone G, Machiraju R) Med Image Comput Comput Assist Interv 2011;14(Pt 2):343-51 9 Citations |
| 1 | Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain. (Budde MD, Gold E, Jordan EK, Smith-Brown M, Frank JA) NMR Biomed 2012 May;25(5):726-36 15 Citations |
| 1 | The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation. (McCormack D, Schneider J, McDonald D, McFadden D) Am J Surg 2011 Nov;202(5):541-4 36 Citations |
| 1 | A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. (Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, Smith RA, Liu S, González-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E, Arteaga CL) Cancer Res 2011 Nov 01;71(21):6773-84 132 Citations |
| 1 | A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies. (Moroney JW, Schlumbrecht MP, Helgason T, Coleman RL, Moulder S, Naing A, Bodurka DC, Janku F, Hong DS, Kurzrock R) Clin Cancer Res 2011 Nov 01;17(21):6840-6 45 Citations |
| 1 | Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons. (Qi X, Hou S, Lepp A, Li R, Basir Z, Lou Z, Chen G) J Biol Chem 2011 Oct 14;286(41):35883-35890 22 Citations |
| 6 | Socioeconomic and racial differences in treatment for breast cancer at a low-volume hospital. (Kong AL, Yen TW, Pezzin LE, Miao H, Sparapani RA, Laud PW, Nattinger AB) Ann Surg Oncol 2011 Oct;18(11):3220-7 23 Citations |
| 4 | Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells. (Cheng G, Lopez M, Zielonka J, Hauser AD, Joseph J, McAllister D, Rowe JJ, Sugg SL, Williams CL, Kalyanaraman B) Cancer Biol Ther 2011 Oct 15;12(8):707-17 26 Citations |
| 1 | Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results. (Howard DH, Kenline C, Lazarus HM, Lemaistre CF, Maziarz RT, McCarthy PL Jr, Parsons SK, Szwajcer D, Douglas Rizzo J, Majhail NS) Health Serv Res 2011 Dec;46(6pt1):1762-77 25 Citations |
| 1 | Identifying nuclear phenotypes using semi-supervised metric learning. (Singh S, Janoos F, Pécot T, Caserta E, Leone G, Rittscher J, Machiraju R) Inf Process Med Imaging 2011;22:398-410 12 Citations |
| 1 | Metastatic neuroendocrine tumor found on screening mammogram. (Amin AL, Kong AL) WMJ 2011 Jun;110(3):140-3; quiz 145 12 Citations |
| 1 | Assessing gynecologic and breast cancer survivors' sexual health care needs. (Hill EK, Sandbo S, Abramsohn E, Makelarski J, Wroblewski K, Wenrich ER, McCoy S, Temkin SM, Yamada SD, Lindau ST) Cancer 2011 Jun 15;117(12):2643-51 146 Citations |
| 2 | Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid. (Singh SK, Baumgart S, Singh G, König AO, Reutlinger K, Hofbauer LC, Barth P, Gress TM, Lomberk G, Urrutia R, Fernandez-Zapico ME, Ellenrieder V) J Biol Chem 2011 Aug 19;286(33):28761-28771 22 Citations |
| 1 | Regulation of glycosyltransferase genes in apoptotic breast cancer cells induced by L: -PPMP and cisplatin. (Ma R, Hopp EA, Decker NM, Loucks A, Johnson JR, Moskal J, Basu M, Banerjee S, Basu S) Adv Exp Med Biol 2011;705:621-42 4 Citations |
| 1 | Interfractional target variations for partial breast irradiation. (Ahunbay EE, Robbins J, Christian R, Godley A, White J, Li XA) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):1594-604 13 Citations |
| 1 | Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach. (Carlson K, Ocean AJ) Clin Breast Cancer 2011 Apr;11(2):73-81 124 Citations |
| 1 | Improvement of survival and prospect of cure in patients with metastatic breast cancer. (Cheng YC, Ueno NT) Breast Cancer 2012 Jul;19(3):191-9 57 Citations |
| 1 | Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population. (Han J, Jiang T, Bai H, Gu H, Dong J, Ma H, Hu Z, Shen H) Breast Cancer Res Treat 2011 Oct;129(3):901-7 17 Citations |
| 1 | Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. (Moulder S, Moroney J, Helgason T, Wheler J, Booser D, Albarracin C, Morrow PK, Koenig K, Kurzrock R) J Clin Oncol 2011 Jul 01;29(19):e572-5 61 Citations |
| 1 | Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. (LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J, WHI Investigators) JAMA 2011 Apr 06;305(13):1305-14 504 Citations |
| 1 | A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. (Miller TW, Balko JM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, González-Angulo AM, Mills GB, Miller WR, Wu H, Shyr Y, Arteaga CL) Clin Cancer Res 2011 Apr 01;17(7):2024-34 80 Citations |
| 1 | Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. (Wallace JA, Li F, Leone G, Ostrowski MC) Cancer Res 2011 Feb 15;71(4):1203-7 38 Citations |
| 1 | Impact of neoadjuvant chemotherapy on breast reconstruction. (Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC) Cancer 2011 Jul 01;117(13):2833-41 42 Citations |
| 1 | Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. (Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, Huang YW, Liyanarachchi S, Deatherage DE, Hsu PY, Taslim C, Ramaswamy B, Shapiro CL, Lin HJ, Cheng AS, Jin VX, Huang TH) Cancer Res 2011 Mar 01;71(5):1752-62 51 Citations |
| 1 | Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data. (Gu F, Hsu HK, Hsu PY, Wu J, Ma Y, Parvin J, Huang TH, Jin VX) BMC Syst Biol 2010 Dec 17;4:170 41 Citations |
| 5 | Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. (Neuner JM, Yen TW, Sparapani RA, Laud PW, Nattinger AB) Osteoporos Int 2011 Nov;22(11):2847-55 31 Citations |
| 1 | Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer. (Hagemann AR, Zighelboim I, Odibo AO, Rader JS, Mutch DG, Powell MA) Breast J 2011;17(1):103-5 8 Citations |
| 1 | Sentinel lymph node dissection is technically feasible in older breast cancer patients. (Valero V 3rd, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA) Clin Breast Cancer 2010 Dec 01;10(6):477-82 4 Citations |
| 2 | PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. (Zhi HY, Hou SW, Li RS, Basir Z, Xiang Q, Szabo A, Chen G) Oncogene 2011 Apr 07;30(14):1706-15 34 Citations |
| 1 | Diagnostic utility of snail in metaplastic breast carcinoma. (Nassar A, Sookhan N, Santisteban M, Bryant SC, Boughey JC, Giorgadze T, Degnim A) Diagn Pathol 2010 Nov 26;5:76 21 Citations |
| 1 | American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. (Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):641-9 38 Citations |
| 1 | Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. (Bardhan R, Chen W, Bartels M, Perez-Torres C, Botero MF, McAninch RW, Contreras A, Schiff R, Pautler RG, Halas NJ, Joshi A) Nano Lett 2010 Dec 08;10(12):4920-8 145 Citations |
| 1 | Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up. (Wynveen CA, Nehhozina T, Akram M, Hassan M, Norton L, Van Zee KJ, Brogi E) Am J Surg Pathol 2011 Jan;35(1):1-14 83 Citations |
| 1 | MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. (Srivastava RK, Kurzrock R, Shankar S) Mol Cancer Ther 2010 Dec;9(12):3254-66 111 Citations |
| 1 | Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. (Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, WHI Investigators) JAMA 2010 Oct 20;304(15):1684-92 457 Citations |
| 1 | Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. (Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, Alaoui-Jamali MA) J Exp Med 2010 Oct 25;207(11):2421-37 133 Citations |
| 1 | Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. (Romieu-Mourez R, François M, Abate A, Boivin MN, Birman E, Bailey D, Bramson JL, Forner K, Young YK, Medin JA, Galipeau J) Cancer Res 2010 Oct 15;70(20):7742-7 16 Citations |
| 1 | Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. (Cheng YC, Valero V, Davis ML, Green MC, Gonzalez-Angulo AM, Theriault RL, Murray JL, Hortobagyi GN, Ueno NT) Br J Cancer 2010 Oct 26;103(9):1331-4 8 Citations |
| 1 | A population-based case-control study of fetal growth, gestational age, and maternal breast cancer. (Nechuta S, Paneth N, Pathak DR, Gardiner J, Copeland G, Velie EM) Am J Epidemiol 2010 Oct 15;172(8):962-70 4 Citations |
| 5 | Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. (Yen TW, Czypinski LK, Sparapani RA, Guo C, Laud PW, Pezzin LE, Nattinger AB) Cancer 2011 Jan 15;117(2):398-405 19 Citations |
| 1 | Tools for consensus analysis of experts' contours for radiotherapy structure definitions. (Allozi R, Li XA, White J, Apte A, Tai A, Michalski JM, Bosch WR, El Naqa I) Radiother Oncol 2010 Dec;97(3):572-8 85 Citations |
| 5 | Heightened attention to medical privacy: challenges for unbiased sample recruitment and a possible solution. (Nattinger AB, Pezzin LE, Sparapani RA, Neuner JM, King TK, Laud PW) Am J Epidemiol 2010 Sep 15;172(6):637-44 28 Citations |
| 1 | Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. (Rudloff U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patil S, Van Zee KJ) J Clin Oncol 2010 Aug 10;28(23):3762-9 274 Citations |
| 1 | Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents. (Konson A, Pradeep S, Seger R) Cancer Res 2010 Aug 01;70(15):6247-57 33 Citations |
| 2 | Carboplatin and docetaxel-induced acute pancreatitis: brief report. (Singh V, Devata S, Cheng YC) Int J Clin Oncol 2010 Dec;15(6):642-4 12 Citations |
| 3 | The relationship of health numeracy to cancer screening. (Schapira MM, Neuner J, Fletcher KE, Gilligan MA, Hayes E, Laud P) J Cancer Educ 2011 Mar;26(1):103-10 15 Citations |
| 1 | Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer. (Miller TW, Hennessy BT, González-Angulo AM, Fox EM, Mills GB, Chen H, Higham C, García-Echeverría C, Shyr Y, Arteaga CL) J Clin Invest 2010 Jul;120(7):2406-13 432 Citations |
| 1 | [Relationship between polymorphisms of X-ray repair cross-complementing group 1 gene Arg194Trp, Arg399Gln and susceptibility of breast cancer]. (Qian Y, Zhang JP, Dong J, Wang FR, Lin YD, Xu M, Wu LL, Shi P, Shen HB) Zhonghua Yu Fang Yi Xue Za Zhi 2010 Mar;44(3):242-6 7 Citations |
| 1 | When to stop screening: a review of breast, gynecologic, and colorectal cancer screening in women over age 65. (Bernstein R, DeJoseph D, Buchanan EM) Care Manag J 2010;11(1):48-57 6 Citations |
| 5 | Elderly breast cancer survivors accurately self-report key treatment information. (Yen TW, Sparapani RA, Guo C, Neuner JM, Laud PW, Nattinger AB) J Am Geriatr Soc 2010 Feb;58(2):410-2 9 Citations |
| 1 | In the clinic. Breast cancer screening and prevention. (Nattinger AB) Ann Intern Med 2010 Apr 06;152(7):ITC41 14 Citations |
| 1 | The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. (Rudloff U, Brogi E, Reiner AS, Goldberg JI, Brockway JP, Wynveen CA, McCormick B, Patil S, Van Zee KJ) Ann Surg 2010 Apr;251(4):583-91 43 Citations |
| 1 | Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. (Nechuta S, Paneth N, Velie EM) Cancer Causes Control 2010 Jul;21(7):967-89 71 Citations |
| 1 | Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. (Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R) Cancer Chemother Pharmacol 2010 Nov;66(6):1087-93 15 Citations |
| 1 | Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience. (Wheler J, Tsimberidou AM, Moulder S, Cristofanilli M, Hong D, Naing A, Pathak R, Liu S, Feng L, Kurzrock R) Clin Breast Cancer 2010 Feb;10(1):46-51 |
| 1 | Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. (Alosi JA, McDonald DE, Schneider JS, Privette AR, McFadden DW) J Surg Res 2010 Jun 15;161(2):195-201 83 Citations |
| 1 | Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 5 Citations |
| 1 | Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells. (Miller TW, Forbes JT, Shah C, Wyatt SK, Manning HC, Olivares MG, Sanchez V, Dugger TC, de Matos Granja N, Narasanna A, Cook RS, Kennedy JP, Lindsley CW, Arteaga CL) Clin Cancer Res 2009 Dec 01;15(23):7266-76 112 Citations |
| 1 | Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. (Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, Ganju RK) Mol Cancer Ther 2009 Nov;8(11):3117-29 193 Citations |
| 2 | The economic consequences of breast cancer adjuvant hormonal treatments. (Pezzin LE, O'Niel MB, Nattinger AB) J Gen Intern Med 2009 Nov;24 Suppl 2(Suppl 2):S446-50 23 Citations |
| 2 | A (99m)Tc-labeled triphenylphosphonium derivative for the early detection of breast tumors. (Li Z, Lopez M, Hardy M, McAllister DM, Kalyanaraman B, Zhao M) Cancer Biother Radiopharm 2009 Oct;24(5):579-87 21 Citations |
| 2 | Pten in stromal fibroblasts suppresses mammary epithelial tumours. (Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G) Nature 2009 Oct 22;461(7267):1084-91 441 Citations |
| 1 | Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts. (Francia G, Man S, Lee CJ, Lee CR, Xu P, Mossoba ME, Emmenegger U, Medin JA, Kerbel RS) Clin Cancer Res 2009 Oct 15;15(20):6358-66 36 Citations |
| 1 | Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. (Li N, Dong J, Hu Z, Shen H, Dai M) Breast Cancer Res Treat 2010 May;121(1):177-84 47 Citations |
| 1 | Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor. (Rabbani ZN, Spasojevic I, Zhang X, Moeller BJ, Haberle S, Vasquez-Vivar J, Dewhirst MW, Vujaskovic Z, Batinic-Haberle I) Free Radic Biol Med 2009 Oct 01;47(7):992-1004 79 Citations |
| 1 | Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. (Shah C, Miller TW, Wyatt SK, McKinley ET, Olivares MG, Sanchez V, Nolting DD, Buck JR, Zhao P, Ansari MS, Baldwin RM, Gore JC, Schiff R, Arteaga CL, Manning HC) Clin Cancer Res 2009 Jul 15;15(14):4712-21 76 Citations |
| 1 | Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. (Le H, Singh S, Shih SJ, Du N, Schnyder S, Loredo GA, Bien C, Michaelis L, Toor A, Diaz MO, Vaughan AT) Genes Chromosomes Cancer 2009 Sep;48(9):806-15 32 Citations |
| 1 | Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. (Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK) Mol Cancer Ther 2009 Jun;8(6):1596-605 52 Citations |
| 1 | A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. (Moulder S, Dhillon N, Ng C, Hong D, Wheler J, Naing A, Tse S, La Paglia A, Dorr R, Hersh E, Boytim M, Kurzrock R) Invest New Drugs 2010 Oct;28(5):634-40 31 Citations |
| 1 | The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. (Pratt MA, Tibbo E, Robertson SJ, Jansson D, Hurst K, Perez-Iratxeta C, Lau R, Niu MY) Oncogene 2009 Jul 30;28(30):2710-22 70 Citations |
| 1 | Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer. (Owen JB, White JR, Zelefsky MJ, Wilson JF) J Am Coll Radiol 2009 Jun;6(6):442-7 15 Citations |
| 1 | Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer. (de Souza JA, Davis ML, Rondon G, Cheng YC, Jones RB, Champlin RE, Ueno NT) Bone Marrow Transplant 2009 Jul;44(2):81-7 9 Citations |
| 1 | Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. (Miller TW, Pérez-Torres M, Narasanna A, Guix M, Stål O, Pérez-Tenorio G, Gonzalez-Angulo AM, Hennessy BT, Mills GB, Kennedy JP, Lindsley CW, Arteaga CL) Cancer Res 2009 May 15;69(10):4192-201 149 Citations |
| 1 | Simulated scatter performance of an inverse-geometry dedicated breast CT system. (Bhagtani R, Schmidt TG) Med Phys 2009 Mar;36(3):788-96 17 Citations |
| 1 | Investigation of helical tomotherapy for partial-breast irradiation of prone-positioned patients. (Kainz K, White J, Herman J, Li XA) Int J Radiat Oncol Biol Phys 2009 May 01;74(1):275-82 19 Citations |
| 1 | Method of breast cancer presentation and depressed mood 1 year after diagnosis in women with locally advanced disease. (Roth EB, Jeffe DB, Margenthaler JA, Aft RL) Ann Surg Oncol 2009 Jun;16(6):1637-41 2 Citations |
| 1 | Methylation not a frequent "second hit" in tumors with germline BRCA mutations. (Dworkin AM, Spearman AD, Tseng SY, Sweet K, Toland AE) Fam Cancer 2009;8(4):339-46 53 Citations |
| 1 | Fluorescence spectroscopy: an adjunct diagnostic tool to image-guided core needle biopsy of the breast. (Zhu C, Burnside ES, Sisney GA, Salkowski LR, Harter JM, Yu B, Ramanujam N) IEEE Trans Biomed Eng 2009 Oct;56(10):2518-28 25 Citations |
| 1 | Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. (Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, Moran JM, Pierce LJ, Rabinovitch R, Taghian A, Vicini F, Woodward W, White JR, Radiation Therapy Oncology Group Multi-Institutional and Multiobserver Study) Int J Radiat Oncol Biol Phys 2009 Mar 01;73(3):944-51 310 Citations |
| 1 | Breast cancer after use of estrogen plus progestin in postmenopausal women. (Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G, WHI Investigators) N Engl J Med 2009 Feb 05;360(6):573-87 404 Citations |
| 4 | A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. (Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB) Ann Surg Oncol 2009 Apr;16(4):979-88 77 Citations |
| 1 | Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. (Rudloff U, Brogi E, Brockway JP, Goldberg JI, Cranor M, Wynveen CA, Nehhozina T, Reiner AS, Patil S, Van Zee KJ) Cancer 2009 Mar 15;115(6):1203-14 19 Citations |
| 1 | A weight loss intervention for African American breast cancer survivors, 2006. (Stolley MR, Sharp LK, Oh A, Schiffer L) Prev Chronic Dis 2009 Jan;6(1):A22 57 Citations |
| 1 | The recognition and surgical management of heritable lesions of the pancreas. (Kim MP, Evans DB, Vu TM, Fleming JB) Surg Oncol Clin N Am 2009 Jan;18(1):99-119, ix 2 Citations |
| 1 | Calcium plus vitamin D supplementation and the risk of breast cancer. (Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, Women's Health Initiative Investigators) J Natl Cancer Inst 2008 Nov 19;100(22):1581-91 369 Citations |
| 1 | Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance. (Spearman AD, Sweet K, Zhou XP, McLennan J, Couch FJ, Toland AE) J Clin Oncol 2008 Nov 20;26(33):5393-400 69 Citations |
| 1 | CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. (Lu C, Dong J, Ma H, Jin G, Hu Z, Peng Y, Guo X, Wang X, Shen H) Breast Cancer Res Treat 2009 Aug;116(3):571-5 29 Citations |
| 1 | Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):34-40 50 Citations |
| 1 | Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. (Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):24-33 121 Citations |
| 2 | Automated computer optimization for 3D treatment planning of breast irradiation. (Chen GP, Ahunbay E, Li XA) Med Phys 2008 Jun;35(6):2253-8 12 Citations |
| 1 | Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. (Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L) Cancer Res 2008 Jul 01;68(13):5226-35 301 Citations |
| 1 | Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. (Mosadegh B, Saadi W, Wang SJ, Jeon NL) Biotechnol Bioeng 2008 Aug 15;100(6):1205-13 62 Citations |
| 1 | Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues. (Graves CW, Philips ST, Bradley SV, Oravecz-Wilson KI, Li L, Gauvin A, Ross TS) Cancer Res 2008 Feb 15;68(4):1064-73 4 Citations |
| 1 | Targeted glycoproteomic identification of biomarkers for human breast carcinoma. (Abbott KL, Aoki K, Lim JM, Porterfield M, Johnson R, O'Regan RM, Wells L, Tiemeyer M, Pierce M) J Proteome Res 2008 Apr;7(4):1470-80 88 Citations |
| 2 | Direct evidence for epithelial-mesenchymal transitions in breast cancer. (Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, Ostrowski MC, Leone G) Cancer Res 2008 Feb 01;68(3):937-45 318 Citations |
| 1 | Predicting cancer on excision of atypical ductal hyperplasia. (Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, Yao K) Am J Surg 2008 Mar;195(3):358-61; discussion 361-2 34 Citations |
| 2 | Allogeneic hematopoietic cell transplantation for metastatic breast cancer. (Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D) Bone Marrow Transplant 2008 Mar;41(6):537-45 42 Citations |
| 2 | Update in women's health 2006-2007. (Zebrack JR, Gonzaga AM, Neuner JM, Nattinger AB) J Gen Intern Med 2008 Jan;23(1):93-9 |
| 4 | Exploring the surgeon volume outcome relationship among women with breast cancer. (Nattinger AB, Laud PW, Sparapani RA, Zhang X, Neuner JM, Gilligan MA) Arch Intern Med 2007 Oct 08;167(18):1958-63 31 Citations |
| 1 | Intra- and interfractional variations for prone breast irradiation: an indication for image-guided radiotherapy. (Morrow NV, Stepaniak C, White J, Wilson JF, Li XA) Int J Radiat Oncol Biol Phys 2007 Nov 01;69(3):910-7 59 Citations |
| 1 | Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. (Wendt MK, Cooper AN, Dwinell MB) Oncogene 2008 Feb 28;27(10):1461-71 104 Citations |
| 2 | p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response. (Qi X, Pohl NM, Loesch M, Hou S, Li R, Qin JZ, Cuenda A, Chen G) J Biol Chem 2007 Oct 26;282(43):31398-408 53 Citations |
| 2 | Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. (Kotamraju S, Williams CL, Kalyanaraman B) Cancer Res 2007 Aug 01;67(15):7386-94 129 Citations |
| 1 | Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. (Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC) J Clin Oncol 2007 Aug 01;25(22):3251-8 45 Citations |
| 1 | Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues. (Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J, Perou CM, Szabo A, Bernard PS) Clin Chem 2007 Jul;53(7):1273-9 61 Citations |
| 1 | Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. (Camacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC, Wallace MJ, Kim EE, Curley SA, Hortobagyi GN, Mavligit G) Cancer 2007 Jun 01;109(11):2190-6 29 Citations |
| 2 | Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation. (Ahunbay EE, Chen GP, Thatcher S, Jursinic PA, White J, Albano K, Li XA) Int J Radiat Oncol Biol Phys 2007 Mar 15;67(4):1248-58 60 Citations |
| 4 | Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. (Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB) Am J Public Health 2007 Mar;97(3):539-44 49 Citations |
| 4 | Surgeon characteristics and variations in treatment for early-stage breast cancer. (Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB) Arch Surg 2007 Jan;142(1):17-22 45 Citations |
| 1 | Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). (Gonzalez RJ, Buzdar AU, Fraser Symmans W, Yen TW, Broglio KR, Lucci A, Esteva FJ, Yin G, Kuerer HM) Breast J 2007;13(1):72-5 23 Citations |
| 1 | Giant apocrine hidradenoma of the breast. (Knoedler D, Susnik B, Gonyo MB, Osipov V) Breast J 2007;13(1):91-3 18 Citations |
| 1 | A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1. (Jin VX, Rabinovich A, Squazzo SL, Green R, Farnham PJ) Genome Res 2006 Dec;16(12):1585-95 58 Citations |
| 2 | The influence of graphic format on breast cancer risk communication. (Schapira MM, Nattinger AB, McAuliffe TL) J Health Commun 2006 Sep;11(6):569-82 84 Citations |
| 1 | Health behaviors and breast cancer: experiences of urban African American women. (Stolley MR, Sharp LK, Wells AM, Simon N, Schiffer L) Health Educ Behav 2006 Oct;33(5):604-24 36 Citations |
| 2 | p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion. (Qi X, Tang J, Loesch M, Pohl N, Alkan S, Chen G) Cancer Res 2006 Aug 01;66(15):7540-7 40 Citations |
| 1 | A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis. (Saadi W, Wang SJ, Lin F, Jeon NL) Biomed Microdevices 2006 Jun;8(2):109-18 175 Citations |
| 1 | The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. (Khakpour N, Zager JS, Yen T, Stephens T, Kuerer HM, Singletary ES, Ross MI, Hunt KK, Babiera GV) Breast J 2006;12(3):212-5 3 Citations |
| 1 | Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. (Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, He X, Palazzo JP, Olopade OI, Szabo A, Perou CM, Bernard PS) Breast Cancer Res 2006;8(2):R23 164 Citations |
| 3 | Effect of model of care delivery on mammography use among elderly breast cancer survivors. (Etim AE, Schellhase KG, Sparapani R, Nattinger AB) Breast Cancer Res Treat 2006 Apr;96(3):293-9 22 Citations |
| 1 | Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts. (du Manoir JM, Francia G, Man S, Mossoba M, Medin JA, Viloria-Petit A, Hicklin DJ, Emmenegger U, Kerbel RS) Clin Cancer Res 2006 Feb 01;12(3 Pt 1):904-16 126 Citations |
| 1 | ErbB receptor signaling and therapeutic resistance to aromatase inhibitors. (Shin I, Miller T, Arteaga CL) Clin Cancer Res 2006 Feb 01;12(3 Pt 2):1008s-1012s 40 Citations |
| 1 | Breast lesions: evaluation with US strain imaging--clinical experience of multiple observers. (Regner DM, Hesley GK, Hangiandreou NJ, Morton MJ, Nordland MR, Meixner DD, Hall TJ, Farrell MA, Mandrekar JN, Harmsen WS, Charboneau JW) Radiology 2006 Feb;238(2):425-37 165 Citations |
| 1 | A fast spin echo two-point Dixon technique and its combination with sensitivity encoding for efficient T2-weighted imaging. (Ma J, Son JB, Bankson JA, Stafford RJ, Choi H, Ragan D) Magn Reson Imaging 2005 Dec;23(10):977-82 38 Citations |
| 1 | Variation in the choice of breast-conserving surgery or mastectomy: patient or physician decision making? (Nattinger AB) J Clin Oncol 2005 Aug 20;23(24):5429-31 17 Citations |
| 1 | Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. (Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM) J Am Coll Surg 2005 Apr;200(4):516-26 258 Citations |
| 1 | Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites. (Wietzke JA, Ward EC, Schneider J, Welsh J) Mol Cell Endocrinol 2005 Jan 31;230(1-2):59-68 22 Citations |
| 1 | Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin. (Edwards IJ, Berquin IM, Sun H, O'flaherty JT, Daniel LW, Thomas MJ, Rudel LL, Wykle RL, Chen YQ) Clin Cancer Res 2004 Dec 15;10(24):8275-83 33 Citations |
| 1 | Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. (Kriska T, Korytowski W, Girotti AW) Arch Biochem Biophys 2005 Jan 15;433(2):435-46 79 Citations |
| 1 | Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. (Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, Nephew KP, Huang TH) Cancer Res 2004 Nov 15;64(22):8184-92 172 Citations |
| 1 | A new key in breast cancer metastasis. (Benovic JL, Marchese A) Cancer Cell 2004 Nov;6(5):429-30 36 Citations |
| 4 | An algorithm for the use of Medicare claims data to identify women with incident breast cancer. (Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL) Health Serv Res 2004 Dec;39(6 Pt 1):1733-49 174 Citations |
| 2 | A combined breast health/weight loss intervention for Black women. (Fitzgibbon ML, Stolley MR, Schiffer L, Sanchez-Johnsen LA, Wells AM, Dyer A) Prev Med 2005 Apr;40(4):373-83 45 Citations |
| 1 | Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. (Wang SJ, Saadi W, Lin F, Minh-Canh Nguyen C, Li Jeon N) Exp Cell Res 2004 Oct 15;300(1):180-9 228 Citations |
| 4 | Decentralization of breast cancer surgery in the United States. (Neuner JM, Gilligan MA, Sparapani R, Laud PW, Haggstrom D, Nattinger AB) Cancer 2004 Sep 15;101(6):1323-9 35 Citations |
| 1 | Statistical modeling for selecting housekeeper genes. (Szabo A, Perou CM, Karaca M, Perreard L, Palais R, Quackenbush JF, Bernard PS) Genome Biol 2004;5(8):R59 162 Citations |
| 3 | Agreement between scales in the measurement of breast cancer risk perceptions. (Schapira MM, Davids SL, McAuliffe TL, Nattinger AB) Risk Anal 2004 Jun;24(3):665-73 69 Citations |
| 1 | Wnt-responsive element controls Lef-1 promoter expression during submucosal gland morphogenesis. (Driskell RR, Liu X, Luo M, Filali M, Zhou W, Abbott D, Cheng N, Moothart C, Sigmund CD, Engelhardt JF) Am J Physiol Lung Cell Mol Physiol 2004 Oct;287(4):L752-63 32 Citations |
| 3 | Predictors of pessimistic breast cancer risk perceptions in a primary care population. (Davids SL, Schapira MM, McAuliffe TL, Nattinger AB) J Gen Intern Med 2004 Apr;19(4):310-5 78 Citations |
| 1 | A multiplex microsphere bead assay for comparative RNA expression analysis using flow cytometry. (Fuja T, Hou S, Bryant P) J Biotechnol 2004 Mar 18;108(3):193-205 24 Citations |
| 1 | Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression. (Zhang X, Kamaraju S, Hakuno F, Kabuta T, Takahashi S, Sachdev D, Yee D) Breast Cancer Res Treat 2004 Jan;83(2):161-70 44 Citations |
| 1 | Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. (Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM) Cancer 2004 Mar 01;100(5):942-9 48 Citations |
| 1 | Addressing multiple breast cancer risk factors in African-American women. (Stolley MR, Fitzgibbon ML, Wells A, Martinovich Z) J Natl Med Assoc 2004 Jan;96(1):76-86 5 Citations |
| 2 | Visual object agnosia and pure word alexia: correlation of functional magnetic resonance imaging and lesion localization. (Salvan CV, Ulmer JL, DeYoe EA, Wascher T, Mathews VP, Lewis JW, Prost RW) J Comput Assist Tomogr 2004;28(1):63-7 22 Citations |
| 1 | A unique collision tumor in breast: invasive ductal carcinoma and mucosa-associated lymphoid tissue lymphoma. (Susnik B, Jordi Rowe J, Redlich PN, Chitambar C, Chang CC, Kampalath B) Arch Pathol Lab Med 2004 Jan;128(1):99-101 29 Citations |
| 2 | Estrogen receptor inhibits c-Jun-dependent stress-induced cell death by binding and modifying c-Jun activity in human breast cancer cells. (Qi X, Borowicz S, Pramanik R, Schultz RM, Han J, Chen G) J Biol Chem 2004 Feb 20;279(8):6769-77 29 Citations |
| 1 | Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. (Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HM) Am J Surg 2003 Oct;186(4):371-7 116 Citations |
| 1 | Effect of nurse case management on the treatment of older women with breast cancer. (Goodwin JS, Satish S, Anderson ET, Nattinger AB, Freeman JL) J Am Geriatr Soc 2003 Sep;51(9):1252-9 116 Citations |
| 1 | IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. (Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS) Bone Marrow Transplant 2003 Jul;32(2):177-86 214 Citations |
| 2 | Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. (Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH) Bone Marrow Transplant 2003 Jul;32(2):151-5 4 Citations |
| 1 | An axillary recurrence of breast cancer following a negative sentinel lymph node biopsy. (Yen TW, Mann GN, Lawton TJ, Livingston RB, Anderson BO) Breast J 2003;9(3):234-6 9 Citations |
| 1 | Measuring the performance of screening mammography in community practice with Medicare claims data. (Freeman JL, Goodwin JS, Zhang D, Nattinger AB, Freeman DH Jr) Women Health 2003;37(2):1-15 16 Citations |
| 2 | Do "elderly fit" patients have less comorbidity? (Firat S, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2003 Apr 01;55(5):1166-8 7 Citations |
| 1 | Quality of care for breast cancer. (Nattinger AB) Med Care 2003 Mar;41(3):341-3 8 Citations |
| 1 | Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis. (Meurer LN, Lená S) J Fam Pract 2002 Dec;51(12):1056-62 32 Citations |
| 1 | Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients. (Anderson GS, Miyagi K, Sampson RW, Sieber F) J Photochem Photobiol B 2002 Nov;68(2-3):101-8 24 Citations |
| 1 | Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate-treated tumor cells overexpressing mitochondrial GPX4. (Kriska T, Korytowski W, Girotti AW) Free Radic Biol Med 2002 Nov 15;33(10):1389-402 54 Citations |
| 1 | Breast cancer: adaptation of fine-needle aspiration to office practice. (Hindle WH, Arias RD, Felix JC, Sueda A) Clin Obstet Gynecol 2002 Sep;45(3):761-6 4 Citations |
| 1 | Phyllodes tumor metastatic to thyroid Hürthle cell adenoma. (Giorgadze T, Ward RM, Baloch ZW, LiVolsi VA) Arch Pathol Lab Med 2002 Oct;126(10):1233-6 25 Citations |
| 1 | Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care. (Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB) J Gerontol A Biol Sci Med Sci 2002 Jun;57(6):M401-6 18 Citations |
| 1 | Survival of women after breast conserving surgery for early stage breast cancer. (Du Xianglin, Freeman JL, Nattinger AB, Goodwin JS) Breast Cancer Res Treat 2002 Mar;72(1):23-31 32 Citations |
| 2 | The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition. (Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J, DeLuca HF, Chen G) J Biol Chem 2002 Jul 19;277(29):25884-92 97 Citations |
| 3 | Does breast tumor location influence success of sentinel lymph node biopsy? (Ahrendt GM, Laud P, Tjoe J, Eastwood D, Walker AP, Otterson MF, Redlich PN) J Am Coll Surg 2002 Mar;194(3):278-84 31 Citations |
| 1 | Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. (Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB) Med Care 2002 Mar;40(3):181-9 87 Citations |
| 1 | High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM) J Clin Oncol 2002 Feb 01;20(3):743-50 58 Citations |
| 1 | Frequency or probability? A qualitative study of risk communication formats used in health care. (Schapira MM, Nattinger AB, McHorney CA) Med Decis Making 2001;21(6):459-67 203 Citations |
| 1 | Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha. (Williams CL, Noti JD) Int J Oncol 2001 Dec;19(6):1227-33 7 Citations |
| 1 | Hyperresistance to cholesterol hydroperoxide-induced peroxidative injury and apoptotic death in a tumor cell line that overexpresses glutathione peroxidase isotype-4. (Hurst R, Korytowski W, Kriska T, Esworthy RS, Chu FF, Girotti AW) Free Radic Biol Med 2001 Nov 01;31(9):1051-65 60 Citations |
| 1 | Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases. (Lazzaro B, Anderson AE, Kajdacsy-Balla A, Hessner MJ) Appl Immunohistochem Mol Morphol 2001 Sep;9(3):234-41 24 Citations |
| 1 | Relationship of distance from a radiotherapy facility and initial breast cancer treatment. (Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA) J Natl Cancer Inst 2001 Sep 05;93(17):1344-6 215 Citations |
| 1 | Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. (Clay CE, Namen AM, Atsumi G, Trimboli AJ, Fonteh AN, High KP, Chilton FH) J Investig Med 2001 Sep;49(5):413-20 63 Citations |
| 1 | Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. (Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F) Oncogene 2001 Mar 22;20(12):1509-18 366 Citations |
| 1 | Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. (Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C, Neumeister P, Finazzi G, Iacobelli M, Bowyer K, Prentice HG, Barbui T) Br J Haematol 2000 Dec;111(4):1122-9 176 Citations |
| 1 | Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. (Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL) J Clin Invest 2001 Jan;107(1):45-52 95 Citations |
| 1 | Is screening mammography effective in elderly women. (Nattinger AB) Am J Med 2000 Aug 01;109(2):172-3 |
| 1 | Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. (Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM) Lancet 2000 Sep 30;356(9236):1148-53 157 Citations |
| 1 | Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. (Lyew MA, Gamblin TC, Ayoub M) Anesthesiology 2000 Oct;93(4):1145-6 51 Citations |
| 1 | Management of women at risk for malignancy. (Basil JB, Rader JS) Curr Opin Oncol 2000 Sep;12(5):508-13 1 Citation |
| 1 | Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. (Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS) Med Care 2000 Jul;38(7):719-27 98 Citations |
| 1 | Care for breast cancer: the adoption of newer clinical paradigms. (Nattinger AB) Med Care 2000 Jul;38(7):693-5 |
| 1 | Lumpectomy margins, reexcision, and local recurrence of breast cancer. (Tartter PI, Kaplan J, Bleiweiss I, Gajdos C, Kong A, Ahmed S, Zapetti D) Am J Surg 2000 Feb;179(2):81-5 170 Citations |
| 2 | Underutilization of mammography in older breast cancer survivors. (Schapira MM, McAuliffe TL, Nattinger AB) Med Care 2000 Mar;38(3):281-9 89 Citations |
| 1 | Older women, mammography, and mortality from breast cancer. (Nattinger AB) Am J Med 2000 Feb;108(2):174-5 12 Citations |
| 1 | Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells. (Trimboli AJ, Waite BM, Atsumi G, Fonteh AN, Namen AM, Clay CE, Kute TE, High KP, Willingham MC, Chilton FH) Cancer Res 1999 Dec 15;59(24):6171-7 29 Citations |
| 1 | Update in women's health. (Charney P, Walsh J, Nattinger AB) Ann Intern Med 1999 Dec 21;131(12):952-8 1 Citation |
| 1 | Breast cancer in Poland syndrome. (Havlik RJ, Sian KU, Wagner JD, Binford R, Broadie TA) Plast Reconstr Surg 1999 Jul;104(1):180-2 28 Citations |
| 1 | Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM) JAMA 1999 Oct 13;282(14):1335-43 66 Citations |
| 1 | Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. (Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, Trimboli AJ, Fonteh AN, Dawson PA, Chilton FH) Carcinogenesis 1999 Oct;20(10):1905-11 171 Citations |
| 1 | Mortality among chemical plant workers exposed to acrylonitrile and other substances. (Marsh GM, Gula MJ, Youk AO, Schall LC) Am J Ind Med 1999 Oct;36(4):423-36 18 Citations |
| 1 | Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K) Bone Marrow Transplant 1999 Aug;24(4):365-8 9 Citations |
| 1 | Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5. (Carey I, Williams CL, Ways DK, Noti JD) Int J Oncol 1999 Jul;15(1):127-36 20 Citations |
| 1 | The effects of preanesthetic oral clonidine on total requirement of propofol for general anesthesia. (Imai Y, Mammoto T, Murakami K, Kita T, Sakai T, Kagawa K, Kirita T, Sugimura M, Kishi Y) J Clin Anesth 1998 Dec;10(8):660-5 29 Citations |
| 1 | Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer. (Rader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, Mutch DG, Herzog TJ) Obstet Gynecol 1998 Oct;92(4 Pt 1):589-95 11 Citations |
| 1 | Update in women's health. (Charney P, Walsh JM, Nattinger AB) Ann Intern Med 1998 Oct 01;129(7):551-8 10 Citations |
| 1 | Parity, age at first birth and the risk of carcinoma in situ of the breast. (Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami HO) Int J Cancer 1998 Jul 29;77(3):330-2 38 Citations |
| 1 | Mammographic screening in women more than 64 years old: a comparison of 1- and 2-year intervals. (Field LR, Wilson TE, Strawderman M, Gabriel H, Helvie MA) AJR Am J Roentgenol 1998 Apr;170(4):961-5 30 Citations |
| 1 | Geographic variations in breast cancer mortality: do higher rates imply elevated incidence or poorer survival? (Goodwin JS, Freeman JL, Freeman D, Nattinger AB) Am J Public Health 1998 Mar;88(3):458-60 31 Citations |
| 1 | Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. (Nattinger AB, Hoffmann RG, Howell-Pelz A, Goodwin JS) JAMA 1998 Mar 11;279(10):762-6 114 Citations |
| 1 | Clinical indications for brachytherapy. (Erickson B, Wilson JF) J Surg Oncol 1997 Jul;65(3):218-27 18 Citations |
| 1 | High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM) J Clin Oncol 1997 May;15(5):1870-9 309 Citations |
| 1 | The multidisciplinary structured clinical instruction module as a vehicle for cancer education. (Sloan DA, Donnelly MB, Schwartz RW, Plymale MA, Strodel WE, Kenady DE, McGrath PC, Edwards MJ, Singletary SE, Evans DB, Souba WW, Bland KI) Am J Surg 1997 Mar;173(3):220-5 11 Citations |
| 1 | The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. (Michalski TA, Nattinger AB) Cancer 1997 Jan 15;79(2):314-9 123 Citations |
| 1 | Microsatellite instability in in situ and invasive sporadic breast cancers of Japanese women. (Toyama T, Iwase H, Iwata H, Hara Y, Omoto Y, Suchi M, Kato T, Nakamura T, Kobayashi S) Cancer Lett 1996 Nov 29;108(2):205-9 21 Citations |
| 1 | Microsatellite instability in sporadic human breast cancers. (Toyama T, Iwase H, Yamashita H, Iwata H, Yamashita T, Ito K, Hara Y, Suchi M, Kato T, Nakamura T, Kobayashi S) Int J Cancer 1996 Nov 15;68(4):447-51 54 Citations |
| 1 | The effect of legislative requirements on the use of breast-conserving surgery. (Nattinger AB, Hoffman RG, Shapiro R, Gottlieb MS, Goodwin JS) N Engl J Med 1996 Oct 03;335(14):1035-40 56 Citations |
| 1 | Maternal risk of breast cancer following multiple births: a nationwide study in Sweden. (Lambe M, Hsieh C, Tsaih S, Ekbom A, Adami HO, Trichopoulos D) Cancer Causes Control 1996 Sep;7(5):533-8 44 Citations |
| 1 | Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. (Kellokumpu-Lehtinen P, Talpaz M, Harris D, Van Q, Kurzrock R, Estrov Z) Int J Cancer 1996 May 16;66(4):515-9 84 Citations |
| 1 | Minimal increase in use of breast-conserving surgery from 1986 to 1990. (Nattinger AB, Gottlieb MS, Hoffman RG, Walker AP, Goodwin JS) Med Care 1996 May;34(5):479-89 79 Citations |
| 1 | Breast cancer in men. (Donegan WL, Redlich PN) Surg Clin North Am 1996 Apr;76(2):343-63 99 Citations |
| 1 | Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. (Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB) J Interferon Cytokine Res 1995 Oct;15(10):905-13 46 Citations |
| 1 | Effect of season and climate on choice of therapy for breast cancer in older women. (Goodwin JS, Nattinger AB) J Am Geriatr Soc 1995 Sep;43(9):962-6 2 Citations |
| 1 | Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. (Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ) Cancer Res 1995 Jul 15;55(14):3140-8 465 Citations |
| 1 | Primary squamous cell carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy. (Dejager D, Redlich PN, Dayer AM, Davis HL, Komorowski RA) J Surg Oncol 1995 Jul;59(3):199-203 66 Citations |
| 1 | Densely calcified breast mass. (Harvey JA, Fondriest JE, Smith MM) Invest Radiol 1994 Apr;29(4):516-8 3 Citations |
| 1 | Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. (Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS) J Clin Oncol 1994 Mar;12(3):475-82 447 Citations |
| 1 | Component processing and intraoperative autotransfusion during bone marrow harvest. (Cook-Craig A, Owen A, Reeder G, Drobyski W, Horowitz M, Brunner J, Flomenberg N, Keever C) Prog Clin Biol Res 1994;389:613-9 1 Citation |
| 1 | Postmenopausal hormone replacement: are two hormones better than one? (Wood H, Wang-Cheng R, Nattinger AB) J Gen Intern Med 1993 Aug;8(8):451-8 1 Citation |
| 1 | Geographic variation in the use of breast-conserving treatment for breast cancer. (Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS) N Engl J Med 1992 Apr 23;326(17):1102-7 510 Citations |
| 1 | Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans. (Whittle J, Steinberg EP, Anderson GF, Herbert R) Med Care 1991 Dec;29(12):1226-36 81 Citations |
| 1 | Orbital metastasis as the presenting sign of adenocarcinoma of the breast. (Glazer LC, Harris GJ, Simons KB) Ophthalmic Plast Reconstr Surg 1991;7(4):252-5 28 Citations |
| 1 | Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients. (Hansen R, Erickson B, Komaki R, Janjan N, Cox J, Wilson JF, Anderson T) Breast Cancer Res Treat 1991;17(3):171-7 1 Citation |
| 1 | Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. (Silverstein RL, Nachman RL, Pannell R, Gurewich V, Harpel PC) J Biol Chem 1990 Jul 05;265(19):11289-94 41 Citations |
| 1 | Improving the utilization of screening mammography in primary care practices. (Nattinger AB, Panzer RJ, Janus J) Arch Intern Med 1989 Sep;149(9):2087-92 50 Citations |
| 1 | Estrogen receptors and the pattern of relapse in breast cancer. (Qazi R, Chuang JL, Drobyski W) Arch Intern Med 1984 Dec;144(12):2365-7 27 Citations |
| 1 | Large scale separation of protease inhibitors from malignant human breast tissue. (Twining SS, Brecher AS) Mol Cell Biochem 1977 Dec 29;18(2-3):101-7 6 Citations |
| 1 | Isolation and identification of alpha1-antitrypsin as a component of normal and malignant human breast and other tissues. (Twining SS, Brecher AS) Proc Soc Exp Biol Med 1975 Oct;150(1):98-103 8 Citations |
